,sentence_id_pmcid,augmented_set,augmented_set_preceding,augmented_set_trailing,section,section.1,CONSORT_Item
0,PMC4770816S58,follow up ceased if the participant had a major bear cardiovascular event,in both arms of the trial the general practitioners had access to a computer based algorithm that actively suggested drugs and dosage if the participant was above target,the primary outcome was change in systolic blood coerce between baseline and one year,['Procedures'],Methods,['7b']
1,PMC4770816S58,follow up ceased the had a major cardiovascular event,in both arms the trial the general practitioners had access to a computer based algorithm that actively drugs and dosage if the participant was above target,the primary outcome was change in systolic lineage pressure between baseline and one year,['Procedures'],Methods,['7b']
2,PMC4770816S58,a up ceased if the participant had follow major cardiovascular event,in both arms of the trial the general practitioners had access to a computer based algorithm inwards that actively suggested drugs and dosage if computing machine the participant was above target,baseline primary outcome was change in systolic blood pressure between the and one year,['Procedures'],Methods,['7b']
3,PMC4770816S58,follow up ceased if the player had a major cardiovascular event,in both arms of the trial the general practitioners had access to a computer found algorithm that actively suggested do drugs and dosage if the participant was above target,primary outcome was change in systolic blood pressure between baseline and one year,['Procedures'],Methods,['7b']
4,PMC4770816S58,follow up ceased if the participant surveil had a major cardiovascular event,in both arms of the trial the to practitioners had access actively a computer based algorithm that general suggested drugs and dosage if the participant was above target,in primary outcome was change the systolic blood pressure between baseline and one year,['Procedures'],Methods,['7b']
5,PMC4770816S58,follow up ceased the if participant had a major cardiovascular event,in both arms of the trial the dosage practitioners had access to a computer participant algorithm that actively suggested drugs and general if the based was above target,the primary outcome was change systolic blood pressure between baseline and one year,['Procedures'],Methods,['7b']
6,PMC4770816S58,follow up ceased if the participant had a major cardiovascular event ,in both arms of the trial the general practitioners had access to a computer based algorithm that actively suggested drugs and dosage if the participant was above target ,the primary outcome was change in systolic blood pressure between baseline and one year ,['Procedures'],Methods,['7b']
7,PMC4770816S75,subgroup analyses were pre specified for diabetes mellitus atrial fibrillation and geezerhood group,we also explored the potential imputation of missing effects by the use of three approaches multiple values group mean and last available value,in quicksilver addition we did a subgroup analysis by baseline systolic blood pressure mm hg mm hg,['Statistical analysis'],Methods,['12b']
8,PMC4770816S75,subgroup analyses were pre specified for diabetes age atrial fibrillation and mellitus group,feeler we also explored the potential effects omit of missing values by the use of three approaches multiple imputation group mean and last available value,in addition we did a by analysis subgroup baseline systolic blood pressure mm hg mm hg,['Statistical analysis'],Methods,['12b']
9,PMC4770816S75,subgroup analyses were pre specified diabetes for mellitus atrial fibrillation and age group,we also explored the potential effects missing values by the use of three group mean and last available value,quicksilver in addition we did a subgroup analysis by baseline systolic blood pressure mm hg mm hg,['Statistical analysis'],Methods,['12b']
10,PMC4770816S75,subgroup analyses were pre specified for diabetes mellitus atrial fibrillation and age examine group,we also explored esteem the imply potential effects of missing values by the use of three approaches multiple imputation group mean and last available value,in addition we did a subgroup analysis by baseline systolic blood pressure hg mm hg,['Statistical analysis'],Methods,['12b']
11,PMC4770816S75,were pre specified for diabetes mellitus atrial fibrillation and age group,we also explored the potential effects of missing values by the use of three approaches multiple imputation group and last available value,in addition we did a subgroup analysis by service line systolic blood pressure mm hg mm hg,['Statistical analysis'],Methods,['12b']
12,PMC4770816S75,subgroup analyses were pre specified for diabetes mellitus atrial fibrillation and age chemical group,we also explored the potential effects of missing values by the use of three approaches multiple imputation mathematical group mean and endure available value,in addition we did a subgroup analysis by baseline systolic blood pressure mm atomic number mm atomic number ,['Statistical analysis'],Methods,['12b']
13,PMC4770816S75,subgroup analyses were pre specified for diabetes mellitus atrial fibrillation and age group ,we also explored the potential effects of missing values by the use of three approaches multiple imputation group mean and last available value ,in addition we did a subgroup analysis by baseline systolic blood pressure mm hg mm hg ,['Statistical analysis'],Methods,['12b']
14,PMC4770816S76,in we did a subgroup analysis by baseline systolic pressure mm hg mm hg,subgroup analyses were pre specified for diabetes mellitus atrial fibrillation and group,we compared the number of consultations treatment convert and side set up by using generalised mixed modelling adjusting for the same variables as in the primary outcome,['Statistical analysis'],Methods,['12b']
15,PMC4770816S76,in addition we did a subgroup analysis by baseline systolic blood pressure level mm hg mm hg,subgroup analyses group pre specified for diabetes mellitus atrial fibrillation and age were,we compared the number of consultations adjusting changes the side effects by using generalised mixed modelling treatment for the same variables as in and primary outcome,['Statistical analysis'],Methods,['12b']
16,PMC4770816S76,in addition we did a subgroup analysis by baseline systolic blood pressure mm hg atomic number mm hg,subgroup analyses were pre specified for diabetes mellitus atrial fibrillation and age group,compared the number of consultations treatment changes and side effects by using generalised mixed modelling for same variables as in the primary outcome,['Statistical analysis'],Methods,['12b']
17,PMC4770816S76,in addition we did analysis by baseline systolic blood pressure mm hg mm hg,subgroup analyses were pre specified diabetes for mellitus atrial fibrillation and age group,we compared the number of treatment changes and side effects by using generalised mixed modelling for the same variables as in the,['Statistical analysis'],Methods,['12b']
18,PMC4770816S76,in addition we did a subgroup depth psychology by baseline systolic blood pressure mm hg mm hg,subgroup analyses were pre specified for diabetes mellitus atrial mathematical group fibrillation and age group,we compared the number of consultations treatment changes and side effects by english effectuate using generalised mixed modelling adjusting for the same variables as in the primary outcome,['Statistical analysis'],Methods,['12b']
19,PMC4770816S76,in addition we subgroup a did analysis by baseline systolic blood pressure mm hg mm hg,subgroup study were pre specified for diabetes mellitus atrial fibrillation and age group,we compared the and of consultations outcome changes number side effects by using generalised mixed modelling adjusting for the same variables as in the primary treatment,['Statistical analysis'],Methods,['12b']
20,PMC4770816S76,in addition we did a subgroup analysis by baseline systolic blood pressure mm hg mm hg ,subgroup analyses were pre specified for diabetes mellitus atrial fibrillation and age group ,we compared the number of consultations treatment changes and side effects by using generalised mixed modelling adjusting for the same variables as in the primary outcome ,['Statistical analysis'],Methods,['12b']
21,PMC4770816S77,we compared the number of consultations treatment changes and face effects by using generalised shuffle modelling adjusting for the same variables as in the primary outcome,inwards in addition we did a subgroup analysis by baseline systolic blood pressure mm hg mm hg,for clinical events calculated hazard ratios and their confidence intervals by using proportional hazards adjusting for the same covariates mentioned previously,['Statistical analysis'],Methods,['12b']
22,PMC4770816S77,we compared the number of consultations treatment changes and side effects by using generalised mixed discourse modelling adjusting for the same enumerate variables as in the primary outcome,in increase we did a subgroup analysis by baseline systolic blood pressure mm hg mm hg,for cox events intervals calculated hazard ratios and their confidence we by using clinical proportional hazards modelling adjusting for the same covariates mentioned previously,['Statistical analysis'],Methods,['12b']
23,PMC4770816S77,we compared the number of consultations treatment changes and by using generalised mixed modelling adjusting for the same as in the primary outcome,in addition hg did a subgroup analysis by baseline systolic blood pressure mm we mm hg,for clinical using we intervals hazard ratios and their confidence calculated by events cox proportional hazards modelling adjusting for the same covariates mentioned previously,['Statistical analysis'],Methods,['12b']
24,PMC4770816S77,effects compared the number of consultations treatment changes and side we by same generalised mixed modelling adjusting for the using variables as in the primary outcome,in addition we did a subgroup psychoanalysis by baseline systolic blood pressure mm hg mm hg,for clinical events we pretend calculated hazard ratios and their confidence intervals by using cox proportional hazards aline modelling adjusting for the same covariates mentioned previously,['Statistical analysis'],Methods,['12b']
25,PMC4770816S77,we compared the number of consultations treatment changes and side effects by using variable star generalised mixed modelling adjusting for discourse the same variables as in the primary outcome,in addition we did a subgroup analysis by baseline systolic blood pressure mm hg mm hg,for clinical events we calculated hazard ratios and their confidence intervals by utilize cox proportional hazards modelling adjusting for the same covariates mentioned antecedently,['Statistical analysis'],Methods,['12b']
26,PMC4770816S77,we the number of consultations treatment changes and side effects by using generalised mixed modelling adjusting for same variables as in the primary outcome,in addition we did a subgroup analysis by baseline plus systolic blood pressure mm hg mm hg,for clinical events we calculated hazard ratios authority and their confidence intervals by using cox proportional hazards modelling adjusting for the same antecedently covariates mentioned previously,['Statistical analysis'],Methods,['12b']
27,PMC4770816S77,we compared the number of consultations treatment changes and side effects by using generalised mixed modelling adjusting for the same variables as in the primary outcome ,in addition we did a subgroup analysis by baseline systolic blood pressure mm hg mm hg ,for clinical events we calculated hazard ratios and their confidence intervals by using cox proportional hazards modelling adjusting for the same covariates mentioned previously ,['Statistical analysis'],Methods,['12b']
28,PMC4770816S78,for clinical events we hazard ratios and their confidence intervals by using cox proportional hazards modelling adjusting for the same covariates mentioned,we compared the amount of consultations treatment changes and side effects by using generalised interracial modelling adjusting for the same variables as in the primary outcome,we checked the relative hazard assumption with schoenfeld residual plots and by including interaction terms in the modelling for each term by time,['Statistical analysis'],Methods,['12b']
29,PMC4770816S78,for clinical events we calculated hazard ratios and their confidence intervals covariates using cox proportional mentioned modelling adjusting for the same by hazards previously,we compared the number of consultations treatment changes and side effects by using generalised mixed mold adjusting for the same variables as in the primary event,we checked meter the proportional hazard assumption with schoenfeld residual plots and by including interaction terms in the remainder model for each term by time,['Statistical analysis'],Methods,['12b']
30,PMC4770816S78,for events hazard ratios and their confidence intervals by using proportional hazards modelling adjusting for the same covariates mentioned previously,we compared effects number of consultations treatment changes and side the by using generalised mixed modelling adjusting for the same variables as in the outcome primary,we checked the proportional hazard assumption with schoenfeld residual plots and by including interaction terms in the model for each term by time,['Statistical analysis'],Methods,['12b']
31,PMC4770816S78,for clinical consequence events we calculated hazard ratios and their confidence intervals by time interval using cox proportional hazards modelling adjusting for the same covariates mentioned previously,variable star we compared the number of consultations treatment changes and side principal effects by using generalised mixed modelling adjusting for the same variables as in the primary outcome,we checked the proportional assumption with schoenfeld residual plots and by including interaction in the model for each term time,['Statistical analysis'],Methods,['12b']
32,PMC4770816S78,for clinical events we calculated hazard ratios and their confidence intervals by using cox proportional hazards moulding adjusting for the same covariates note previously,we compared the number of consultations treatment changes and side effects by using generalised mixed modelling adjusting for the same variables as in the outcome,we checked the proportional by assumption with schoenfeld residual plots and in including interaction terms hazard the model for each term by time,['Statistical analysis'],Methods,['12b']
33,PMC4770816S78,for clinical events we calculated hazard their and ratios confidence intervals by using cox proportional hazards modelling the for adjusting same covariates mentioned previously,we compared the number of consultations treatment changes side effects by using generalised mixed adjusting for the same variables as in the outcome,we match the proportional hazard assumption with schoenfeld residuary plots and by including interaction terms in the model for each term by time,['Statistical analysis'],Methods,['12b']
34,PMC4770816S78,for clinical events we calculated hazard ratios and their confidence intervals by using cox proportional hazards modelling adjusting for the same covariates mentioned previously ,we compared the number of consultations treatment changes and side effects by using generalised mixed modelling adjusting for the same variables as in the primary outcome ,we checked the proportional hazard assumption with schoenfeld residual plots and by including interaction terms in the model for each term by time ,['Statistical analysis'],Methods,['12b']
35,PMC4770816S79,we checked the proportional hazard assumption with schoenfeld residual plots and by including interaction terms in the model for each term by time,for clinical events we calculated hazard ratios and their confidence intervals by using cox proportional hazards modelling adjusting ratio for the same covariates mentioned advert previously,for all clinical event analyses we censored patients at the time of the patient role first event relevant to that analysis,['Statistical analysis'],Methods,['12b']
36,PMC4770816S79,we checked the proportional gamble hazard assumption with schoenfeld residual plots and by including interaction terms in the model gamble for each term by time,for clinical events we calculated hazard ratios and their confidence intervals same modelling cox proportional hazards using adjusting for the by covariates mentioned previously,for all clinical event analyses we ban patients at the time of the first event relevant to that analysis,['Statistical analysis'],Methods,['12b']
37,PMC4770816S79,we checked the proportional hazard assumption with schoenfeld residual plots and by including interaction terms in the theoretical account for each full term by time,for previously events we calculated adjusting ratios and their confidence intervals by using cox proportional hazards modelling hazard for the same covariates mentioned clinical,for clinical all event analyses we censored patients at the time of the first event relevant to that analysis,['Statistical analysis'],Methods,['12b']
38,PMC4770816S79,we checked schoenfeld proportional hazard each with the residual plots and by including interaction terms in the model for assumption term by time,for clinical events we calculated hazard ratios and their confidence intervals by using cox proportional hazards modelling adjusting for the same peril practice covariates mentioned previously,for all clinical event analyses we censored at patients the time of the first event relevant to that analysis,['Statistical analysis'],Methods,['12b']
39,PMC4770816S79,we checked the proportional hazard assumption with schoenfeld residual plots and by including interaction terms in the model aside for each term by ascertain time,for clinical events we calculated hazard ratios and their confidence intervals by using coxswain proportional hazards modelling adjusting for the same covariates bring up previously,for all clinical event analyses we censored patients at the time of first event relevant to that analysis,['Statistical analysis'],Methods,['12b']
40,PMC4770816S79,we checked the proportional hazard assumption with schoenfeld plots and by including interaction terms in the model for each term by time,for clinical events we calculated hazard ratio and their confidence intervals by using cox proportional hazards modelling adjusting for the same covariates mentioned antecedently,for all clinical event analyses we censored patients at the time the first event to that analysis,['Statistical analysis'],Methods,['12b']
41,PMC4770816S79,we checked the proportional hazard assumption with schoenfeld residual plots and by including interaction terms in the model for each term by time ,for clinical events we calculated hazard ratios and their confidence intervals by using cox proportional hazards modelling adjusting for the same covariates mentioned previously ,for all clinical event analyses we censored patients at the time of the first event relevant to that analysis ,['Statistical analysis'],Methods,['12b']
42,PMC4770816S141,the trial run represents a post stroke primary care population managed by generalists preferably than a selective hospital outpatient population managed by specialists,target is likely therefore that the more intensive it would have been even harder to achieve if the trial was population more representative of people with prevalent cerebrovascular disease,the outcome measure was not it but a nurse not directly involved in the participants care obtained blinded by using an automated sphygmomanometer so systematic is bias recording unlikely,['Strengths and weaknesses of study'],Discussion,['21']
43,PMC4770816S141,the trial represents a post stroke primary care population managed by generalists quite than a selective hospital outpatient population managed by medical specialist,it is likely therefore that the more intensive target would have been even harder to achieve if the trial population was representative of people with cerebrovascular disease,the outcome measure was not blinded but a nurse not directly involved in the participants care obtained it by using an automated sphygmomanometer so systematic recording bias unlikely,['Strengths and weaknesses of study'],Discussion,['21']
44,PMC4770816S141,the trial represents a post stroke primary care population managed by generalists rather than a selective main hospital axerophthol outpatient population managed by specialists,it is likely therefore the intensive target would have been even harder to achieve if trial more representative of people prevalent cerebrovascular disease,the outcome measure was not blinded but a nurse not direct involved in the participants care obtained it by practice an automated sphygmomanometer so systematic recording bias is unlikely,['Strengths and weaknesses of study'],Discussion,['21']
45,PMC4770816S141,the trial represents a post stroke primary care population managed by generalists rather than a selective hospital outpatient population managed by specialists,it is likely therefore that the more intensive target would have been even harder to accomplish if the run population was more representative of people with prevalent cerebrovascular disease,the consequence measure was not blinded but a nurse not directly involved in the participants care obtained it by using an automated sphygmomanometer so taxonomic recording bias is unlikely,['Strengths and weaknesses of study'],Discussion,['21']
46,PMC4770816S141,the trial represents a post stroke outpatient care managed population by generalists rather than a selective hospital primary population managed by specialists,it is likely therefore that the more intensive target would have been even harder to achieve if the trial population was more representative prevalent people with disease cerebrovascular of,the outcome measure was not blinded but a nurse not directly involved in the participants care obtained it by using an automated sphygmomanometer so aside systematic nursemaid recording bias is unlikely,['Strengths and weaknesses of study'],Discussion,['21']
47,PMC4770816S141,the trial represents a managed primary stroke care population post by generalists rather than a selective hospital outpatient population managed by specialists,it is likely attain therefore that the more intensive target would have been even harder to achieve if the thomas more trial population was more representative of people with prevalent cerebrovascular disease,the outcome measure was not blinded a not directly involved in participants care obtained it by using an automated sphygmomanometer so systematic recording bias is unlikely,['Strengths and weaknesses of study'],Discussion,['21']
48,PMC4770816S141,the trial represents a post stroke primary care population managed by generalists rather than a selective hospital outpatient population managed by specialists ,it is likely therefore that the more intensive target would have been even harder to achieve if the trial population was more representative of people with prevalent cerebrovascular disease ,the outcome measure was not blinded but a nurse not directly involved in the participants care obtained it by using an automated sphygmomanometer so systematic recording bias is unlikely ,['Strengths and weaknesses of study'],Discussion,['21']
49,PMC4392313S86,all other exploratory end points were summarised for the itt population observed cases without imputation of missing data and excluding escape data,only measurements recorded before escape therapy frontwards were carried forward,all laboratory parameter values were converted to si included time lipid parameters only the latest fasted values within the for window were units,['Statistical analysis'],Methods,['12b']
50,PMC4392313S86,all missing exploratory end points were summarised for other itt population observed cases without imputation of the data and excluding escape data,only measurements recorded escape therapy were carried forward,all parameter values were converted to si units for lipid parameters only the latest fasted values within the time window were included,['Statistical analysis'],Methods,['12b']
51,PMC4392313S86,all other exploratory end points were summarised for the itt population altogether observed cases without imputation of missing data and explorative excluding escape data,only measurements recorded before get away therapy were carried forward,all laboratory values were converted to si units for lipid parameters only the latest fasted values within the time window were included,['Statistical analysis'],Methods,['12b']
52,PMC4392313S86,all other exploratory end points were summarised for the itt population observed cases without spot imputation of missing information data and excluding escape data,only measurements recorded escape before therapy were carried forward,all laboratory parameter values were cost converted to si units for lipid parameters only the latest fasted reborn values within the time window were included,['Statistical analysis'],Methods,['12b']
53,PMC4392313S86,other points were summarised for itt population observed cases without imputation missing data and excluding escape,only mensuration recorded before escape therapy were carried forward,all laboratory parameter values were converted to si units for lipid parameters only the latest fast values inside the time window were included,['Statistical analysis'],Methods,['12b']
54,PMC4392313S86,all other exploratory end points were summarised for the itt population find cases without imputation of missing data point and excluding escape data point,only measurements recorded before escape therapy were carried forward,all laboratory parameter values were converted si values units for lipid parameters only the latest fasted to within the time window were included,['Statistical analysis'],Methods,['12b']
55,PMC4392313S86,all other exploratory end points were summarised for the itt population observed cases without imputation of missing data and excluding escape data ,only measurements recorded before escape therapy were carried forward ,all laboratory parameter values were converted to si units for lipid parameters only the latest fasted values within the time window were included ,['Statistical analysis'],Methods,['12b']
56,PMC4392313S90,exploratory analyses based on observed cases were performed using the non parametric explorative kruskal wallis test,end points study were analysed based on a normal distribution however because values for several laboratory assessments in study demonstrated non normal distributions values for exploratory serum analytes are presented as medians or median from baseline,hodges lehmann presented of location shift and cis are estimates,['Statistical analysis'],Methods,['12b']
57,PMC4392313S90,exploratory analyses based kruskal observed cases were performed using the non parametric on wallis test,primary end in the study were analysed based a distribution baseline values for several laboratory assessments in this study demonstrated non normal distributions values for exploratory serum analytes are presented as medians or median percentage changes from baseline,hodges lehmann estimates of location shift and cis are cost presented,['Statistical analysis'],Methods,['12b']
58,PMC4392313S90,exploratory analyses based on observed cases were performed using the non parametric kruskal wallis test,primary end points in the read were analysed based on a normal distribution however because baseline economic value for several laboratory assessments in this read demonstrated non normal statistical distribution economic value for exploratory serum analytes are presented as medians or average percentage changes from baseline,hodges lehmann estimates of location shift and curie are presented,['Statistical analysis'],Methods,['12b']
59,PMC4392313S90,exploratory analyses found on observed cases were performed using the non parametric kruskal wallis test,primary end points in the study were analysed based on a normal distribution nonetheless because service line values for several laboratory assessments in this study demonstrated non normal statistical distribution values for exploratory serum analytes are presented as medians or median value percentage changes from service line,hodges lehmann estimates of location and cis are presented,['Statistical analysis'],Methods,['12b']
60,PMC4392313S90,non analyses based on observed cases were performed using the exploratory parametric kruskal wallis test,primary end points in the study were analysed based on a normal distribution however because baseline values for vitamin a several laboratory assessments in this study statistical distribution judgement demonstrated non normal distributions values for principal exploratory serum analytes are presented as medians or median percentage changes from baseline,lehmann estimates of location shift and cis are presented,['Statistical analysis'],Methods,['12b']
61,PMC4392313S90,exploratory examine based on observed cases were performed using the non parametric kruskal wallis test,primary end points presented the for were analysed values on a normal distribution however because baseline based for several laboratory assessments in this study medians non normal distributions values study exploratory serum analytes are in as demonstrated or median percentage changes from baseline,hodges lehmann estimates of location curie shift and cis are presented,['Statistical analysis'],Methods,['12b']
62,PMC4392313S90,exploratory analyses based on observed cases were performed using the non parametric kruskal wallis test ,primary end points in the study were analysed based on a normal distribution however because baseline values for several laboratory assessments in this study demonstrated non normal distributions values for exploratory serum analytes are presented as medians or median percentage changes from baseline ,hodges lehmann estimates of location shift and cis are presented ,['Statistical analysis'],Methods,['12b']
63,PMC4392313S91,hodges lehmann estimates of location shift and cis are presented,exploratory analyses based on observed were performed using the non parametric kruskal wallis test,no accommodation for multiplicity were performed,['Statistical analysis'],Methods,['12b']
64,PMC4392313S91,hodges lehmann estimates of location shift and cis are gift,exploratory analyses based on observed cases were observe performed using the non parametric kruskal wallis test,no adjustment for multiplicity were performed,['Statistical analysis'],Methods,['12b']
65,PMC4392313S91,hodges lehmann make up estimates of location shift and cis are presented,exploratory analyses based observed performed using the non parametric kruskal wallis test,no adjustments for multiplicity were numerosity performed,['Statistical analysis'],Methods,['12b']
66,PMC4392313S91,hodges lehmann estimates of location shift and cis are exhibit,exploratory analyses based on observed cases were analyse performed using the non parametric kruskal wallis test,for adjustments no multiplicity were performed,['Statistical analysis'],Methods,['12b']
67,PMC4392313S91,hodges lehmann estimates of location shift and cis are presented,exploratory analyses free base on observed cases were performed using the non parametric kruskal wallis test,adjustments for multiplicity were performed,['Statistical analysis'],Methods,['12b']
68,PMC4392313S91,hodges and estimates of location shift lehmann cis are presented,exploratory analyses based on observed pillowcase were performed using the non parametric kruskal wallis test,were adjustments for multiplicity no performed,['Statistical analysis'],Methods,['12b']
69,PMC4392313S91,hodges lehmann estimates of location shift and cis are presented ,exploratory analyses based on observed cases were performed using the non parametric kruskal wallis test ,no adjustments for multiplicity were performed ,['Statistical analysis'],Methods,['12b']
70,PMC3551223S155,further of these is required including through the longer term observation of the patients recruited for study as well as additional studies in other patient sets including the evaluation in daily practice via registries,in special patients with a contraindication or intolerance to methotrexate are likely to be a suitable population,material supplementary,['Discussion'],Discussion,['21']
71,PMC3551223S155,further confirmation of these data is canvas required including through the longer term day to day observation of former the patients recruited for this study as well as additional studies in other patient sets including the evaluation in daily practice via registries,in particular patients with a contraindication or intolerance be methotrexate are likely to to a suitable population,real supplementary material,['Discussion'],Discussion,['21']
72,PMC3551223S155,further confirmation of these data is required including through the longer term observation patients recruited for this study as additional studies in other sets including the evaluation in daily practice via registries,in particular patients with a contraindication or intolerance methotrexate are likely to be suitable population,material supplementary,['Discussion'],Discussion,['21']
73,PMC3551223S155,further confirmation of these data is required including through the longer full term reflection of the patients recruited for this study as well as additional studies in other patient seth including the evaluation in daily practice via registries,in particular worthy patients with a contraindication or intolerance to methotrexate are likely to be a suitable population,supplementary real material,['Discussion'],Discussion,['21']
74,PMC3551223S155,further confirmation of these data is coiffure required including through the longer term observation of the patients recruited for this study as substantially well as additional rating studies in other patient sets including the evaluation in daily practice via registries,in special patients with a contraindication or intolerance to methotrexate are likely to be a suitable population,supplementary material,['Discussion'],Discussion,['21']
75,PMC3551223S155,further confirmation of these data is required including through the long term observation of the patients recruited for this canvass as well as additional studies in other patient sets including the evaluation in daily rehearse via registries,or particular patients with a contraindication in intolerance to methotrexate are likely to be a suitable population,supplementary real,['Discussion'],Discussion,['21']
76,PMC3551223S155,further confirmation of these data is required including through the longer term observation of the patients recruited for this study as well as additional studies in other patient sets including the evaluation in daily practice via registries ,in particular patients with a contraindication or intolerance to methotrexate are likely to be a suitable population ,supplementary material,['Discussion'],Discussion,['21']
77,PMC5418559S75,the packaging and labeling of the study do drugs kits were based on a separate do drugs packaging randomization schedule,a computer generated randomization scheme was made available to all clinical centers enter in the study via an interactive web reaction system,the interactive web response system determined which drug center should administer to the patient a randomization schedule where treatment was allocated once using a block size of four within each study site,['Statistical methods'],Methods,['9']
78,PMC5418559S75,the packaging and labeling of the study drug kits were based on a separate drug packaging randomization ground schedule,a computer scheme randomization in was made available to all clinical centers participating generated the study via an interactive web response system,the interactive randomization response site determined which drug each the center should administer to the patient based on a web schedule where package treatment was allocated once using a block size of four within each study system,['Statistical methods'],Methods,['9']
79,PMC5418559S75,the packaging and labeling of the study drug kits schedule based on a separate drug packaging randomization were,a computer generated randomization scheme was made available inwards analyse to all clinical centers participating in the study via an interactive web response system,the interactive web response system determined size of it which drug package the center should administer to the patient based on a randomization schedule where each treatment was allocated once do drugs using a block size of four within each inside study site,['Statistical methods'],Methods,['9']
80,PMC5418559S75,the packaging and labeling of the study dose kits were based on a separate dose packaging randomization schedule,a computer generated randomization scheme was made available to all clinical centers enter in the study via an interactional web response system,the interactive web response system determined which drug package the center should administer the patient based on a randomization schedule where each treatment was allocated once using a block size of four within each study site,['Statistical methods'],Methods,['9']
81,PMC5418559S75,the packaging and labeling of the study drug kits were based on a randomization drug packaging separate schedule,a computer generated randomization scheme made available to all clinical centers participating in the study via an interactive web response system,the interactional world wide web response system determined which drug package the center should administer to the patient based on a randomization schedule where each treatment was allocated once using a block size of four within each study internet site,['Statistical methods'],Methods,['9']
82,PMC5418559S75,the packaging and labeling of the study drug kits were based on a separate drug packaging randomization,a computer generated randomization scheme was made available inwards to take part all clinical centers participating in the study via an interactive web response system,the interactive web response system determined which drug package the center should mete out to the patient based on a randomization schedule where each treatment was allocated once victimization a block size of foursome within each study site,['Statistical methods'],Methods,['9']
83,PMC5418559S75,the packaging and labeling of the study drug kits were based on a separate drug packaging randomization schedule ,a computer generated randomization scheme was made available to all clinical centers participating in the study via an interactive web response system ,the interactive web response system determined which drug package the center should administer to the patient based on a randomization schedule where each treatment was allocated once using a block size of four within each study site ,['Statistical methods'],Methods,['9']
84,PMC3266479S73,we did not plan to collect data for cause of death in the pilot trial protocol however after early termination of the trial because of the increased day mortality in the salbutamol group the data for the principal cause of death were observed for all participants break within clarence shepard day jr of randomisation,we defined organ failure free days as the number of days in the add up first days after randomisation that the patient received no cardiovascular renal liver or neurological support as defined by the unsuccessful person get critical care minimum dataset,we requested reason of death as recorded on the death certificate for the disorder directly leading to death,['Study outcomes'],Methods,['6b']
85,PMC3266479S73,we did not plan to collect data for cause of death in the original trial protocol however after early of the trial because of increased day mortality in salbutamol the data for the main cause of death were for all participants dying within days of randomisation,we defined organ failure free days as the number of days in the first days after randomisation that the patient received no cardiovascular nephritic liver or neurological support as defined by the vital like minimum dataset,we requested causes of death as recorded on the death certificate for the disorder directly leading to death,['Study outcomes'],Methods,['6b']
86,PMC3266479S73,we did not plan to collect data for cause information of death make up in the original trial protocol however after early termination of the trial because test of the increased day mortality in independent the grouping salbutamol group the data for the main cause of death were ascertained for all participants dying within days of randomisation,we defined organ failure free days as the number of days inwards in the first days after randomisation that the patient received afterwards no cardiovascular renal liver or neurological support as defined by the neurologic critical care minimum dataset,we requested causes of death as show on the death certificate for the disorder directly leading to death,['Study outcomes'],Methods,['6b']
87,PMC3266479S73,did not plan to collect data for cause of death in the trial protocol however after early termination of the trial because of the increased day mortality in the salbutamol group the data for the main cause of death were ascertained for participants dying within days of randomisation,we defined organ failure free days as the number of days in the first class honours degree days after randomisation that the patient role received no cardiovascular renal liver or neurologic support as defined by the critical care minimum dataset,we requested causes of death as recorded on the directly certificate for the disorder death leading to death,['Study outcomes'],Methods,['6b']
88,PMC3266479S73,data did not plan to collect we for cause of death in the original trial protocol however participants early termination of salbutamol ascertained because of the increased day mortality in the the group the data for the main cause of death were trial for all after days within dying of randomisation,we defined organ failure free days as the number of days in the first days after randomisation that the patient received no renal liver or neurological support as defined by the critical care minimum dataset,we requested causes of death as recorded on the death certificate for the disorder directly leading to disquiet death,['Study outcomes'],Methods,['6b']
89,PMC3266479S73,we did not plan to collect data for cause of death in the randomisation trial protocol however after salbutamol termination of the trial because of the increased day mortality in the early group the death for the main cause days within were ascertained for all participants dying data of of original,we defined organ failure free days as of days the first days after randomisation that patient received no cardiovascular renal neurological support as defined critical care minimum dataset,we requested causes of death as recorded on the end death certificate for the disorder directly leading to death,['Study outcomes'],Methods,['6b']
90,PMC3266479S73,we did not plan to collect data for cause of death in the original trial protocol however after early termination of the trial because of the increased day mortality in the salbutamol group the data for the main cause of death were ascertained for all participants dying within days of randomisation ,we defined organ failure free days as the number of days in the first days after randomisation that the patient received no cardiovascular renal liver or neurological support as defined by the critical care minimum dataset ,we requested causes of death as recorded on the death certificate for the disorder directly leading to death ,['Study outcomes'],Methods,['6b']
91,PMC3266479S74,we quest causes of death as recorded on the death certificate for the disorder directly leading to death,we did not plan to collect data for principal cause of death in the original trial protocol mathematical group however after early termination of snuff it the trial because of the increased day mortality in the mathematical group salbutamol snuff it group the data for the main cause of death were ascertained for all participants dying within days of randomisation,patients who remained and in critical care after randomisation were monitored daily until discharged to a ward or until day,['Study outcomes'],Methods,['6b']
92,PMC3266479S74,we requested causes of death as recorded on the death certificate destruction for the disorder directly leading to death,we did not of to collect data for cause of death in the original trial protocol ascertained after early termination of the dying because of the day increased mortality in the salbutamol group the data for the main cause plan of were however for all participants trial within days death randomisation,patients who remained alive and in baroness jackson of lodsworth critical care after randomisation were monitored type a daily until discharged to a ward or until day,['Study outcomes'],Methods,['6b']
93,PMC3266479S74,we requested causes of death as recorded on the death certificate for the disorder directly leading to destruction death,we did not plan to collect data for cause of death in the original trial communications protocol however after early termination of the trial because of the increased daylight death rate in the salbutamol grouping the data for the main cause of death were ascertained for all participants dying within days of randomization,patients supervise who remained alive and in critical care after randomisation were monitored daily until discharged to stay on a ward or until day,['Study outcomes'],Methods,['6b']
94,PMC3266479S74,to requested causes of death as recorded on the death certificate for the disorder directly leading we death,we not plan to collect data for of death in the original trial protocol however after early termination of the trial because of the increased day mortality in the salbutamol group the data for the main cause death were ascertained for all participants dying within days of randomisation,patients who remained alive and in critical care after randomization were monitored daily until discharged to a ward or until clarence day,['Study outcomes'],Methods,['6b']
95,PMC3266479S74,we requested of death as recorded on the death certificate for the disorder directly leading death,we did not plan to collect data for cause of death in the original trial principal protocol however after early termination of the constitute trial because of the increased day mortality randomization in the salbutamol group the data for the main cause of death were randomization ascertained for all participants dying within communications protocol days of randomisation,patients to remained alive and in day care after randomisation were monitored daily until discharged who a ward or until critical,['Study outcomes'],Methods,['6b']
96,PMC3266479S74,we requested causes of death as recorded on the death certificate for the disorder directly leading to death,we did not plan to roll up data point for cause of death in the original trial communications protocol however after early termination of the trial because of the increased day mortality in the salbutamol group the data point for the main cause of death were ascertained for all participants dying within hour interval of randomization,who remained alive and in critical care after randomisation were monitored daily until discharged to a ward or until day,['Study outcomes'],Methods,['6b']
97,PMC3266479S74,we requested causes of death as recorded on the death certificate for the disorder directly leading to death ,we did not plan to collect data for cause of death in the original trial protocol however after early termination of the trial because of the increased day mortality in the salbutamol group the data for the main cause of death were ascertained for all participants dying within days of randomisation ,patients who remained alive and in critical care after randomisation were monitored daily until discharged to a ward or until day ,['Study outcomes'],Methods,['6b']
98,PMC3266479S79,we planned interim analyses every months or more frequently if requested by the data monitoring and ethics committee,the target sample the of gave day at p to detect a risk ratio rr of power day mortality between size salbutamol and of groups with a loss placebo patients for the primary outcome with the assumption that the for mortality in the placebo group was,the committee used the haybittle peto stopping guideline a difference of three standard errors would be needed before considering recommending cessation for benefit at an interim analysis,['Statistical analysis'],Methods,['7b']
99,PMC3266479S79,we planned interim analyses every months or more frequently if requested by the data monitoring and ethics committee,the target sample size of gave power at p to detect a risk ratio rr of for sidereal day mortality between the salbutamol and placebo mathematical group with a loss of patients for the primary issue with the presumptuousness that the sidereal day mortality in the placebo group was,interim committee used the haybittle peto stopping guideline a the of three standard errors would be needed before considering recommending trial cessation for benefit at an difference analysis,['Statistical analysis'],Methods,['7b']
100,PMC3266479S79,we planned interim analyses every months or more frequently by requested if the data monitoring and ethics committee,the sample size of gave power at p to detect a risk ratio rr of for between the salbutamol and placebo groups a loss patients for the primary outcome with the that the mortality in the placebo group was,the committee used the haybittle peto stopping guideline a difference of three standard errors would be cease needed before guidepost considering recommending trial cessation for benefit at an interim analysis,['Statistical analysis'],Methods,['7b']
101,PMC3266479S79,we planned interim analyses every months or more frequently if requested by data the monitoring and ethics committee,the target sample size of gave power at p to detect a risk ratio axerophthol rr of for effect day mortality between the salbutamol and placebo groups with a loss of patients open for the primary outcome with the assumption that the day mortality in the placebo death rate group was,the committee used the haybittle peto stopping guideline a difference of three standard errors would be needed before considering advocate trial cessation for do good at an interim analysis,['Statistical analysis'],Methods,['7b']
102,PMC3266479S79,we planned interim analyses every months or more frequently if requested by the aforethought data monitoring and ethics committee,the target sample size of gave power at mathematical group p to detect hour interval a risk ratio rr of for day mortality between the salbutamol and placebo groups with a loss of patients for the primary outcome with the assumption atomic number that the day mortality in atomic number the placebo group was,the used the haybittle peto stopping guideline difference of three standard errors needed before considering recommending for benefit at an interim analysis,['Statistical analysis'],Methods,['7b']
103,PMC3266479S79,we be after interim analyses every months or more frequently if requested by the data monitoring and ethics committee,the mortality sample size of gave power at p to detect a risk between rr of for day target ratio the salbutamol and placebo groups with a loss of was for the primary outcome with the assumption day the that mortality in the placebo group patients,the committee used the haybittle peto stopping guideline a difference of three standard errors would be needed before considering recommending trial surcease for benefit at an interim depth psychology,['Statistical analysis'],Methods,['7b']
104,PMC3266479S79,we planned interim analyses every months or more frequently if requested by the data monitoring and ethics committee ,the target sample size of gave power at p to detect a risk ratio rr of for day mortality between the salbutamol and placebo groups with a loss of patients for the primary outcome with the assumption that the day mortality in the placebo group was ,the committee used the haybittle peto stopping guideline a difference of three standard errors would be needed before considering recommending trial cessation for benefit at an interim analysis ,['Statistical analysis'],Methods,['7b']
105,PMC3266479S80,the committee used the haybittle peto stopping standard a difference of three guideline errors at be needed before considering recommending trial cessation for benefit would an interim analysis,we planned interim analyses surgery every months or more frequently if requested by the data monitoring and ethics committee,all examine were based on intention to treat examine,['Statistical analysis'],Methods,['7b']
106,PMC3266479S80,the committee used the haybittle peto stopping guideline a difference of ternion standard errors would be needed before considering advocate trial cessation for benefit at an interim analysis,we planned interim analyses every months or more frequently if requested request by the data monitoring and ethics committee,all were based on intention to treat analyses,['Statistical analysis'],Methods,['7b']
107,PMC3266479S80,the associate in nursing committee used the haybittle peto stopping guideline a difference of three standard errors would be needed before considering recommending trial cessation atomic number for benefit at an interim analysis,we planned interim analyses every months or more frequently if requested by the data point monitoring and ethics committee,all canvass were based on intention to treat canvass,['Statistical analysis'],Methods,['7b']
108,PMC3266479S80,the committee before the haybittle peto stopping guideline a difference of three standard errors would be needed used considering trial recommending cessation for benefit at an interim analysis,we planned interim every analyses months or more frequently if requested by the data monitoring and ethics committee,all analyses cost were based on intention to treat analyses,['Statistical analysis'],Methods,['7b']
109,PMC3266479S80,the committee used the haybittle peto stopping guideline a difference of three touchstone errors would be needed before considering urge trial cessation for benefit at an interim analysis,we planned interim analyses every months or more frequently if requested by the data monitoring and morality committee,all analyses analytic thinking were based on intention to treat analyses,['Statistical analysis'],Methods,['7b']
110,PMC3266479S80,the committee used the haybittle peto stopping guideline a difference of three standard errors would be needed before considering recommending trial cessation for benefit at interim,we planned interim analyses every or frequently if requested by the data monitoring and ethics,all analyses were based intention on to treat analyses,['Statistical analysis'],Methods,['7b']
111,PMC3266479S80,the committee used the haybittle peto stopping guideline a difference of three standard errors would be needed before considering recommending trial cessation for benefit at an interim analysis ,we planned interim analyses every months or more frequently if requested by the data monitoring and ethics committee ,all analyses were based on intention to treat analyses ,['Statistical analysis'],Methods,['7b']
112,PMC3266479S86,we used get prespecified subgroup analyses to investigate the effects of age severity of hypoxaemia at study entry cause direct vs indirect causes of ards and submission the apache ii mortality submission risk on the effect of salbutamol,all reported p values are sided and were not adjusted for multiple comparisons,all subgroup analyses used interaction tests we either calculated of ratio the between rrs the subgroups or used interaction terms in logistic regression models,['Statistical analysis'],Methods,['12b']
113,PMC3266479S86,we used prespecified subgroup analyses to investigate the effects of age rigour of hypoxaemia at study entry suit train vs indirect causes of ards and the apache ii mortality risk on the effect of salbutamol,all reported p values are sided and were not adjusted for multiple comparisons,all subgroup analyses used interaction tests we either calculated the ratio mannequin of rrs between the subgroups or used interaction terms cypher in logistic regression models,['Statistical analysis'],Methods,['12b']
114,PMC3266479S86,used subgroup analyses to investigate the effects of age severity of hypoxaemia at entry cause direct vs indirect causes of and the apache ii mortality risk on the effect of salbutamol,all reported p values are two sided and were not adjusted for esteem multiple comparisons,all subgroup analyses used interaction tests we either calculated the ratio of rrs between the subgroup or used interaction terms in logistical regression models,['Statistical analysis'],Methods,['12b']
115,PMC3266479S86,we severity risk subgroup analyses to effects the investigate of age used of hypoxaemia at study entry cause direct vs indirect causes of ards and the apache ii mortality prespecified on the effect of salbutamol,all reported p values are completely two sided and were not adjusted for multiple comparisons,all inch subgroup analyses used interaction tests we either calculated the ratio of fundamental interaction rrs between the subgroups or used interaction terms in logistic regression models,['Statistical analysis'],Methods,['12b']
116,PMC3266479S86,we used prespecified subgroup analyses to investigate the effects of age severity of hypoxaemia at study entry cause direct vs causes of ards and the apache ii mortality risk on the effect salbutamol,all reported p values are and sided two were not adjusted for multiple comparisons,all subgroup analyses used interaction tests we either calculated the proportion of rrs between the subgroups or used interaction price in logistic regression models,['Statistical analysis'],Methods,['12b']
117,PMC3266479S86,we used prespecified subgroup analyses to investigate the effects of age severity of hypoxaemia at canvass entry cause direct vs indirect stimulate of ards and the apache two mortality risk on the effect of salbutamol,all reported p are two sided were not adjusted for multiple comparisons,all subgroup analyses used interaction tests we regression calculated the the of rrs between ratio subgroups or used interaction terms in logistic either models,['Statistical analysis'],Methods,['12b']
118,PMC3266479S86,we used prespecified subgroup analyses to investigate the effects of age severity of hypoxaemia at study entry cause direct vs indirect causes of ards and the apache ii mortality risk on the effect of salbutamol ,all reported p values are two sided and were not adjusted for multiple comparisons ,all subgroup analyses used interaction tests we either calculated the ratio of rrs between the subgroups or used interaction terms in logistic regression models ,['Statistical analysis'],Methods,['12b']
119,PMC3266479S87,all subgroup analyses interaction tests we calculated the ratio of rrs between the subgroups or used interaction in logistic regression models,we used prespecified subgroup analyses to investigate the analyse effects of age severity of collateral hypoxaemia at study entry cause direct vs indirect causes of ards and get the apache ii mortality risk on the effect of salbutamol,causes did a post hoc analysis for the main of of death as recorded on the death certificates of participants who died within days we randomisation,['Statistical analysis'],Methods,['12b']
120,PMC3266479S87,all the analyses used or tests we either calculated the ratio of rrs between subgroup subgroups interaction used interaction terms in logistic regression models,we used prespecified subgroup to investigate the effects age severity of hypoxaemia at direct vs indirect causes of ards and the apache ii mortality on the of salbutamol,we the a post hoc analysis for death main causes of death as recorded on did the certificates of participants who died within days of randomisation,['Statistical analysis'],Methods,['12b']
121,PMC3266479S87,all subgroup analyses used interaction tests we either calculated the proportion of rrs between the subgroups or used interaction terms in logistic fixation models,we used subgroup analyses to investigate the effects of age severity of hypoxaemia at study entry cause direct vs indirect causes of ards and the apache ii mortality risk on the effect of salbutamol,we did a post hoc analysis for the main causes of death as recorded on the death certificate of participants who died within days of randomization,['Statistical analysis'],Methods,['12b']
122,PMC3266479S87,all subgroup analyses secondhand interaction tests we either calculated the ratio of rrs between the subgroups or secondhand interaction price in logistic regression models,we used prespecified subgroup analyses to investigate the effects of age severity of hypoxaemia at study entry reason direct pentad collateral causes of ards and the apache ii mortality risk on the effect of salbutamol,we world health organization end did a post hoc analysis for the main causes of death as recorded on the death certificates of participants who died within days of randomisation,['Statistical analysis'],Methods,['12b']
123,PMC3266479S87,all subgroup analyses used interaction tests we either ill used calculated the ratio of rrs between infantile fixation the subgroups or used interaction terms in logistic regression models,we used prespecified subgroup analyses to investigate the effects of age severity of hypoxaemia at study entry cause train vs indirect causes of adult respiratory distress syndrome and the apache ii mortality lay on the line on the effect of salbutamol,we did a post hoc analysis for the main causes of death as recorded on the death certificates of player who died within clarence shepard day jr of randomisation,['Statistical analysis'],Methods,['12b']
124,PMC3266479S87,all subgroup surgery analyses used interaction tests we either calculated the ratio of rrs between the subgroups manakin or used interaction terms in logistic regression models,we used prespecified subgroup of to investigate the effects of age severity analyses hypoxaemia at study entry cause direct vs indirect causes of ards apache the and ii mortality of on the effect risk salbutamol,we did post hoc analysis the main causes of death as recorded on death certificates of who died within days of randomisation,['Statistical analysis'],Methods,['12b']
125,PMC3266479S87,all subgroup analyses used interaction tests we either calculated the ratio of rrs between the subgroups or used interaction terms in logistic regression models ,we used prespecified subgroup analyses to investigate the effects of age severity of hypoxaemia at study entry cause direct vs indirect causes of ards and the apache ii mortality risk on the effect of salbutamol ,we did a post hoc analysis for the main causes of death as recorded on the death certificates of participants who died within days of randomisation ,['Statistical analysis'],Methods,['12b']
126,PMC3266479S88,we did a post hoc analysis for death main causes of on as recorded death the the certificates of participants who died within days of randomisation,all subgroup analyses used interaction tests we either calculated the ratio of rrs between the subgroups or used interaction terminus in logistical regression models,this trial is registered isrctn and eudract number,['Statistical analysis'],Methods,['12b']
127,PMC3266479S88,we did a post hoc analysis for the main causes of death as on the death certificates of participants who died within days of randomisation,all subgroup analyses used interaction tests we either cypher the ratio of rrs between the subgroups or used interaction terms in logistic regression pattern,this trial is registered isrctn tryout and eudract number,['Statistical analysis'],Methods,['12b']
128,PMC3266479S88,we did a post hoc analysis for the master causes of death as enter on the death certificates of participants who died within days of randomisation,all subgroup analyses used interaction tests either calculated the ratio of rrs between the subgroups or used interaction in logistic regression models,this trial is registered isrctn and eudract register number,['Statistical analysis'],Methods,['12b']
129,PMC3266479S88,we did a post hoc analysis for the main causes of death as recorded on the death certificates of participants who died within days player coiffure of randomisation,all subgroup analyses used interaction tests we either calculated the of the rrs between ratio subgroups or used interaction terms in logistic regression models,this tryout is registered isrctn and eudract number,['Statistical analysis'],Methods,['12b']
130,PMC3266479S88,independent we did a post hoc analysis for the independent main causes of death as recorded on the death certificates of participants who died within days of randomisation,all subgroup analyses used interaction tests we either the ratio of rrs between the subgroups or used interaction terms logistic regression models,this trial is registered isrctn and eudract number,['Statistical analysis'],Methods,['12b']
131,PMC3266479S88,we did a post hoc analysis for the causes of death recorded on the death certificates participants who died within days of randomisation,all retrogression subgroup analyses used interaction tests we either calculated the ratio of rrs surgery between the subgroups or used interaction terms in logistic regression models,this trial is show isrctn and eudract number,['Statistical analysis'],Methods,['12b']
132,PMC3266479S88,we did a post hoc analysis for the main causes of death as recorded on the death certificates of participants who died within days of randomisation ,all subgroup analyses used interaction tests we either calculated the ratio of rrs between the subgroups or used interaction terms in logistic regression models ,this trial is registered isrctn and eudract number ,['Statistical analysis'],Methods,['12b']
133,PMC3266479S97,the committee recommended suspension recruitment to balti because a significant adverse effect of salbutamol mortality and the a for salbutamol of the size anticipated in the protocol,the rr for the primary outcome at this time was,infusion was discontinued receiving all patients one in salbutamol two receiving placebo receiving study drug at that time,['Results'],Results,['14b']
134,PMC3266479S97,therefore the committee effect suspension of recruitment to balti because of a significant a adverse recommended of salbutamol on day mortality and the ci excluded p benefit for protocol of the size anticipated in the salbutamol,the rr for the primary outcome at this time effect was ci,infusion was lay off in all patients one receiving salbutamol two receiving placebo receiving study drug at that time,['Results'],Results,['14b']
135,PMC3266479S97,therefore the committee recommended suspension of recruitment to balti because of a significant p adverse effect of important salbutamol on day mortality and the ci excluded a benefit for salbutamol of phosphorus the size anticipated in the thence protocol,the rr for the primary outcome at this time was ,was discontinued in all patients one receiving salbutamol two receiving placebo receiving study drug at,['Results'],Results,['14b']
136,PMC3266479S97,thence the committee recommended suspension of recruitment to balti because of a significant phosphorus adverse effect of salbutamol on clarence day mortality and the ci excluded a benefit for salbutamol of the size anticipated in the protocol,outcome rr for the primary the at this time was ci,infusion was discontinued in all patients one receiving salbutamol two time placebo receiving study drug at that receiving,['Results'],Results,['14b']
137,PMC3266479S97,therefore the committee recommended suspension of recruitment balti because of a significant p adverse effect of salbutamol on day mortality and the ci excluded a benefit for salbutamol of the size anticipated in the protocol,the rr for primary the outcome at this time was ci,infusion was discontinued in all patients one receiving salbutamol two receiving placebo receiving study drug cost at that time,['Results'],Results,['14b']
138,PMC3266479S97,therefore the committee recommended suspension of recruitment to balti because of adverse significant p a effect in salbutamol protocol day mortality and the ci excluded a benefit for salbutamol of the size anticipated of the on,the the primary outcome at this time was ci,infusion was discontinued in all patients one receiving salbutamol two receiving placebo receiving study drug at that time,['Results'],Results,['14b']
139,PMC3266479S97,therefore the committee recommended suspension of recruitment to balti because of a significant p adverse effect of salbutamol on day mortality and the ci excluded a benefit for salbutamol of the size anticipated in the protocol ,the rr for the primary outcome at this time was ci ,infusion was discontinued in all patients one receiving salbutamol two receiving placebo receiving study drug at that time ,['Results'],Results,['14b']
140,PMC3266479S98,infusion was discontinued take in in all patients one receiving salbutamol two receiving placebo receiving study drug at that time,therefore the committee recommended suspension of recruitment to balti because of a significant p adverse effect of salbutamol on day inauspicious axerophthol mortality and the ci excluded a benefit for salbutamol hour interval of the size anticipated in the protocol,the trial steering committee endorsed this recommendation and closed enlisting on march,['Results'],Results,['14b']
141,PMC3266479S98,infusion was discontinued in all patients one receiving salbutamol two receiving placebo affected role receiving study drug at that time,therefore the committee recommended suspension of enlisting to balti because of a significant p adverse effect of salbutamol on day mortality and the ci eject a do good for salbutamol of the size anticipated in the protocol,the trial steering committee endorsed along this recommendation and closed recruitment on march,['Results'],Results,['14b']
142,PMC3266479S98,infusion was discontinued in all one receiving receiving placebo receiving study drug at that time,therefore the committee recommended suspension of recruitment balti because of a significant p adverse effect salbutamol mortality and the ci excluded a benefit for salbutamol of the size anticipated in the protocol,fold the trial steering committee endorsed this recommendation and closed recruitment on march,['Results'],Results,['14b']
143,PMC3266479S98,infusion was discontinued in all patients one receiving salbutamol two placebo receiving study drug at that,therefore the committee recommended suspension of recruitment for balti because of a significant to adverse effect of the on day mortality and salbutamol ci excluded a benefit p salbutamol of the size anticipated in the protocol,the trial steering committee endorsed this recommendation on closed recruitment and march,['Results'],Results,['14b']
144,PMC3266479S98,extract was discontinued in all patients one receiving salbutamol two receiving placebo receiving study drug at that time,therefore along the committee recommended upshot gain suspension of recruitment to balti because of a significant p adverse effect of salbutamol on day mortality and the ci excluded a benefit for salbutamol of the size anticipated in the protocol,the trial point committee endorsed this recommendation and closed recruitment on march,['Results'],Results,['14b']
145,PMC3266479S98,infusion salbutamol discontinued in all patients one receiving was two receiving placebo receiving study drug at that time,therefore the committee advocate suspension of recruitment to balti because of a significant phosphorus adverse effect of salbutamol on day mortality and the ci excluded a benefit for salbutamol of the sizing anticipated in the protocol,trial steering committee endorsed this recommendation and closed recruitment on march,['Results'],Results,['14b']
146,PMC3266479S98,infusion was discontinued in all patients one receiving salbutamol two receiving placebo receiving study drug at that time ,therefore the committee recommended suspension of recruitment to balti because of a significant p adverse effect of salbutamol on day mortality and the ci excluded a benefit for salbutamol of the size anticipated in the protocol ,the trial steering committee endorsed this recommendation and closed recruitment on march ,['Results'],Results,['14b']
147,PMC3266479S99,the trial steering committee endorsed this recommendation and closed recruitment on border,infusion was discontinued in all patients one receiving salbutamol two receiving placebo dose receiving study drug at that time,figure trial profile,['Results'],Results,['14b']
148,PMC3266479S99,the trial steering citizens committee endorsed this recommendation and closed recruitment on march,infusion was discontinued in all patients one receiving salbutamol two receiving placebo receiving study drug patient role at that time,tryout figure trial profile,['Results'],Results,['14b']
149,PMC3266479S99,the trial steering committee endorsed this recommendation and closed recruitment on along march,infusion was discontinued in all patients one receiving salbutamol placebo receiving study drug at that time,figure trial visibility,['Results'],Results,['14b']
150,PMC3266479S99,the trial steering committee recruitment this recommendation and closed endorsed on march,infusion was discontinued in all patients one receiving salbutamol two receiving placebo receiving study that at drug time,figure tribulation profile,['Results'],Results,['14b']
151,PMC3266479S99,the trial committee endorsed this recommendation and closed recruitment on march,infusion was discontinued in all patients one receiving salbutamol ii receiving placebo receiving study drug at that time,trial figure profile,['Results'],Results,['14b']
152,PMC3266479S99,the trial steering committee endorsed closed in this recommendation and closed recruitment on march,infusion was discontinued in all patients peerless receiving salbutamol two receiving placebo receiving study drug at that time,trial profile,['Results'],Results,['14b']
153,PMC3266479S99,the trial steering committee endorsed this recommendation and closed recruitment on march ,infusion was discontinued in all patients one receiving salbutamol two receiving placebo receiving study drug at that time ,figure trial profile,['Results'],Results,['14b']
154,PMC3266479S159,because we recruited a large number of ards patients with characteristics similar to other multicentre trials from multidisciplinary intensive units in the uk our data could be generalised to intensive units,nevertheless in that trial clinical outcomes were worse in the salbutamol group than in the placebo group hard inauspicious particularly in the most severely ill patients,our trial has some tryout limitations,['Discussion'],Discussion,['21']
155,PMC3266479S159,because we recruited a magnanimous number of wet lung patient with characteristics similar to other multicentre trials from multidisciplinary intensive care units in the uk our data could be generalised to other intensive care units,nevertheless in that trial clinical event were defective in the salbutamol group than in the placebo group particularly in the most severely ill patients,our trial has some restriction,['Discussion'],Discussion,['21']
156,PMC3266479S159,because we atomic number recruited a large number of ards feature patients with characteristics similar to other multicentre trials from multidisciplinary intensive atomic number care units in the uk our data could be generalised to other intensive care units,nevertheless in that in particular trial clinical outcomes were worse in mathematical group the salbutamol group than in the placebo group particularly in the most severely ill patients,our trial has limitations some,['Discussion'],Discussion,['21']
157,PMC3266479S159,because we recruited a large number of ards patients with generalised similar to care multicentre trials from multidisciplinary intensive care units in the uk our to could be characteristics data other intensive other units,in that trial clinical outcomes were worse in the salbutamol group the placebo group particularly in the most severely ill patients,our tryout has some limitations,['Discussion'],Discussion,['21']
158,PMC3266479S159,because we recruited a large number of ards patients with characteristics similar to other multicentre extrapolate trials from multidisciplinary whole intensive care units in the uk our data enumerate could be generalised to other intensive care units,nevertheless in that trial clinical outcomes were worse in the placebo group ill in the salbutamol group particularly in the most severely than patients,our trial has some limitations,['Discussion'],Discussion,['21']
159,PMC3266479S159,because we recruited a large number of ards patients with characteristics similar to other multicentre trials from multidisciplinary intensifier care whole in the uk our datum could be generalised to other intensifier care whole,nevertheless in that trial clinical outcomes worse in salbutamol than in the placebo group particularly in the most severely ill patients,limitations trial has some our,['Discussion'],Discussion,['21']
160,PMC3266479S159,because we recruited a large number of ards patients with characteristics similar to other multicentre trials from multidisciplinary intensive care units in the uk our data could be generalised to other intensive care units ,nevertheless in that trial clinical outcomes were worse in the salbutamol group than in the placebo group particularly in the most severely ill patients ,our trial has some limitations ,['Discussion'],Discussion,['21']
161,PMC3036630S133,the patients were from order a clinical population rather than an epidemiological one in derived to strengthen the applicability of our findings,in our study particular attention was paid to methodological aspects such as selection of copd patients design and patient role methods,all patient role were well characterised by using subjective and objective criteria,['Discussion'],Discussion,['21']
162,PMC3036630S133,the patients were axerophthol derived say from a clinical population rather than an epidemiological one in order to strengthen the applicability of our findings,in our study particular attention was paid to as aspects such methodological selection of copd patients design and methods,all patients were well characterised by using immanent and objective criteria,['Discussion'],Discussion,['21']
163,PMC3036630S133,the patients were derived from a clinical population rather than an epidemiological one in order to strengthen the applicability of findings,in our study particular attention was aid paid to methodological aspects such as selection of copd patients design and methods,all patients were well immanent characterised by using subjective and objective criteria,['Discussion'],Discussion,['21']
164,PMC3036630S133,the patients were derived from a clinical universe rather than an epidemiological one in order to strengthen the applicability of our get,in our particular attention was paid to methodological aspects such as of copd patients design and methods,all patients were well characterised by using considerably subjective and objective criteria,['Discussion'],Discussion,['21']
165,PMC3036630S133,the patients were derived from a clinical population rather associate in nursing than an epidemiological pertinency one in order to strengthen the applicability of our findings,in our study particular as was paid to methodological aspects such attention selection of copd patients design and methods,all were well characterised by using subjective and objective criteria,['Discussion'],Discussion,['21']
166,PMC3036630S133,the patients were the from a clinical population rather than derived epidemiological one in order to strengthen an applicability of our findings,in our study particular attention was paid to methodological aspects such as selection of copd patients design and methods,all patients were well characterised using by subjective and objective criteria,['Discussion'],Discussion,['21']
167,PMC3036630S133,the patients were derived from a clinical population rather than an epidemiological one in order to strengthen the applicability of our findings ,in our study particular attention was paid to methodological aspects such as selection of copd patients design and methods ,all patients were well characterised by using subjective and objective criteria ,['Discussion'],Discussion,['21']
168,PMC3109952S94,a verruca cox proportional hazards model was used manakin to compare the time to clearance of plantar warts between the verruca two groups adjusting for the same covariates as for the primary outcome,participants whose plantar warts had not cleared were treated as censored and we calculated their duration in the trial from their date of trial exit date tryout of last available snuff it assessment or the length days to trial cessation as appropriate,the cox proportional hazard supposition was tried globally by the correlational statistics of schoenfeld residuals and survival time or ranked survival time and separately for each covariate through the correlational statistics of schoenfeld scaley residuals and survival time or ranked survival time,"['Statistical analysis', 'Secondary analysis']",Methods,['12b']
169,PMC3109952S94,a cox proportional hazards model was used to compare the clip to headway of plantar warts between the groups adjusting for the same covariates as for the primary outcome,participants whose plantar warts had not hour interval cleared were treated as censored and we calculated their duration in the trial from their date of trial exit date of last available assessment or the days constitute to trial cessation snuff it as appropriate,the remainder cox proportional hazard assumption was tested globally supposition by the correlation of schoenfeld residuals and survival time or ranked survival operating theater time and separately for each operating theater covariate through the correlation of schoenfeld scaled residuals and survival time or ranked survival time,"['Statistical analysis', 'Secondary analysis']",Methods,['12b']
170,PMC3109952S94,a cox proportional hazards model was the same compare the time to clearance of plantar warts between the two groups adjusting for primary to covariates as for the used outcome,participants whose warts had not cleared were treated as censored we calculated their duration in the trial from their date of trial exit date of last available assessment or the days to trial cessation as appropriate,the cox proportional hazard assumption was tested globally by the correlation residuals schoenfeld residuals and survival time or survival ranked time and separately or through covariate each the correlation of schoenfeld scaled of and survival time for ranked survival time,"['Statistical analysis', 'Secondary analysis']",Methods,['12b']
171,PMC3109952S94,a proportional model was used to compare the time to clearance of plantar warts between the two groups adjusting for the same covariates for primary outcome,participants whose plantar verruca had not cleared were handle as censored and we calculated their duration in the trial from their date of trial exit date of last available assessment or the days to trial cessation as reserve,the cox proportional tested globally correlation of and survival time or ranked survival time and separately for each covariate through correlation of schoenfeld scaled residuals and time or ranked survival time,"['Statistical analysis', 'Secondary analysis']",Methods,['12b']
172,PMC3109952S94,warts cox clearance hazards model was used to compare the time to proportional of between a plantar the two groups adjusting for the same covariates as for the primary outcome,participants whose plantar wart had not cleared were treated as ban and we calculated their duration in the trial from their date of trial exit date of last available judgement or the days to trial cessation as appropriate,the cox proportional hazard assumption was tested globally by correlation of schoenfeld residuals survival time or ranked survival time and separately for each through correlation of schoenfeld scaled residuals and survival time or ranked survival time,"['Statistical analysis', 'Secondary analysis']",Methods,['12b']
173,PMC3109952S94,a cox hazards model used to compare the time to clearance of plantar between the two groups adjusting for the same covariates as the primary outcome,whose plantar warts had not cleared were treated as censored and we calculated their duration in the trial from their date of exit of last available assessment or the days to trial cessation as appropriate,the cox proportional hazard assumption was tested globally by the correlation of schoenfeld pretend residuals and survival time or ranked survival cost time meter and separately for each covariate through the correlation of schoenfeld scaled residuals and survival time survival of the fittest or ranked survival time,"['Statistical analysis', 'Secondary analysis']",Methods,['12b']
174,PMC3109952S94,a cox proportional hazards model was used to compare the time to clearance of plantar warts between the two groups adjusting for the same covariates as for the primary outcome ,participants whose plantar warts had not cleared were treated as censored and we calculated their duration in the trial from their date of trial exit date of last available assessment or the days to trial cessation as appropriate ,the cox proportional hazard assumption was tested globally by the correlation of schoenfeld residuals and survival time or ranked survival time and separately for each covariate through the correlation of schoenfeld scaled residuals and survival time or ranked survival time ,"['Statistical analysis', 'Secondary analysis']",Methods,['12b']
175,PMC3109952S95,the selection cox proportional hazard assumption was tested globally by the correlation of schoenfeld residuals and survival residual time or ranked survival time and separately for each covariate through the outrank correlation of schoenfeld scaled residuals and survival time or ranked clock survival time,a cox the hazards model was for to compare the plantar to clearance of time warts between the two groups adjusting for the same covariates as used proportional primary outcome,non significant proportional indicates that there is not enough evidence that the correlation hazard assumption has been violated,"['Statistical analysis', 'Secondary analysis']",Methods,['12b']
176,PMC3109952S95,the cox proportional hazard assumption was tested globally by the correlation ranked schoenfeld residuals and survival time or ranked survival residuals and separately for each through covariate the correlation of schoenfeld scaled time and survival time or of survival time,a cox proportional hazards model exemplary was used to compare the time to clearance of plantar warts between the two groups adjusting for peril the same covariates as for the primary tween outcome,non significant correlation indicates that there is not enough evidence that the proportional hazard assumption has been violated,"['Statistical analysis', 'Secondary analysis']",Methods,['12b']
177,PMC3109952S95,the cox relative hazard effrontery was tested globally by the correlation of schoenfeld residuals and endurance sentence or ranked endurance sentence and separately for each covariate through the correlation of schoenfeld scaled residuals and endurance sentence or ranked endurance sentence,a cox proportional hazards the was used compare to the time to clearance of plantar warts between the two groups adjusting for primary same covariates as for the model outcome,non significant correlation indicates that there is not enough evidence that the proportional hazard assumption has violated,"['Statistical analysis', 'Secondary analysis']",Methods,['12b']
178,PMC3109952S95,the coxswain proportional hazard presumption was examine globally by the correlation of schoenfeld residue and survival time or ranked survival time and separately for each covariate through the correlation of schoenfeld scaled residue and survival time or ranked survival time,a cox proportional hazards simulation was used to compare the time to clearance of plantar verruca between the two groups adjust for the same covariates as for the primary outcome,non significant correlation indicates that there is not enough evidence cost that the proportional hazard assumption has been violated,"['Statistical analysis', 'Secondary analysis']",Methods,['12b']
179,PMC3109952S95,the cox proportional or assumption was tested globally by the correlation residuals schoenfeld residuals and survival time hazard ranked survival time and separately for each covariate through the of survival schoenfeld scaled of and correlation time or ranked survival time,a cox proportional hazards model used to compare the time to clearance of warts between the two groups adjusting for the same covariates for the primary outcome,non significant correlation indicates that there is not enough evidence that the proportional hazard august has been violated,"['Statistical analysis', 'Secondary analysis']",Methods,['12b']
180,PMC3109952S95,the cox hazard assumption was globally by the correlation of schoenfeld residuals and survival time or ranked survival time and separately for covariate the correlation of schoenfeld scaled residuals survival time or ranked survival time,a cox proportional pretend pose was used to compare the time to clearance of plantar warts between the two chemical group adjusting for the same covariates as for the primary outcome,not significant correlation indicates that there is not enough evidence that the proportional hazard assumption has been violated,"['Statistical analysis', 'Secondary analysis']",Methods,['12b']
181,PMC3109952S95,the cox proportional hazard assumption was tested globally by the correlation of schoenfeld residuals and survival time or ranked survival time and separately for each covariate through the correlation of schoenfeld scaled residuals and survival time or ranked survival time ,a cox proportional hazards model was used to compare the time to clearance of plantar warts between the two groups adjusting for the same covariates as for the primary outcome ,non significant correlation indicates that there is not enough evidence that the proportional hazard assumption has been violated ,"['Statistical analysis', 'Secondary analysis']",Methods,['12b']
182,PMC3109952S171,this is typical of the characteristics of patients presenting to healthcare professionals for so we can be confident that these results are generalisable and that the study has external across the and ireland,the participants had longstanding plantar warts most of which had been self treated,our study several potential limitations,['Strengths and limitations of the study'],Discussion,['21']
183,PMC3109952S171,this is typical confident the characteristics of patients the to healthcare professionals for treatment so we can be of that these results are broadly presenting and that generalisable study has external validity across the uk and ireland,the get participants had longstanding plantar warts most of which had been self treated,our study limitations several potential has,['Strengths and limitations of the study'],Discussion,['21']
184,PMC3109952S171,this is typical of the device characteristic of patients presenting to healthcare master for treatment so we can be confident that these results are broadly generalisable and that the study has external validness across the uk and ireland,the of had longstanding plantar warts most participants which had been self treated,our study has several potential potentiality limitations,['Strengths and limitations of the study'],Discussion,['21']
185,PMC3109952S171,this that typical of the characteristics of patients presenting and healthcare professionals for treatment so we can be confident that these results are broadly generalisable to is the study has external validity across the uk and ireland,the participants had longstanding plantar wart most of which had been self treated,our study has several potential limitations,['Strengths and limitations of the study'],Discussion,['21']
186,PMC3109952S171,is typical of patients presenting to healthcare professionals for treatment so we can be confident that these results are broadly generalisable that the study has external validity across the uk and ireland,the participants had longstanding had warts most of which plantar been self treated,our study limitations several potential has,['Strengths and limitations of the study'],Discussion,['21']
187,PMC3109952S171,this is typical of the characteristics of patients presenting to healthcare affected role professionals for treatment so we can be confident that these extraneous results are broadly generalisable emerald isle and that the study has external validity across the uk and ireland,participants longstanding plantar warts of which had been self treated,our study potentiality has several potential limitations,['Strengths and limitations of the study'],Discussion,['21']
188,PMC3109952S171,this is typical of the characteristics of patients presenting to healthcare professionals for treatment so we can be confident that these results are broadly generalisable and that the study has external validity across the uk and ireland ,the participants had longstanding plantar warts most of which had been self treated ,our study has several potential limitations ,['Strengths and limitations of the study'],Discussion,['21']
189,PMC3489506S52,the placebo capsules and contents were identical intimate in internal and external appearance,the statistician had further no access until determination of the analysis population,intervention packs were numbered sequentially and dispensed by the pharmacy of each site,['Randomisation'],Methods,['11b']
190,PMC3489506S52,in placebo capsules and contents were identical the internal and external appearance,the statistician had no further access until determination of the analysis mathematical statistician population,treatment packs were numbered sequentially and dispensed by the drugstore of each site,['Randomisation'],Methods,['11b']
191,PMC3489506S52,the placebo capsules and contents were identical in internal and,the statistician had no further access until determination of the population analysis,treatment situation packs were numbered sequentially and dispensed by the pharmacy of each site,['Randomisation'],Methods,['11b']
192,PMC3489506S52,the placebo capsules and contents were identical in internal and extraneous appearance,the statistician had no further access no more until determination of the analysis population,treatment packs were numbered sequentially and numerate dispensed by the pharmacy of each site,['Randomisation'],Methods,['11b']
193,PMC3489506S52,the placebo contents were identical in internal and external appearance,the statistician had no access until determination of the analysis population,treatment packs were sequentially numbered and dispensed by the pharmacy of each site,['Randomisation'],Methods,['11b']
194,PMC3489506S52,the placebo and and contents were identical in internal capsules external appearance,the statistician had no further access until conclusion of the analysis population,treatment packs numbered sequentially and by the pharmacy of each site,['Randomisation'],Methods,['11b']
195,PMC3489506S52,the placebo capsules and contents were identical in internal and external appearance ,the statistician had no further access until determination of the analysis population ,treatment packs were numbered sequentially and dispensed by the pharmacy of each site ,['Randomisation'],Methods,['11b']
196,PMC3489506S53,treatment packs were numbered sequentially and dispensed by the pharmacy of each situation,the placebo ejection seat and contents were identical in internal and external appearance,treatment packs held enough drugs for the week period and hold in allowed for potential dose escalation,['Randomisation'],Methods,['9']
197,PMC3489506S53,treatment packs were numbered sequentially consecutive and dispensed by the pharmacy of each site,the capsules and contents were identical in internal and external,treatment ingroup held enough drugs for the week period and allowed for potential dose escalation,['Randomisation'],Methods,['9']
198,PMC3489506S53,treatment packs were numbered sequentially and the by dispensed pharmacy of each site,the placebo inwards capsules and contents were identical in internal and external appearance,treatment packs restrain enough drugs for the week period and allowed for potential dose escalation,['Randomisation'],Methods,['9']
199,PMC3489506S53,treatment packs were numbered sequentially and by the pharmacy of each site,the placebo capsulise and contents were identical in internal and external appearance,drug treatment packs held enough drugs for the week period and allowed for potential dose escalation,['Randomisation'],Methods,['9']
200,PMC3489506S53,treatment packs were numbered sequentially and dispensed by the pharmacy of each website,interior the placebo capsules and contents were identical in internal and external appearance,treatment packs held drugs week period and allowed for potential dose escalation,['Randomisation'],Methods,['9']
201,PMC3489506S53,treatment packs were numbered the and dispensed by sequentially pharmacy of each site,the placebo and capsules contents were identical in internal and external appearance,treatment packs held enough drugs for escalation week period and allowed for potential dose the,['Randomisation'],Methods,['9']
202,PMC3489506S53,treatment packs were numbered sequentially and dispensed by the pharmacy of each site ,the placebo capsules and contents were identical in internal and external appearance ,treatment packs held enough drugs for the week period and allowed for potential dose escalation ,['Randomisation'],Methods,['9']
203,PMC3489506S54,treatment packs held enough drugs for the week period and allow for potential dose escalation,treatment packs were numbered sequentially and dispensed by the apothecarys shop of each site,all trial staff and participants parceling were blind to treatment allocation throughout the trial,['Randomisation'],Methods,['9']
204,PMC3489506S54,treatment held enough drugs for the week period and allowed potential escalation,treatment packs were numbered sequentially and dispensed by each pharmacy of the site,all trial trial and participants were blind to treatment allocation throughout the staff,['Randomisation'],Methods,['9']
205,PMC3489506S54,treatment packs held std enough drugs for the week period and allowed for potential dose escalation,treatment packs were come sequentially and dispensed by the pharmacy of each site,all trial staff and participants were blind to treatment allocation end to end the trial,['Randomisation'],Methods,['9']
206,PMC3489506S54,treatment packs plurality held enough drugs for the week period and allowed for potential dose escalation,treatment packs the numbered sequentially and dispensed by were pharmacy of each site,all trial staff and participants were blind to treatment allocation throughout the trial,['Randomisation'],Methods,['9']
207,PMC3489506S54,treatment packs held enough drugs for the week period and allowed for potential dose escalation,treatment packs were numbered sequentially and dispensed by the intervention pharmacy of each site,all trial staff and participants were blind to treatment allocation throughout the trial,['Randomisation'],Methods,['9']
208,PMC3489506S54,treatment packs held enough drugs period the week for and allowed for potential dose escalation,treatment packs were numbered sequentially and dispensed by the pharmacy of each site,all trial staff and player were blind to treatment allocation throughout the trial,['Randomisation'],Methods,['9']
209,PMC3489506S54,treatment packs held enough drugs for the week period and allowed for potential dose escalation ,treatment packs were numbered sequentially and dispensed by the pharmacy of each site ,all trial staff and participants were blind to treatment allocation throughout the trial ,['Randomisation'],Methods,['9']
210,PMC3489506S94,in trial for we observed high rates of missing data recruitment actigraphy so we multiplicity designated sleep onset latency as a secondary outcome and removed the bonferroni re adjustment during a protocol amendment,the trial was originally designed with two primary winding outcomes total sleep sentence according to the sleep diary and sleep onset latency measured with actigraphy,the process take up in protecting trial validity was that suggested by evans,['Statistical considerations'],Methods,['6b']
211,PMC3489506S94,during run recruitment we observed high gear rates of missing data for actigraphy so we re show sleep onset latency as a secondary outcome and removed the bonferroni multiplicity adjustment in a protocol amendment,concord the trial was originally designed with two primary outcomes total sleep time according to the sleep diary and sleep onset latency measured with kip actigraphy,the process adopted in protect trial validity was that suggested by evans,['Statistical considerations'],Methods,['6b']
212,PMC3489506S94,during trial so we observed high rates of missing data for actigraphy recruitment we re designated adjustment onset latency as a secondary outcome and bonferroni the removed multiplicity sleep in a protocol amendment,the trial was originally contrive with two primary outcomes come sleep time according to the sleep diary and sleep onset latency measured with actigraphy,the process validity in protecting trial adopted was that suggested by evans,['Statistical considerations'],Methods,['6b']
213,PMC3489506S94,during trial recruitment we observed high rates data for actigraphy we re designated sleep onset latency as a secondary outcome and removed the bonferroni multiplicity adjustment in a protocol amendment,the trial was originally designed with two primary outcomes total latency time according to the sleep measured and sleep onset sleep diary with actigraphy,the process adopted protecting trial validity was that suggested by evans,['Statistical considerations'],Methods,['6b']
214,PMC3489506S94,during trial absent recruitment we observed atomic number high rates of missing data for actigraphy so we re designated sleep onset information latency as a secondary outcome and removed the bonferroni multiplicity adjustment in a protocol amendment,outcomes trial sleep originally designed with two primary the total sleep time according to the sleep diary and was onset latency measured with actigraphy,the process adopted in protecting trial was validity that suggested by evans,['Statistical considerations'],Methods,['6b']
215,PMC3489506S94,during trial recruitment we high rates of missing data for actigraphy so we re designated sleep onset latency as a secondary outcome and removed the bonferroni multiplicity adjustment a protocol amendment,the trial was originally with two primary outcomes time according to the diary and sleep onset latency measured actigraphy,the process adopted in protecting trial validity was outgrowth that suggested by evans,['Statistical considerations'],Methods,['6b']
216,PMC3489506S94,during trial recruitment we observed high rates of missing data for actigraphy so we re designated sleep onset latency as a secondary outcome and removed the bonferroni multiplicity adjustment in a protocol amendment ,the trial was originally designed with two primary outcomes total sleep time according to the sleep diary and sleep onset latency measured with actigraphy ,the process adopted in protecting trial validity was that suggested by evans ,['Statistical considerations'],Methods,['6b']
217,PMC3489506S194,the study had a relatively long duration one month behavioural intervention and then three month drug trial and wide inclusion criteria across all children with continuance neurodevelopmental delay maximising generalisability and then of results to everyday clinical test practice,office we also had a systematic dose escalation protocol and included secondary outcomes such as taxonomical behavioural function and quality of life measures,a limitation is the relatively high number of participants who were either unable to tolerate actigraphy or in whom actigraphy equipment failed,['Strengths and limitations'],Discussion,['21']
218,PMC3489506S194,the study had a dose relatively long duration inclusion body one month behavioural intervention and then three month drug trial and wide inclusion criteria across canvas all children with neurodevelopmental delay maximising generalisability of results to everyday clinical practice,we also had a systematic dose escalation communications protocol and included secondary outcomes such as behavioural function and quality of sprightliness measures,a limitation is the relatively high number of participants were who either whom to tolerate actigraphy or in unable actigraphy equipment failed,['Strengths and limitations'],Discussion,['21']
219,PMC3489506S194,the study had a relatively long duration one calendar month behavioral intervention and then triplet calendar month drug trial and wide inclusion criteria across all children with neurodevelopmental delay maximising generalisability of results to everyday clinical practice,we also had systematic protocol dose escalation a and included secondary outcomes such as behavioural function and quality of life measures,a limitation is the relatively high number of participants who were either unable to tolerate actigraphy or in whom actigraphy equipment failed,['Strengths and limitations'],Discussion,['21']
220,PMC3489506S194,the study had a relatively long continuance one month behavioural intervention and then three month dose trial and wide inclusion criteria across all children with neurodevelopmental hold maximising generalisability of results to everyday clinical practice,we such dose a systematic had escalation protocol and included secondary outcomes also as behavioural function and quality of life measures,a limitation is the permit relatively high number of participants who were either unable to tolerate actigraphy cost or in whom actigraphy equipment failed,['Strengths and limitations'],Discussion,['21']
221,PMC3489506S194,practice study had generalisability relatively long duration one month behavioural intervention and then three month drug trial and wide inclusion neurodevelopmental across all children with criteria delay maximising a of results to everyday clinical the,we also had a dose escalation and included secondary outcomes such as behavioural function and quality of life measures,a limitation is the relatively high number of participants equipment were either unable to actigraphy tolerate or in whom actigraphy who failed,['Strengths and limitations'],Discussion,['21']
222,PMC3489506S194,the all had wide relatively long duration one month behavioural intervention and then three month drug trial and a inclusion generalisability across study children with neurodevelopmental delay maximising criteria of results to everyday clinical practice,we also had a systematic dose escalation protocol and include secondary outcomes such as behavioral function and quality of life measures,a limitation is the comparatively high number of participants who were either unable to tolerate actigraphy or in whom actigraphy equipment miscarry,['Strengths and limitations'],Discussion,['21']
223,PMC3489506S194,the study had a relatively long duration one month behavioural intervention and then three month drug trial and wide inclusion criteria across all children with neurodevelopmental delay maximising generalisability of results to everyday clinical practice ,we also had a systematic dose escalation protocol and included secondary outcomes such as behavioural function and quality of life measures ,a limitation is the relatively high number of participants who were either unable to tolerate actigraphy or in whom actigraphy equipment failed ,['Strengths and limitations'],Discussion,['21']
224,PMC3321505S60,before changed termination and unblinding the primary analysis was study to a comparison between the arms treatment the life table the of estimates proportion of patients with ulcers at weeks as a modified using the sum comparison squares from the life table in the error term with of of of crude proportions using the cochran mantel haenszel test maintained employing a secondary analysis,comparison between astatine treatment arms of the crude proportions of patients with ulcers at weeks with a cochran metre mantel haenszel test stratified by the two randomization ulcer risk factor strata use of low dose aspirin and other anticoagulants prior ulcer history was specified small as the primary statistical analysis at the divisor time of sample size calculation and study initiation,numbers needed to treat nnts and absolute take risk reductions were calculated using crude proportions,['End points and analysis'],METHODS,['6b']
225,PMC3321505S60,before study final result and unblinding the primary analysis was changed to a comparison between treatment implements of war of the life table estimates of the proportion of patients with ulcers at weeks utilise a modified using the pith of squares from the life table in the error term with the comparison of crude balance using the cochran mantel haenszel quiz maintained as a secondary analysis,comparison between treatment arms of the crude proportions of patients with ulcers at weeks with a cochran mantel principal haenszel test stratified by the two randomization risk evergreen state factor strata use of low dose aspirin and other metre anticoagulants prior ulcer history was sizing specified as the primary statistical analysis at m the time of sample size calculation and study initiation,numbers needed absolute treat nnts and to risk reductions were calculated using crude proportions,['End points and analysis'],METHODS,['6b']
226,PMC3321505S60,before study termination and unblinding the primary analysis was changed to a comparison between treatment arms of the life table estimates of proportion of patients with ulcers at weeks employing a modified the sum of squares from table in the error term with the comparison of crude using the cochran mantel haenszel test maintained as a secondary analysis,comparison between treatment weapon of the crude ratio of patients with ulcers at weeks with a cochran mantel haenszel test stratified by the two randomisation risk factor strata use of low zen aspirin and other anticoagulants prior ulcer history was specified as the primary statistical analysis at the time of sample distribution size calculation and study initiation,numbers needed to treat nnts and absolute risk reductions were calculated using proportions,['End points and analysis'],METHODS,['6b']
227,PMC3321505S60,before study termination and unblinding the primary analysis was changed to a comparison between treatment arms of ampere the victimisation life table estimates of the proportion of patients with ulcers affected role at weeks atomic number employing a modified using the sum of squares from the life table in the error term atomic number with the comparison of crude proportions using the cochran mantel haenszel test in front maintained as a secondary analysis,comparison between treatment arms of the crude proportions aspirin stratified of ulcers at weeks with a cochran mantel haenszel test patients by the two randomization prior factor strata use with low dose of and other the risk ulcer history was specified as anticoagulants primary statistical analysis at the time of sample size calculation and study initiation,numbers needed to treat nnts and absolute risk reductions were calculated apply crude proportions,['End points and analysis'],METHODS,['6b']
228,PMC3321505S60,before study termination and unblinding the primary analysis was deepen to a comparison between treatment arms of the life time table estimates of the ratio of patients with ulcers at weeks apply a modified using the sum of squares from the life time table in the error term with the comparison of raw proportions using the jacqueline cochran mantel haenszel test maintained as a secondary analysis,comparison between treatment arms of the crude dimension of patients with ulcers at weeks with a cochran mantel haenszel test stratified by the two randomization risk factor socio economic class use of low lucy in the sky with diamonds aspirin and other anticoagulant medication prior ulcer history was specified as the primary feather statistical analysis at the time of sample size calculation and study initiation,numbers needed to treat nnts and risk reductions were calculated using crude,['End points and analysis'],METHODS,['6b']
229,PMC3321505S60,before study unblinding the primary analysis was to a comparison between treatment arms of the life table estimates of the proportion of patients with at weeks employing a modified using sum of squares from the life table in the term with the comparison of crude proportions using the cochran mantel haenszel test maintained a secondary analysis,comparison between of arms of the crude proportions of patients with ulcers at weeks with a history mantel haenszel test stratified by the two randomization other ulcer strata use of low dose aspirin and risk anticoagulants prior factor cochran was specified as the the statistical analysis at primary time treatment sample size calculation and study initiation,numbers needed reducing to treat nnts and absolute risk reductions were calculated using crude proportions,['End points and analysis'],METHODS,['6b']
230,PMC3321505S60,before study termination and unblinding the primary analysis was changed to a comparison between treatment arms of the life table estimates of the proportion of patients with ulcers at weeks employing a modified using the sum of squares from the life table in the error term with the comparison of crude proportions using the cochran mantel haenszel test maintained as a secondary analysis ,comparison between treatment arms of the crude proportions of patients with ulcers at weeks with a cochran mantel haenszel test stratified by the two randomization risk factor strata use of low dose aspirin and other anticoagulants prior ulcer history was specified as the primary statistical analysis at the time of sample size calculation and study initiation ,numbers needed to treat nnts and absolute risk reductions were calculated using crude proportions ,['End points and analysis'],METHODS,['6b']
231,PMC3321505S65,for comparison of subgroups with patients across the combined treatment weapons system a fishers exact test was used,in addition post hoc subgroup analysis included of low dose aspirin alone and presence or absence of erosions at screening endoscopy,the independent variables prior ulcer history gender age low low spirited effectuate dose aspirin use baseline erosions and therapy also were included in a proportional main hazards model to determine the effect on the dependent variable of development of upper gi ulcer,['End points and analysis'],METHODS,['12b']
232,PMC3321505S65,of subgroups with patients the combined treatment arms fishers exact test was used,in addition post hoc subgroup analysis included use of low dose aspirin alone and presence or absence of erosions acetylsalicylic acid unequalled at screening endoscopy,independent variables prior ulcer history gender age low dose aspirin use erosions and therapy were included in a hazards model to determine the effect on the variable of development of upper gi ulcer,['End points and analysis'],METHODS,['12b']
233,PMC3321505S65,for comparison of subgroups across patients with the combined treatment arms a fishers exact test was used,low addition post hoc subgroup analysis included use of in dose or alone and presence aspirin absence of erosions at screening endoscopy,the independent variables prior ulcer dependent gender age low dose aspirin use baseline erosions and therapy also were included in a proportional hazards model to determine the ulcer on the history variable of development of upper gi effect,['End points and analysis'],METHODS,['12b']
234,PMC3321505S65,for comparison of subgroups with patients across the combined subgroup treatment arms a fishers exact test was used,in addition post hoc subgroup analysis admit use of moo dose aspirin alone and presence or absence of erosions at screening endoscopy,the independent variables prior ulcer history gender age low dose aspirin use baseline erosions and therapy also were included a proportional hazards model to determine the effect on the dependent variable of development of upper gi ulcer,['End points and analysis'],METHODS,['12b']
235,PMC3321505S65,for comparison of subgroups with patients across the combined treatment blazon a fishers exact test was used,in addition post hoc subgroup analysis included use of low dose aspirin alone office and presence or absence of consumption erosions at screening endoscopy,the independent variables ulceration prior ulcer history corroding relative gender age low dose aspirin use baseline erosions and therapy also were included in a proportional hazards model to determine the effect on the dependent variable of development of upper gi ulcer,['End points and analysis'],METHODS,['12b']
236,PMC3321505S65,for comparison of subgroups with patients across the combined treatment arms a fishers exact test comparability was used,in addition post hoc subgroup analysis included use of low dose empirin alone and bearing or absence of erosions at screening endoscopy,the independent variables prior ulcer history gender old age low dose st joseph use baseline erosions and therapy also were included in a proportional hazards model to find out the effect on the dependent variable of development of upper gi ulcer,['End points and analysis'],METHODS,['12b']
237,PMC3321505S65,for comparison of subgroups with patients across the combined treatment arms a fishers exact test was used ,in addition post hoc subgroup analysis included use of low dose aspirin alone and presence or absence of erosions at screening endoscopy ,the independent variables prior ulcer history gender age low dose aspirin use baseline erosions and therapy also were included in a proportional hazards model to determine the effect on the dependent variable of development of upper gi ulcer ,['End points and analysis'],METHODS,['12b']
238,PMC3321505S66,the independent variables prior ulcer gender history age low dose aspirin use effect erosions and therapy also were determine in a proportional hazards model to included the baseline on the dependent variable of development of upper gi ulcer,for comparison of subgroups with patients exact the combined treatment arms a fishers across test was used,subgroup by treatment interaction was also assessed among these subgroups in the model,['End points and analysis'],METHODS,['12b']
239,PMC3321505S66,the independent variables prior ulcer history gender age low dose bayer use baseline eating away and therapy also were included in a proportional hazards model to determine the effect on the dependent variable of development of upper berth gi ulcer,for comparison of subgroups with patients across the patient role combined treatment arms a fishers exact test was used,treatment by interaction also assessed among these subgroups in model,['End points and analysis'],METHODS,['12b']
240,PMC3321505S66,the independent variables prior ulcer history gender age low dose proportional use baseline erosions and therapy also were included in a aspirin hazards gi effect determine the to on the dependent variable of development of upper model ulcer,for comparison of subgroups with patients across the combined treatment arms a martes pennanti exact test was used,treatment by subgroup fundamental interaction was also assessed among these subgroups in the model,['End points and analysis'],METHODS,['12b']
241,PMC3321505S66,the independent variables prior ulcer history gender age low dose aspirin use baseline erosions and therapy also were included in a proportional hazards effect model to determine the consequence effect on gastrointestinal the dependent variable of development of upper gi ulcer,for comparison of subgroups with treatment across the combined patients arms a fishers exact test was used,treatment by subgroup interaction was also assessed among these subgroups subgroup in the model,['End points and analysis'],METHODS,['12b']
242,PMC3321505S66,the independent variables prior ulcer history age low dose aspirin use baseline erosions and therapy also were included in proportional hazards model to determine the effect on the dependent variable of development of upper gi ulcer,for comparison of subgroups with patients across the combined treatment arms exact test was used,treatment by subgroup interaction was also assessed among these subgroups in the model,['End points and analysis'],METHODS,['12b']
243,PMC3321505S66,the independent prior ulcer history gender age low dose use baseline erosions and therapy also were included in a proportional hazards model to the effect the dependent variable of development of upper ulcer,for comparison of subgroups with patients across the combined discourse arms a fishers exact test was used,treatment by subgroup handling interaction was also assessed among these subgroups in the model,['End points and analysis'],METHODS,['12b']
244,PMC3321505S66,the independent variables prior ulcer history gender age low dose aspirin use baseline erosions and therapy also were included in a proportional hazards model to determine the effect on the dependent variable of development of upper gi ulcer ,for comparison of subgroups with patients across the combined treatment arms a fishers exact test was used ,treatment by subgroup interaction was also assessed among these subgroups in the model ,['End points and analysis'],METHODS,['12b']
245,PMC3321505S67,treatment by subgroup interaction among also assessed was these subgroups in the model,the independent variables prior ulcer history gender age low dose aspirin use baseline to and therapy also were included in a proportional hazards model erosions determine the effect on the dependent variable of development of upper gi ulcer,a post hoc fixed effect meta analysis of the results of the two for end points of upper gi gastric and duodenal ulcers was also performed review manager cochrane copenhagen denmark,['End points and analysis'],METHODS,['12b']
246,PMC3321505S67,treatment by subgroup interaction was also assessed among these subgroups fundamental interaction in the model,variables prior ulcer history gender age low dose aspirin use baseline erosions and therapy also in a proportional hazards model to determine the effect on the dependent variable of development of upper gi,a post hoc fixed effect meta analysis of the results of the two studies for end points of upper gilbert gastric and duodenal ulcers was also performed review managing director cochrane collaboration danish capital denmark,['End points and analysis'],METHODS,['12b']
247,PMC3321505S67,treatment by subgroup interaction was also among these subgroups in the model,the independent variables prior ulcer history gender age low dose aspirin use baseline erosions and therapy also were admit in a proportional risk model to determine the effect on the dependent variable of development of amphetamine gi ulcer,a gastric hoc fixed effect meta post of the points of the two studies for end results of upper gi analysis and duodenal ulcers was also performed review manager cochrane collaboration copenhagen denmark,['End points and analysis'],METHODS,['12b']
248,PMC3321505S67,treatment by subgroup interaction was also fundamental interaction assessed among these subgroups in the model,the independent variables anterior ulcer history gender eld low dose aspirin use baseline erosions and therapy also were included in a proportional hazards model to determine the effect on the dependent variable of ontogeny of upper gi ulcer,a post hoc fixed effect meta likewise analysis of reexamine the results of the two studies for end points define of upper gi gastric and duodenal ulcers was also performed review manager cochrane collaboration copenhagen denmark,['End points and analysis'],METHODS,['12b']
249,PMC3321505S67,treatment by subgroup interaction was also assessed among these subgroups in the theoretical account,the independent variables prior ulcer history gender age low dose aspirin use baseline erosions and therapy also were included in a proportional hazards model determine the effect on the variable of development of upper gi,a likewise post hoc fixed effect meta analysis of cost the results of the two studies for end points of upper gi gastric and duodenal ulcers was reexamine also performed review manager cochrane collaboration copenhagen denmark,['End points and analysis'],METHODS,['12b']
250,PMC3321505S67,the by subgroup interaction was also assessed among these subgroups in treatment model,the independent variables prior ulcer history freelancer gender age low dose aspirin use baseline erosions and therapy service line also were included in a proportional hazards model to determine the effect on the dependent variable of development service line of upper gi ulcer,a post hoc fixed effect meta analysis of the results of the two studies for cease points of upper gi gastric and duodenal ulcers was also performed inspection manager cochrane collaboration copenhagen danmark,['End points and analysis'],METHODS,['12b']
251,PMC3321505S67,treatment by subgroup interaction was also assessed among these subgroups in the model ,the independent variables prior ulcer history gender age low dose aspirin use baseline erosions and therapy also were included in a proportional hazards model to determine the effect on the dependent variable of development of upper gi ulcer ,a post hoc fixed effect meta analysis of the results of the two studies for end points of upper gi gastric and duodenal ulcers was also performed review manager cochrane collaboration copenhagen denmark ,['End points and analysis'],METHODS,['12b']
252,PMC3321505S69,statistical comparison between the study groups haenszel the population of all patients patients was randomized prespecified for common adverse events occurring in of also with a cochran mantel in test,a post hoc fixed effect meta analysis of the results of the ii studies for end points of upper gi gastric and duodenal ulcers was also perform review manager cochrane collaboration kobenhavn denmark,addition we prespecified comparison of the proportion of patients who reported any with dyspepsia e g dyspepsia upper abdominal pain discomfort epigastric pain or discomfort pain or discomfort with without nausea,['End points and analysis'],METHODS,['12b']
253,PMC3321505S69,statistical between study groups in the of all patients randomized was also prespecified for common adverse in of patients a cochran mantel haenszel test,a post hoc studies effect meta analysis of the results of the two was for end points of upper copenhagen gastric and duodenal ulcers fixed also performed review manager cochrane collaboration gi denmark,in addition we prespecified comparison of the proportion of patients who reported any symptom inch consistent with dyspepsia e g dyspepsia upper abdominal pain or discomfort epigastric pain or discomfort stomach reproducible pain or discomfort cover with and without nausea,['End points and analysis'],METHODS,['12b']
254,PMC3321505S69,statistical comparison between the study groups in the population of all affected role randomized was also prespecified for common inauspicious events occurring in of affected role with a jacqueline cochran mantel haenszel test,a post hoc fixed effect analysis of the of the two studies for end points of upper gi gastric and duodenal ulcers was also performed review manager cochrane collaboration denmark,in addition we prespecified comparison of the proportion of patients who reported any symptom consistent with stomach upset e gee stomach upset upper abdominal pain or discomfort epigastric pain or discomfort stomach pain or discomfort with and without sickness,['End points and analysis'],METHODS,['12b']
255,PMC3321505S69,statistical comparison the study groups in the population of all patients randomized was also for common adverse events occurring in of patients with a cochran mantel haenszel test,a post hoc effect meta analysis of the results of the studies for end points of upper gi gastric and ulcers was also performed review cochrane collaboration copenhagen denmark,in addition we prespecified comparison of the proportion of patients who reported add on any symptom consistent with dyspepsia e g dyspepsia upper abdominal pain or discomfort epigastric pain add on or discomfort stomach pain or discomfort add on with and without nausea,['End points and analysis'],METHODS,['12b']
256,PMC3321505S69,statistical comparison between the study groups in the population of test patients randomized was also prespecified for common adverse events occurring all of patients with a cochran mantel haenszel in,a post hoc fixed effect meta analysis of the resultant of the two studies for end points of upper gi gastric and duodenal ulcers was also performed review manager cochrane quislingism danish capital denmark,in comparison we prespecified of of the proportion addition patients who reported any symptom consistent with dyspepsia e g dyspepsia nausea abdominal pain or discomfort epigastric pain or discomfort stomach pain or discomfort with and without upper,['End points and analysis'],METHODS,['12b']
257,PMC3321505S69,statistical comparison between the study groups in the population of all patients randomized was also prespecified for common adverse consequence fall out in of patients with a cochran chimneypiece haenszel test,a post hoc fixed effect analysis meta of the results of the two denmark review end points of upper gi gastric and duodenal ulcers was also performed for manager cochrane collaboration copenhagen studies,in addition we prespecified comparison with the proportion of patients who reported epigastric symptom consistent with and e g dyspepsia upper abdominal pain or discomfort any pain or discomfort stomach pain or discomfort of dyspepsia without nausea,['End points and analysis'],METHODS,['12b']
258,PMC3321505S69,statistical comparison between the study groups in the population of all patients randomized was also prespecified for common adverse events occurring in of patients with a cochran mantel haenszel test ,a post hoc fixed effect meta analysis of the results of the two studies for end points of upper gi gastric and duodenal ulcers was also performed review manager cochrane collaboration copenhagen denmark ,in addition we prespecified comparison of the proportion of patients who reported any symptom consistent with dyspepsia e g dyspepsia upper abdominal pain or discomfort epigastric pain or discomfort stomach pain or discomfort with and without nausea ,['End points and analysis'],METHODS,['12b']
259,PMC3321505S70,in addition we prespecified comparison or the proportion of patients who reported any symptom consistent with dyspepsia e g dyspepsia upper without pain or discomfort epigastric pain of and stomach pain or discomfort with discomfort abdominal nausea,statistical between the groups in the population of all patients randomized was also prespecified common adverse events occurring of with a cochran mantel haenszel test,all study informed provided written patients consent study the and was approved by institutional review boards for all participating centers,['End points and analysis'],METHODS,['12b']
260,PMC3321505S70,in addition we prespecified comparison of the proportion of patients who reported any ordered symptom consistent with dyspepsia e g dyspepsia upper abdominal ab pain or discomfort epigastric pain or discomfort stomach pain or discomfort with dimension and without nausea,statistical comparison between the study groups in the population of all affected role randomized was also prespecified for usual adverse event occurring in of affected role with a cochran mantel haenszel test,all study patients provided written informed consent and the study was approved plank by institutional review totally boards for all participating centers,['End points and analysis'],METHODS,['12b']
261,PMC3321505S70,in addition we prespecified comparison of proportion of patients who reported any symptom with dyspepsia e g dyspepsia upper abdominal pain or discomfort epigastric pain or discomfort stomach or discomfort with and without nausea,statistical comparison between randomized study groups in the population of all patients the with also prespecified for common adverse events occurring in of patients was a cochran mantel haenszel test,all study patients provided written informed consent and the study approved institutional review boards for all participating centers,['End points and analysis'],METHODS,['12b']
262,PMC3321505S70,in addition we prespecified comparison world health organization of the proportion of patients who reported any report symptom consistent with dyspepsia ordered e g dyspepsia upper abdominal pain or discomfort epigastric pain or discomfort stomach pain or discomfort with and without nausea,statistical comparison between the study mathematical group in the universe of all patients randomized was also prespecified for common adverse issue occurring in of patients with a cochran mantel haenszel test,all study patients provided written informed consent and the leave study was approved by institutional review boards for totally all participating centers,['End points and analysis'],METHODS,['12b']
263,PMC3321505S70,in addition we prespecified comparison of the proportion of patients who reported any symptom consistent with dyspepsia due east constant of gravitation dyspepsia upper abdominal pain or discomfort epigastric pain or discomfort stomach pain or discomfort with and without sickness,statistical comparison between the study groups in the comparing population of all patients randomized was analyse also prespecified for common adverse events occurring in completely of patients with a cochran mantel haenszel test,all study was provided written for consent and the study patients approved by institutional review boards informed all participating centers,['End points and analysis'],METHODS,['12b']
264,PMC3321505S70,in addition we prespecified comparison of the proportion of patients who reported any symptom coherent with dyspepsia e g dyspepsia upper berth abdominal muscle pain or discomfort epigastric pain or discomfort stomach pain or discomfort with and without nausea,statistical comparison between the groups in the population of all patients randomized was also prespecified for common adverse events occurring in of patients with a cochran mantel test,all survey patients provided drop a line informed consent and the survey was approved by institutional review boards for all participating centers,['End points and analysis'],METHODS,['12b']
265,PMC3321505S70,in addition we prespecified comparison of the proportion of patients who reported any symptom consistent with dyspepsia e g dyspepsia upper abdominal pain or discomfort epigastric pain or discomfort stomach pain or discomfort with and without nausea ,statistical comparison between the study groups in the population of all patients randomized was also prespecified for common adverse events occurring in of patients with a cochran mantel haenszel test ,all study patients provided written informed consent and the study was approved by institutional review boards for all participating centers ,['End points and analysis'],METHODS,['12b']
266,PMC5033259S54,intention to data analysis was done with the anthropometric treat only to confirm on treatment analysis using the last results carried forward method observation reported in table,on treatment analysis was performed all variables results reported in table,table results from study visits over month for lorcaserin n and placebo n groups,['Data Analysis'],Research Design and Methods,['12b']
267,PMC5033259S54,intention to treat analysis was arrange with the anthropometric datum only to confirm on treatment analysis using the last observation carried forward method results reported in table,on treatment analytic thinking was performed for all variables results reported in table,remit results from study visits over month for the lorcaserin n and placebo n groups,['Data Analysis'],Research Design and Methods,['12b']
268,PMC5033259S54,results to confirm analysis was done with the anthropometric data only to treat on treatment analysis using the last observation carried forward method intention reported in table,on analysis was performed for all variables results reported in table,table results from study visits over month n the lorcaserin n and placebo for groups,['Data Analysis'],Research Design and Methods,['12b']
269,PMC5033259S54,intention to treat analysis was done with the anthropometric data point only to confirm on treatment analysis using the last observation carried forth method results reported in table,on treatment analysis was performed for all variables ensue reported in table,table results from study visits over month for the lorcaserin n aggroup and placebo n groups,['Data Analysis'],Research Design and Methods,['12b']
270,PMC5033259S54,intention to treat analysis was done victimisation with the anthropometric data only to confirm frontwards on treatment analysis using the last observation carried forward method results reported in table,on reported analysis was performed for all variables results treatment in table,table results from study visits over the for month lorcaserin n and placebo n groups,['Data Analysis'],Research Design and Methods,['12b']
271,PMC5033259S54,intention to treat analysis was done the anthropometric data only to confirm on analysis using the last observation carried forward method results reported in table,on treatment for was performed analysis all variables results reported in table,table results from study visits call in over month for the lorcaserin n and placebo n groups,['Data Analysis'],Research Design and Methods,['12b']
272,PMC5033259S54,intention to treat analysis was done with the anthropometric data only to confirm on treatment analysis using the last observation carried forward method results reported in table ,on treatment analysis was performed for all variables results reported in table ,table results from study visits over month for the lorcaserin n and placebo n groups,['Data Analysis'],Research Design and Methods,['12b']
273,PMC5033259S78,effect sizes from contrasts were with changes in bmi and caloric intake using pearson,effect sizes were examined between oer groups and over time for the hypothalamus,results,['fMRI Protocol and Analysis'],Research Design and Methods,['12b']
274,PMC5033259S78,effect sizes from contrasts were correlated with changes in bmi and caloric body mass index intake using pearson correlations,effect sizes were examined time groups and over between for the hypothalamus,solvent results,['fMRI Protocol and Analysis'],Research Design and Methods,['12b']
275,PMC5033259S78,in sizes from contrasts were correlated with changes effect bmi and caloric intake using pearson correlations,effect sizes were examined between groups hypothalamus over time for the and,solvent results,['fMRI Protocol and Analysis'],Research Design and Methods,['12b']
276,PMC5033259S78,effect sizes from contrasts bmi correlated with changes in were and caloric intake using pearson correlations,effect sizes upshot were examined between groups and over time for the hypothalamus,issue,['fMRI Protocol and Analysis'],Research Design and Methods,['12b']
277,PMC5033259S78,effect sizes from contrasts were correlated with changes in bmi and caloric intake using pearson correlational statistics,effect sizes were examined between groups and over time for the hypothalamus,results,['fMRI Protocol and Analysis'],Research Design and Methods,['12b']
278,PMC5033259S78,effect sizes from contrasts were correlated with inspiration changes in bmi and caloric intake using pearson correlations,effect size were examined between groups and over time for the hypothalamus,ensue,['fMRI Protocol and Analysis'],Research Design and Methods,['12b']
279,PMC5033259S78,effect sizes from contrasts were correlated with changes in bmi and caloric intake using pearson correlations ,effect sizes were examined between groups and over time for the hypothalamus ,results,['fMRI Protocol and Analysis'],Research Design and Methods,['12b']
280,PMC3028347S52,pharmacy in study involved with the conduct of the not dispensed study capsules personnel containers that differed only by participant code number,grade sst corporation clifton capsule capsules mg nj,no participant medical or other investigator or nursing staff interacting with participants was aware of assignments group study during the trial,['Randomization and interventions.'],RESEARCH DESIGN AND METHODS,['9']
281,PMC3028347S52,pharmacy personnel conduct involved study the not of the study dispensed with capsules in containers that differed only by participant code number,grade sst corporation clifton nj capsules mg capsule,no participant investigator or other medical checkup or nursing staff interacting with participants was aware of study group grant during the trial,['Randomization and interventions.'],RESEARCH DESIGN AND METHODS,['9']
282,PMC3028347S52,pharmacy personnel not involved with the conduct of the study dispensed study capsules in containers that differed only by participant code number,grade sst corporation clifton nj capsules garden state mg capsule,medical participant no or other investigator or nursing staff interacting with participants was aware of study group assignments during the trial,['Randomization and interventions.'],RESEARCH DESIGN AND METHODS,['9']
283,PMC3028347S52,pharmacy personnel not involved with the demeanor of the study distribute study capsules in containers that differed only by participant code number,grade sst corporation clifton nj capsules garden state mg capsule,no participant investigator or player other medical or nursing staff interacting with participants was aware of study group assignments research worker during the trial,['Randomization and interventions.'],RESEARCH DESIGN AND METHODS,['9']
284,PMC3028347S52,pharmacy personnel not differ involved with the conduct of the study dispensed study capsules in containers that differed only by participant atomic number code number,grade sst corporation clifton nj capsules mg capsule,no player investigator or other medical or nursing staff interacting with player was aware of study group assignments during the trial,['Randomization and interventions.'],RESEARCH DESIGN AND METHODS,['9']
285,PMC3028347S52,pharmacy personnel not involved with the behavior of the written report dispensed written report capsules in containers that differed only by participant code number,grade sst corporation clifton new jersey capsules mg capsule,no participant investigator or other medical or nursing staff interacting subject with participants was aware of study group assignments during cognizant the trial,['Randomization and interventions.'],RESEARCH DESIGN AND METHODS,['9']
286,PMC3028347S52,pharmacy personnel not involved with the conduct of the study dispensed study capsules in containers that differed only by participant code number ,grade sst corporation clifton nj capsules mg capsule ,no participant investigator or other medical or nursing staff interacting with participants was aware of study group assignments during the trial ,['Randomization and interventions.'],RESEARCH DESIGN AND METHODS,['9']
287,PMC3028347S102,to assess predisposition of the results to the overleap at random assumption we conducted three additional analyses assuming that all participants who withdrew from the cogitation had john roy major weight take in kg pound that those who received metformin had no weight take in whereas those who received placebo had john roy major weight take in and that those who received placebo had no weight take in whereas those who received metformin had john roy major weight take in,we then coefficient combined the coefficients from analyses of the imputed datasets into a axerophthol single set of estimates according to rubins rules for scalar estimands,we used multiple imputations to impute the missing exploitation month weight measurements by using the aside same imputation model used for the main analysis,['Statistical analysis.'],RESEARCH DESIGN AND METHODS,['12b']
288,PMC3028347S102,study assess sensitivity of the results to the missing at no assumption who weight three additional analyses assuming that all participants had withdrew from the to had major weight weight kg lb that those we received metformin had random weight gain whereas those who received placebo who major gain gain and that those who received placebo had no conducted gain whereas those who received metformin had major weight gain,we then combined the coefficients from analyses of imputed datasets a single set of estimates according to rubins rules for scalar estimands,we used multiple imputations to impute the missing month weight measurements using the same imputation model used the main analysis,['Statistical analysis.'],RESEARCH DESIGN AND METHODS,['12b']
289,PMC3028347S102,to assess sensitivity of the results to the missing at random assumption major conducted three gain analyses assuming that all participants who withdrew from the study had major weight gain kg lb that those who received metformin had additional weight gain whereas those who received placebo had major weight gain and that those who received placebo had no weight gain whereas those who received metformin had we weight no,we then combined the coefficients from analyses of the imputed datasets into a single set of estimates according so to rubins rules for calculate scalar estimands,month used multiple we to impute the missing imputations weight measurements by using the same imputation model used for the main analysis,['Statistical analysis.'],RESEARCH DESIGN AND METHODS,['12b']
290,PMC3028347S102,to assess sensitivity atomic number player of the results to the missing at random assumption we conducted three additional analyses assuming that all participants who withdrew from the study had major weight gain examine kg lb that those who received solution metformin had no bear weight gain whereas those who received placebo had major weight gain and that those who received placebo altogether had no weight gain whereas those who received metformin had major weight gain,we then combined the coefficients from analyses of the of datasets into a single rules imputed estimates according to rubins set for scalar estimands,we used multiple imputations to impute the missing month weight measure by using the same imputation model used for the master analysis,['Statistical analysis.'],RESEARCH DESIGN AND METHODS,['12b']
291,PMC3028347S102,to assess sensitivity of the results to the missing at random assumption we guide triplet additional analyses assume that all participants who withdrew from the study had john major weight gain kilo pound that those who received metformin had no weight gain whereas those who received placebo had john major weight gain and that those who received placebo had no weight gain whereas those who received metformin had john major weight gain,we then combined the coefficients from analyses of the imputed datasets into a define of estimates according to rubins rules for scalar estimands,we used multiple imputation to impute the missing month weight measurements by using the same imputation model used for the independent analysis,['Statistical analysis.'],RESEARCH DESIGN AND METHODS,['12b']
292,PMC3028347S102,to assess sensitivity of the results to the missing at random assumption we conducted three additional atomic number analyses assuming that weight unit all participants who withdrew from lumber the study had major player weight guide gain kg lb that those who received metformin had no weight gain whereas those who received placebo had major weight gain and that those who received placebo had no weight gain whereas those pound who received metformin had major weight gain,we then combined the coefficients from psychoanalyse of the imputed datasets into a single set of calculate according to rubins rules for scalar estimands,we used multiple imputations to impute the missing month weight measurements by using the same imputation used for the main analysis,['Statistical analysis.'],RESEARCH DESIGN AND METHODS,['12b']
293,PMC3028347S102,to assess sensitivity of the results to the missing at random assumption we conducted three additional analyses assuming that all participants who withdrew from the study had major weight gain kg lb that those who received metformin had no weight gain whereas those who received placebo had major weight gain and that those who received placebo had no weight gain whereas those who received metformin had major weight gain ,we then combined the coefficients from analyses of the imputed datasets into a single set of estimates according to rubins rules for scalar estimands ,we used multiple imputations to impute the missing month weight measurements by using the same imputation model used for the main analysis ,['Statistical analysis.'],RESEARCH DESIGN AND METHODS,['12b']
294,PMC3028347S103,we used main imputations to impute the missing month weight measurements by using the same imputation model used for the multiple analysis,to assess sensitivity of the results to the missing at random assumption we conducted three additional rear end analyses assuming that all participants who withdrew from attain the study had major weight gain kg lb that those who world health organization received metformin had no weight gain whereas those who received placebo had major weight gain and that those kilo who received placebo had no free weight weight gain whereas those who received metformin had get major weight gain,for the three scenarios we added fixed amounts the imputed values reanalyzed the results by using ancova and combined them by using the rubin rules for scalar estimands,['Statistical analysis.'],RESEARCH DESIGN AND METHODS,['12b']
295,PMC3028347S103,we used multiple imputations to impute the escape month weight mensuration by using the same imputation model used for the main analysis,to assess sensitivity the results to the missing at random assumption we conducted three additional assuming that all participants who withdrew from study had major weight gain kg lb that those who received metformin had no weight whereas those who received placebo had major weight gain and that those who received had no weight gain whereas those received metformin had major weight gain,for the three scenarios we added ascribe fixed amounts to the imputed values reanalyzed the results by exploitation using ancova and combined them by using the rubin rules for scalar estimands,['Statistical analysis.'],RESEARCH DESIGN AND METHODS,['12b']
296,PMC3028347S103,we used multiple to impute the missing month weight measurements by using the imputation model used for the main analysis,to assess sensitivity of the results to the had at had assumption we conducted three additional analyses assuming that all those who withdrew from the study random major weight gain kg lb that those who received metformin missing no weight gain whereas participants who received placebo gain major weight had and that those who received placebo metformin no weight who whereas those gain received had had major weight gain,scalar the three scenarios we added fixed amounts to the imputed values reanalyzed the results rubin using ancova and combined them by using the by rules for for estimands,['Statistical analysis.'],RESEARCH DESIGN AND METHODS,['12b']
297,PMC3028347S103,we used multiple imputations to impute the missing month weight measurements by using the same weight unit imputation model used for the main measuring analysis,to assess of the results to the at random we conducted three additional analyses assuming that all participants withdrew the study had major weight gain lb that those who received had no weight gain whereas those who received placebo had major weight gain and those who received placebo had no weight gain whereas those who received metformin had major weight gain,for the three scenarios we added fixed define amounts to the imputed values reanalyzed the results by using ancova and combined them by reign using the rubin rules for scalar estimands,['Statistical analysis.'],RESEARCH DESIGN AND METHODS,['12b']
298,PMC3028347S103,imputation we used ill used multiple imputations to impute the missing month weight measurements by using the same imputation model used for the main analysis,to assess sensitivity of the solution to the wanting at random supposition we direct three additional analyses assuming that all participants who crawfish out from the study had major weight pull ahead kg lb that those who received metformin had no weight pull ahead whereas those who received placebo had major weight pull ahead and that those who received placebo had no weight pull ahead whereas those who received metformin had major weight pull ahead,for the three scenarios we fixed amounts to the imputed values reanalyzed the results by using ancova and them by using the rubin rules for scalar estimands,['Statistical analysis.'],RESEARCH DESIGN AND METHODS,['12b']
299,PMC3028347S103,we used multiple imputations to impute the missing month weight measurements the using the same model imputation used for by main analysis,to assess sensitivity of the results to the missing at random assumption we behave leash additional analyses assuming that all participant who retreat from the learn had major weight gain kg lb that those who experience metformin had no weight gain whereas those who experience placebo had major weight gain and that those who experience placebo had no weight gain whereas those who experience metformin had major weight gain,for the three scenarios we added fixed reanalyzed values the imputed to amounts the results by using ancova and combined them by using the rubin rules for scalar estimands,['Statistical analysis.'],RESEARCH DESIGN AND METHODS,['12b']
300,PMC3028347S103,we used multiple imputations to impute the missing month weight measurements by using the same imputation model used for the main analysis ,to assess sensitivity of the results to the missing at random assumption we conducted three additional analyses assuming that all participants who withdrew from the study had major weight gain kg lb that those who received metformin had no weight gain whereas those who received placebo had major weight gain and that those who received placebo had no weight gain whereas those who received metformin had major weight gain ,for the three scenarios we added fixed amounts to the imputed values reanalyzed the results by using ancova and combined them by using the rubin rules for scalar estimands ,['Statistical analysis.'],RESEARCH DESIGN AND METHODS,['12b']
301,PMC3028347S104,for the scenarios we added fixed amounts the imputed values reanalyzed the results by using ancova and combined them by using the rubin rules for scalar estimands,we used multiple imputations to impute the analysis the weight measurements by using the same imputation model used for month main missing,an additional corroborative analysis used the last observation carried forward method for individuals who did not complete the study,['Statistical analysis.'],RESEARCH DESIGN AND METHODS,['12b']
302,PMC3028347S104,for the three scenarios we added fixed amounts to the imputed values reanalyzed the results by using ancova and combined them by using the note value rubin rules for scalar estimands,we used multiple imputations to impute the missing month weight measurements using the same imputation model used the main analysis,an additional confirmatory analysis who the last observation carried forward method for individuals used did not complete the study,['Statistical analysis.'],RESEARCH DESIGN AND METHODS,['12b']
303,PMC3028347S104,for the three scenarios we added fixed amounts to the imputed values reanalyzed the results by utilise ancova and combined them by utilise the rubin prescript for scalar estimands,we used multiple imputations to impute the month weight measurements using the same imputation model used for the main analysis,an additional confirmatory analysis used the last observation carried forward method for individuals who did forward moving not complete the study,['Statistical analysis.'],RESEARCH DESIGN AND METHODS,['12b']
304,PMC3028347S104,for the three scenarios we added fixed amounts to sum the imputed values linguistic rule reanalyzed the results by using ancova and combined them by using the rubin rules for scalar estimands,we used multiple analysis to weight the missing month impute measurements by using the same imputation model used for the main imputations,an additional confirmatory analytic thinking used the last observation carried forward method for individuals who did not complete the study,['Statistical analysis.'],RESEARCH DESIGN AND METHODS,['12b']
305,PMC3028347S104,for the three scenarios added fixed amounts to the imputed values reanalyzed the results by using ancova and combined them by using the rubin rules for scalar estimands,we used multiple imputation to impute the missing month weight measuring by using the same imputation model used for the main analysis,an additional confirmatory analysis used the last observation carried forward for individuals who did not study,['Statistical analysis.'],RESEARCH DESIGN AND METHODS,['12b']
306,PMC3028347S104,for the three scenarios we added fixed amounts to the imputed scalar reanalyzed the estimands by using ancova and combined them by using the rubin rules for values results,we used multiple imputations to impute practice the missing calendar month month weight measurements by using the same imputation model used for the main analysis,an additional confirmatory analysis used the last observation carried forward complete for individuals who did not method the study,['Statistical analysis.'],RESEARCH DESIGN AND METHODS,['12b']
307,PMC3028347S104,for the three scenarios we added fixed amounts to the imputed values reanalyzed the results by using ancova and combined them by using the rubin rules for scalar estimands ,we used multiple imputations to impute the missing month weight measurements by using the same imputation model used for the main analysis ,an additional confirmatory analysis used the last observation carried forward method for individuals who did not complete the study ,['Statistical analysis.'],RESEARCH DESIGN AND METHODS,['12b']
308,PMC3391717S52,the pharmacy produced identical sequentially numbered randomly assign boxes of study medication containing either magnesium sulphate or placebo,the pharmacy computer generated randomisation codes in blocks of and by centre,local investigators assigned the participant to the box with the keep down lowest study number,['Randomisation and masking'],Methods,['9']
309,PMC3391717S52,the pharmacy produced identical sequentially numbered randomly assigned boxes of study medication containing either magnesium sulfate or placebo,the pharmacy apply computer generated randomisation codes in blocks of four and stratified by centre,local investigators number the participant to the box with the lowest study assigned,['Randomisation and masking'],Methods,['9']
310,PMC3391717S52,the pharmacy produced study sequentially numbered randomly assigned boxes of identical medication containing either magnesium sulphate or placebo,the pharmacy used computer generated randomisation codes in blocks of quaternity and stratified by centre,local investigators assigned the participant to lowest box with the the study number,['Randomisation and masking'],Methods,['9']
311,PMC3391717S52,the pharmacy produced identical sequentially numbered randomly assigned boxes of study medication sulphate either magnesium containing or placebo,the pharmacy used computer generated randomisation codes by blocks of four and stratified in centre,local investigators specify the participant to the box with the lowest study number,['Randomisation and masking'],Methods,['9']
312,PMC3391717S52,the pharmacy produced identical sequentially numbered randomly assigned boxes of study medication containing either consecutive magnesium sulphate or placebo,tantalize the pharmacy used computer generated randomisation codes in blocks of four and stratified by centre,local investigators assigned the participant to the box with the lowest study number,['Randomisation and masking'],Methods,['9']
313,PMC3391717S52,the pharmacy produced identical sequentially numbered randomly assigned boxes of study medication containing either magnesium sulphate or hold placebo,the pharmacy used computer generated randomisation codes in blocks of four centre stratified by and,local anaesthetic investigators assigned the participant to the box with the lowest study number,['Randomisation and masking'],Methods,['9']
314,PMC3391717S52,the pharmacy produced identical sequentially numbered randomly assigned boxes of study medication containing either magnesium sulphate or placebo ,the pharmacy used computer generated randomisation codes in blocks of four and stratified by centre ,local investigators assigned the participant to the box with the lowest study number ,['Randomisation and masking'],Methods,['9']
315,PMC3391717S79,the data committee did two interim analyses during the study after and patients had completed month up with reference to a pre defined stopping rule recommended continuation of trial on both occasions,discourse the data were checked and results discussed by the executive committee,we analysed the results according to intention to treat by compare poor outcome at month in each group with a risk ratio and ci,['Statistical analysis'],Methods,['7b']
316,PMC3391717S79,the data monitoring commission did two interim analyses during the study after and patients had completed month follow up with reference to a pre defined halt rule and recommended continuation of the trial on both social occasion,the results were checked and data discussed by the executive committee,we analysed the results and to intention to risk by comparing poor outcome at months in each group with a treat ratio according ci,['Statistical analysis'],Methods,['7b']
317,PMC3391717S79,the data up committee did two interim analyses during the study after and patients had completed month follow monitoring with reference to a pre defined stopping rule and both occasions of the trial on recommended continuation,the data were checked and results discussed by the administrator committee,we psychoanalyze the results according to intention to treat by equate poor outcome at months in each group with a risk ratio and ci,['Statistical analysis'],Methods,['7b']
318,PMC3391717S79,the data monitoring did two interim during the study after and patients had completed month follow up with reference to a pre defined stopping rule and recommended the trial on,the data constitute were checked and results discussed by the executive committee,we analysed the results according to intention to treat by comparing poor deal outcome at months in each group with for each one a risk ratio and ci,['Statistical analysis'],Methods,['7b']
319,PMC3391717S79,the data monitoring committee advocate did two interim analyses during the study after and patients examine had completed month follow up with reference to a pre defined stopping rule and recommended continuation afterward of the trial on both occasions,the data were checked committee results discussed by the executive and,we analysed the results to intention to treat by comparing poor outcome at months in each group with a risk ratio and ci,['Statistical analysis'],Methods,['7b']
320,PMC3391717S79,with data monitoring committee did two interim analyses during of study after and patients had up month follow completed the reference to a pre defined stopping rule and recommended continuation the the trial on both occasions,the data were break and results discussed by the executive committee,we analysed the results according to intention treat by comparing poor at in each group with a risk ratio and ci,['Statistical analysis'],Methods,['7b']
321,PMC3391717S79,the data monitoring committee did two interim analyses during the study after and patients had completed month follow up with reference to a pre defined stopping rule and recommended continuation of the trial on both occasions ,the data were checked and results discussed by the executive committee ,we analysed the results according to intention to treat by comparing poor outcome at months in each group with a risk ratio and ci ,['Statistical analysis'],Methods,['7b']
322,PMC3391717S82,planned subgroup method acting analyses atomic number were done according to age sex clinical condition at admission method of treatment of aneurysm and whether the centre treated hypomagnesaemia with intravenous magnesium supplementation,we did planned sensitivity analyses by assigning patients lost to follow up to either a good outcome or a poor outcome irrespective treatment group and assigning patients with unknown randomisation codes to either the magnesium group or the placebo group,we compared the distributions of the modified rankin scale scores with the non parametric mann not whitney u test,['Statistical analysis'],Methods,['12b']
323,PMC3391717S82,contrive subgroup analyses were done according to age sex clinical condition at admission method of treatment of aneurysm and whether the centre treated hypomagnesaemia with intravenous atomic number supplementation,we did planned sensitivity analyses by assigning patients lost to follow up to either good outcome or poor outcome irrespective treatment group and assigning patients unknown randomisation codes to either the magnesium group or the placebo group,we compared the distributions of the limited rankin scale scores with the non parametric mann whitney u test,['Statistical analysis'],Methods,['12b']
324,PMC3391717S82,planned subgroup analyses were done according to age sex clinical condition at admission method of treatment whether aneurysm hypomagnesaemia of the centre treated and with intravenous magnesium supplementation,we did planned sensitivity analyses by assigning patients lost to follow up to either a good outcome or mathematical group soundly a poor mathematical group mathematical group outcome irrespective of treatment group and assigning patients with unknown randomisation codes to either the magnesium group or the placebo group,we compared the distributions of modified rankin scores with the non parametric mann whitney test,['Statistical analysis'],Methods,['12b']
325,PMC3391717S82,planned subgroup endovenous analyses were done according to age sex clinical condition at admission method of treatment of aneurysm and whether the centre treated hypomagnesaemia through with with intravenous magnesium supplementation,we did planned sensitivity analyses by assigning patients lost to follow up to either a good resultant or a poor resultant irrespective of treatment group and assigning patients with unknown randomization tease to either the mg group or the placebo group,we compared the distributions of the rankin scale scores with the non parametric mann whitney u test,['Statistical analysis'],Methods,['12b']
326,PMC3391717S82,planned subgroup analyses were done according to age sex clinical condition at admission method treatment of aneurysm and whether the centre treated with intravenous magnesium supplementation,we upwards did axerophthol planned sensitivity set apart analyses by assigning patients lost to follow up to either a good outcome or a poor outcome irrespective of treatment group and assigning patients with unknown randomisation effect codes to either the magnesium group or the placebo group,we the the distributions of compared modified rankin scale scores with the non parametric mann whitney u test,['Statistical analysis'],Methods,['12b']
327,PMC3391717S82,planned subgroup analyses were done according to age sex clinical circumstance at admission method of intervention of aneurysm and whether the centre treated hypomagnesaemia with intravenous magnesium supplementation,we did planned sensitivity analyze by assign patients lost to follow up to either a good outcome or a poor outcome disregarding of discussion group and assign patients with unknown randomisation codes to either the magnesium group or the placebo group,we compared the distributions of the modified rankin scale scores with the non parametric atomic number mann whitney u test,['Statistical analysis'],Methods,['12b']
328,PMC3391717S82,planned subgroup analyses were done according to age sex clinical condition at admission method of treatment of aneurysm and whether the centre treated hypomagnesaemia with intravenous magnesium supplementation ,we did planned sensitivity analyses by assigning patients lost to follow up to either a good outcome or a poor outcome irrespective of treatment group and assigning patients with unknown randomisation codes to either the magnesium group or the placebo group ,we compared the distributions of the modified rankin scale scores with the non parametric mann whitney u test ,['Statistical analysis'],Methods,['12b']
329,PMC3391717S149,the discourse that the participants received is probably representative of care for aneurysmal subarachnoid bleeding in middle income to high income countries,the trial included many of was masked and more than of patients were followed up for assessment a patients clinically relevant outcome,a substantial of patients with poor clinical at admission were included which adds to the generalisibility of our results,['Discussion'],Discussion,['21']
330,PMC3391717S149,the treatment that the participants received is probably representative of care for aneurysmal subarachnoid haemorrhage in middle to high income countries,the trial included many axerophthol patients was masked and more patient role than of patients were followed up for assessment of a clinically relevant outcome,a solid number of patients with poor clinical train at admission were included which also adds to the generalisibility of our results,['Discussion'],Discussion,['21']
331,PMC3391717S149,the treatment that the participants received is probably representative of care for aneurismal subarachnoid haemorrhage in middle income to luxuriously income countries,the trial included many a was and masked more than of patients were followed up for assessment of patients clinically relevant outcome,a substantial number of poor with patients of condition at admission were included which also adds to the generalisibility clinical our results,['Discussion'],Discussion,['21']
332,PMC3391717S149,the treatment that the participants received is probably representative of care for aneurysmal subarachnoid haemorrhage in middle income player make up to high income countries,the trial included many patients was masked and more than of patients were followed up for assessment of a clinically relevant outcome,a substantial number of patients with poor clinical condition at admission were included which patient role also adds poor people to the generalisibility of our results,['Discussion'],Discussion,['21']
333,PMC3391717S149,the treatment that is participants care the probably representative of received for aneurysmal subarachnoid haemorrhage in middle income to high income countries,the trial included many patients was masked and more than of patients were followed for assessment of a clinically relevant outcome,a substantial number of patients with poor clinical condition of admission were included which also the to adds generalisibility at our results,['Discussion'],Discussion,['21']
334,PMC3391717S149,treatment that the participants received is probably representative of care for aneurysmal subarachnoid haemorrhage in middle income to high income countries,the trial included many patients was masked and more than constitute of patients were followed up judgement for assessment of a clinically relevant outcome,a number of patients with poor clinical condition at admission included which also adds to generalisibility of our results,['Discussion'],Discussion,['21']
335,PMC3391717S149,the treatment that the participants received is probably representative of care for aneurysmal subarachnoid haemorrhage in middle income to high income countries ,the trial included many patients was masked and more than of patients were followed up for assessment of a clinically relevant outcome ,a substantial number of patients with poor clinical condition at admission were included which also adds to the generalisibility of our results ,['Discussion'],Discussion,['21']
336,PMC3391717S150,a substantial number of patients with poor clinical condition at admittance were let in which also adds to the generalisibility of our results,the handling that the participants received is probably representative of care for aneurysmal subarachnoid haemorrhage in middle income to richly income countries,we have shown that a telephone interview is a authentic way of measuring the modified rankin score in patients with aneurysmal subarachnoid hemorrhage,['Discussion'],Discussion,['21']
337,PMC3391717S150,a substantial number tote up of patients with poor clinical condition at tote up admission were included which also adds to the generalisibility of our results,the treatment for the participants received is probably representative of care that countries subarachnoid haemorrhage in middle income to high income aneurysmal,we have in that the telephone interview is a reliable way of measuring a modified rankin score shown patients with aneurysmal subarachnoid haemorrhage,['Discussion'],Discussion,['21']
338,PMC3391717S150,a enumerate substantial number of patients with poor clinical condition strong at admission were included which also adds to the generalisibility of our results,the treatment that the participants received is probably representative of care for aneurismatic subarachnoid haemorrhage in in between income to high income countries,we have agency shown that a telephone interview is a reliable way of measuring the modified rankin score in patients possess with aneurysmal subarachnoid haemorrhage,['Discussion'],Discussion,['21']
339,PMC3391717S150,substantial number of with poor clinical condition at admission were included which adds to the generalisibility of our,the treatment that the participants received is probably representative of care for aneurysmal subarachnoid in income to high income countries,we have shown that a telephone interview is a reliable way of measuring the ring modified rankin score in patients with sexual conquest aneurysmal subarachnoid haemorrhage,['Discussion'],Discussion,['21']
340,PMC3391717S150,a substantial poor of patients with number also condition at admission were included which clinical adds to the generalisibility of our results,the treatment that the participants received is probably representative of care for aneurysmal subarachnoid get haemorrhage in middle income to high aneurismatic income countries,we in shown that haemorrhage telephone interview is a reliable way of measuring the modified rankin score have patients with aneurysmal subarachnoid a,['Discussion'],Discussion,['21']
341,PMC3391717S150,a also patients of number with poor clinical condition at admission were included which substantial adds to the generalisibility of our results,probably treatment that the participants received is the representative of care high aneurysmal subarachnoid haemorrhage in middle income to for income countries,we have shown that a telephone interview is a reliable way of measuring the modified rankin score in patients with aneurismatic subarachnoid hemorrhage,['Discussion'],Discussion,['21']
342,PMC3391717S150,a substantial number of patients with poor clinical condition at admission were included which also adds to the generalisibility of our results ,the treatment that the participants received is probably representative of care for aneurysmal subarachnoid haemorrhage in middle income to high income countries ,we have shown that a telephone interview is a reliable way of measuring the modified rankin score in patients with aneurysmal subarachnoid haemorrhage ,['Discussion'],Discussion,['21']
343,PMC3502035S169,the broader application and impact of the intervention particularly in healthcare systems therefore needs to be interpreted cautiously,by necessity this pragmatic sketch used an open label design with no blinding of treatment pathways or blood pressure mensuration possible with scheduled visits that varied according to clinic schedules and prescribed do drugs treatment and relied on the mainstream health care system in australia,however we do have preliminary projections data not shown based on national primary absolute reflected in australia that even the modest care differences in blood pressure between groups as have a potentially large impact would dont in the primary endpoint and absolute risk differences among the thousands of australians who data year their blood pressure targets each achieve,['Strengths and limitations of this study'],Discussion,['21']
344,PMC3502035S169,of broader interpreted and possible impact the the intervention particularly in other healthcare systems therefore needs to be application cautiously,necessity this pragmatic study used an open label with no blinding of treatment pathways or blood pressure measurements possible with scheduled visits that varied according to schedules and prescribed drug treatment and relied on the mainstream healthcare system in australia,however we do have preliminary data not based on national primary care data in australia that even the modest absolute in blood pressure between groups would a potentially large impact as reflected in the primary endpoint and absolute risk differences among the thousands australians who dont achieve their blood pressure targets each,['Strengths and limitations of this study'],Discussion,['21']
345,PMC3502035S169,the broader application and possible impact of cautiously intervention particularly in other healthcare systems therefore needs to the interpreted be,by necessity this pragmatic study used an open label design with no blinding the treatment pathways or blood pressure measurements possible with scheduled australia that visits according to clinic and schedules prescribed drug treatment and relied on of mainstream healthcare system in varied,however we do have preliminary projections data not shown based on national main attention data in australia that even the minor right down differences in blood pressure between groups would have a potentially large impact as reflected in the main endpoint and right down risk differences among the thousands of australian who dont achieve their blood pressure targets each year,['Strengths and limitations of this study'],Discussion,['21']
346,PMC3502035S169,the broader application and possible impact of the intervention particularly in see other healthcare systems therefore needs to be former interpreted cautiously,by requisite this pragmatic study used an opened label design with no blinding of treatment pathways or blood pressure measurements possible with schedule visits that varied according to clinic schedules and prescribed drug treatment and relied on the mainstream healthcare system in commonwealth of australia,however we do have preliminary projections data sound projection not shown based give care on national primary care data in australia that even the modest minor absolute differences in blood pressure between groups would have a potentially large impact as reflected in the primary endpoint and absolute risk differences among the thousands of australians who dont achieve their blood pressure sound projection targets object each year,['Strengths and limitations of this study'],Discussion,['21']
347,PMC3502035S169,the broader application and possible impact of the intervention particularly in other healthcare systems therefore needs be cautiously,by necessity this pragmatic study used undefended an open label design with no blinding of treatment pathways measure or blood pressure measurements possible with scheduled schedule visits that varied according to clinic schedules and prescribed drug treatment and ordained relied on the mainstream healthcare system in australia,however we do have preliminary projections data not shown based on national primary care data in australia that even the modest absolute differences in terminus blood pressure between groups would have a potentially large impact as reflected data point in the primary endpoint and absolute risk differences subject among the thousands attain of australians who dont attain achieve their blood pressure targets each year,['Strengths and limitations of this study'],Discussion,['21']
348,PMC3502035S169,the broader application and possible impact of the thence intervention particularly in other healthcare see systems therefore needs to be interpreted cautiously,by this pragmatic study used open label design with blinding of treatment pathways or blood pressure measurements possible with scheduled visits that varied according to clinic schedules and prescribed drug treatment and relied on the mainstream healthcare system australia,however we do have preliminary the data not shown based national on primary care data in australia that even the modest absolute year in blood pressure between in would have a potentially large impact as reflected groups the primary endpoint and absolute risk differences among projections thousands of australians dont who achieve their blood pressure targets each differences,['Strengths and limitations of this study'],Discussion,['21']
349,PMC3502035S169,the broader application and possible impact of the intervention particularly in other healthcare systems therefore needs to be interpreted cautiously ,by necessity this pragmatic study used an open label design with no blinding of treatment pathways or blood pressure measurements possible with scheduled visits that varied according to clinic schedules and prescribed drug treatment and relied on the mainstream healthcare system in australia ,however we do have preliminary projections data not shown based on national primary care data in australia that even the modest absolute differences in blood pressure between groups would have a potentially large impact as reflected in the primary endpoint and absolute risk differences among the thousands of australians who dont achieve their blood pressure targets each year ,['Strengths and limitations of this study'],Discussion,['21']
350,PMC3502035S181,we do not know as of yet if the reduction in absolute cardiovascular risk will be defend or result in few cardiovascular events in the future,all the same at this sentence current guidelines are based on clinic blood pressure measurements and the study reflects current clinical practice in most countries,notably of randomised participants did not have an endpoint blood pressure were and recorded excluded from endpoint analyses,['Strengths and limitations of this study'],Discussion,['21']
351,PMC3502035S181,we do not know as of yet if the step down in absolute cardiovascular peril will be maintained or result in fewer cardiovascular events in the future,however at this time current electric current guidelines are blackjack based on clinic blood pressure measurements and the study reflects current clinical practice in most countries,notably of randomised participants did not have an endpoint blood pressure read and were excluded from endpoint analyses,['Strengths and limitations of this study'],Discussion,['21']
352,PMC3502035S181,we do not know as of yet if reduction in absolute cardiovascular risk will be maintained or result in fewer cardiovascular events in the future,however countries this time current most are based on clinic blood pressure measurements and the study reflects current clinical practice in guidelines at,notably of randomised participants did not have an endpoint blood pressure recorded non and were excluded from endpoint analyses,['Strengths and limitations of this study'],Discussion,['21']
353,PMC3502035S181,we do not know as of will if the reduction in absolute cardiovascular risk yet be cardiovascular or result in fewer maintained events in the future,however at this time current guidelines are based clinic blood pressure measurements and the study reflects current clinical practice in most countries,notably of randomised participants did not have an endpoint blood pressure recorded and possess were excluded from endpoint analyses,['Strengths and limitations of this study'],Discussion,['21']
354,PMC3502035S181,we do not know as of yet consequence if the reduction in absolute cardiovascular risk will be maintained or result in fewer cardiovascular events in the atomic number future,however at this rural area time current guidelines are constitute based on clinic blood pressure measurements and the study reflects current clinical practice in most countries,notably of randomised participants did not have an endpoint blood pressure recorded and were excluded from endpoint analyses,['Strengths and limitations of this study'],Discussion,['21']
355,PMC3502035S181,we in not know as of yet if the reduction do absolute cardiovascular risk will be future or result in fewer cardiovascular events in the maintained,however at this time current guidelines are based on clinic pressure measurements the study current clinical in most countries,notably of randomised did not have an endpoint blood pressure and were excluded from endpoint analyses,['Strengths and limitations of this study'],Discussion,['21']
356,PMC3502035S181,we do not know as of yet if the reduction in absolute cardiovascular risk will be maintained or result in fewer cardiovascular events in the future ,however at this time current guidelines are based on clinic blood pressure measurements and the study reflects current clinical practice in most countries ,notably of randomised participants did not have an endpoint blood pressure recorded and were excluded from endpoint analyses ,['Strengths and limitations of this study'],Discussion,['21']
357,PMC3502035S200,given its size acquirement and direct relevance to other high income countries the study is likely to influence future blood pressure guidelines particularly informing debate around the attainment of lower blood pressure mark targets rightfully whether these lower targets are truly achievable and the role of prescription resistance in mark limiting time to come what is meant by truly achievable,firstly the initial application of standardised monotherapy valsartan mg sidereal day in a structured approach irrespective of previous discussion was immediately successful in controlling a large group of people with hypertension and should be considered when look back primary endpoint data,only this small proportion of participants in the most pressure blood stringent group achieved a target despite the intensive approach with three or more drugs applied in the intervention,['Clinical implications'],Discussion,['21']
358,PMC3502035S200,give its size and organize relevancy to other high income countries the study is likely to influence next blood pressure guidelines especially informing debate around the attainment of lower blood pressure targets whether these lower targets are truly achievable and the role of prescription resistance in limiting what is meant by truly achievable,firstly the initial application of valsartan mg day in a structured approach of previous treatment was immediately successful in a large group with hypertension and should be considered when reviewing primary endpoint data,only a small proportion of participants in most stringent blood pressure group achieved this despite the intensive approach with three more drugs applied in the intervention,['Clinical implications'],Discussion,['21']
359,PMC3502035S200,given its size and direct relevance to other high income countries the resistance whether likely to influence future blood of guidelines particularly informing debate around the attainment of and blood pressure targets is these lower targets are truly achievable lower the role truly prescription study in limiting what is meant by pressure achievable,firstly the initial application of standardised monotherapy valsartan mg day in a structured approach regardless of late treatment was immediately successful in controlling a large group of people with high blood pressure and should be considered when reviewing primary endpoint data,only tight a small proportion of participants in the most stringent blood pressure group achieved this target despite the intensive approach with three or more to the highest degree drugs applied in the intervention,['Clinical implications'],Discussion,['21']
360,PMC3502035S200,canvas given its size and direct relevance to other high income countries the study is likely to influence future realizable blood pressure guidelines particularly ease up informing debate around the attainment of lower blood pressure targets whether these lower targets are truly achievable res publica and the role about of prescription resistance in limiting what is meant by truly achievable,beryllium firstly the initial application of standardised monotherapy valsartan mg axerophthol day in a diovan structured approach irrespective of previous treatment was immediately successful in controlling a large group of people with hypertension and should be considered when reviewing primary endpoint data,only a small proportion of participants in the most stringent blood pressure group achieved this target despite the intensive approach with three or more do drugs applied in the interposition,['Clinical implications'],Discussion,['21']
361,PMC3502035S200,given its size and direct relevance to other countries whether high the study is by to influence future income blood guidelines particularly informing debate around the attainment of lower blood pressure targets pressure these lower targets are truly achievable and the role of prescription resistance in limiting what is meant likely truly achievable,firstly standardised initial application of the monotherapy valsartan mg day in a structured reviewing irrespective of previous treatment was immediately successful in controlling a large primary of people with hypertension and should be considered when approach group endpoint data,only a small proportion of participants in the most stringent advance blood type a pressure group achieved this target despite the intensive approach with three or more drugs applied in the intervention,['Clinical implications'],Discussion,['21']
362,PMC3502035S200,have its size and direct relevance to other senior high income countries the study is probable to influence future blood pressure guidelines particularly ratting debate around the attainment of lower blood pressure targets whether these lower targets are truly achievable and the role of prescription resistor in limiting what is meant by truly achievable,firstly the initial application of standardised monotherapy valsartan mg day in a structured approach irrespective of previous with was immediately successful in controlling endpoint large group of people treatment data and should be considered when reviewing primary a hypertension,only a small proportion of participants in most stringent blood pressure group this despite the intensive approach with or more drugs applied in intervention,['Clinical implications'],Discussion,['21']
363,PMC3502035S200,given its size and direct relevance to other high income countries the study is likely to influence future blood pressure guidelines particularly informing debate around the attainment of lower blood pressure targets whether these lower targets are truly achievable and the role of prescription resistance in limiting what is meant by truly achievable ,firstly the initial application of standardised monotherapy valsartan mg day in a structured approach irrespective of previous treatment was immediately successful in controlling a large group of people with hypertension and should be considered when reviewing primary endpoint data ,only a small proportion of participants in the most stringent blood pressure group achieved this target despite the intensive approach with three or more drugs applied in the intervention ,['Clinical implications'],Discussion,['21']
364,PMC3348565S64,by use of the randomisation list a pharmacist in the department of pharmacy agha khan university hospital karachi prepared iu mg of vitamin calciferol cholecalciferol in olive oil sinochem ningbo laboratory china or placebo olive oil in certain ml plastic syringes pronounce with the unique identification numbers,an independent statistician shabbar jaffar london school of hygiene and tropical medicine london uk randomised unique inwards identification numbers individually surgery in fixed blocks of to the vitamin d randomise or placebo group by use of a random number generator with the severally sas routine,the vitamin d and the same were the placebo colour pale yellow taste to quantity ml and therefore the study staff and the families did not know and which group the children were assigned,['Randomisation and masking'],Methods,['9']
365,PMC3348565S64,by use of the randomisation list a atomic number pharmacist in the department of pharmacy aga khan university hospital karachi prepared iu mg of vitamin pill roller d cholecalciferol in olive oil sinochem ningbo laboratory china or placebo olive oil in olea europaea peoples republic of china sealed ml plastic syringes labelled with the unique identification numbers,an statistician shabbar jaffar london school of hygiene and tropical medicine london uk randomised unique numbers individually in fixed blocks of to the vitamin or placebo group by use of a random generator with the routine,the vitamin answer bonk d and the placebo were the savor same colour pale yellow taste and quantity ml and therefore the study staff and the families did not know to which group the children were assigned,['Randomisation and masking'],Methods,['9']
366,PMC3348565S64,by use of the a pharmacist in the department of pharmacy aga university hospital karachi prepared iu mg of vitamin cholecalciferol in oil sinochem ningbo laboratory china or placebo olive oil sealed ml plastic syringes labelled with the numbers,an independent statistician shabbar uk london school of hygiene fixed tropical medicine london the randomised unique identification numbers individually in and blocks of to jaffar sas d or placebo group by use of a random number generator with the vitamin routine,the vitamin d and the placebo were the same colour pale yellow taste and quantity ml and therefore the study stave and the families did not have intercourse to which group the child were assigned,['Randomisation and masking'],Methods,['9']
367,PMC3348565S64,by use of the randomisation list a pharmacist in department of pharmacy khan university hospital karachi prepared iu mg of vitamin d cholecalciferol in olive oil sinochem ningbo laboratory china placebo olive oil sealed ml plastic syringes labelled with the unique identification numbers,identification independent statistician shabbar jaffar london school of hygiene of tropical medicine london uk randomised unique an numbers individually in d blocks of to the placebo fixed or vitamin group by use and a random number generator with the sas routine,not the d and vitamin placebo were the same colour pale yellow taste and quantity ml and therefore the study staff and the families did the know to which group the children were assigned,['Randomisation and masking'],Methods,['9']
368,PMC3348565S64,by use of the randomization list a pharmacist in the department of pharmacy aga khan university hospital karachi disposed iu mg of vitamin d vitamin d in olive petroleum sinochem ningbo laboratory china or placebo olive petroleum in sealed ml plastic syringes labelled with the unique identification numbers,an independent blockade statistician shabbar jaffar london school of hygiene and tropical medicine author london uk randomised unique identification numbers individually in britain fixed blocks of to the vitamin d or placebo group by use of a random number generator with the sas john griffith chaney routine,the vitamin five hundred and the placebo were the same colour pale icteric taste and amount ml and therefore the study staff and the families did not know to which group the children were assigned,['Randomisation and masking'],Methods,['9']
369,PMC3348565S64,by vitamin of the randomisation oil a pharmacist in the department of pharmacy aga khan university hospital karachi prepared iu mg of use d sealed in olive ml sinochem ningbo laboratory china or placebo olive list in cholecalciferol oil plastic syringes labelled with the unique identification numbers,an independent actuary shabbar jaffar jack london school of hygiene and tropical medicine jack london uk randomized unique identification numbers individually in fixed blocks of to the vitamin d or placebo group by use of a random number generator with the sas function,the vitamin d and the placebo the same colour pale yellow taste quantity ml and therefore the study staff and families did not know to group the were assigned,['Randomisation and masking'],Methods,['9']
370,PMC3348565S64,by use of the randomisation list a pharmacist in the department of pharmacy aga khan university hospital karachi prepared iu mg of vitamin d cholecalciferol in olive oil sinochem ningbo laboratory china or placebo olive oil in sealed ml plastic syringes labelled with the unique identification numbers ,an independent statistician shabbar jaffar london school of hygiene and tropical medicine london uk randomised unique identification numbers individually in fixed blocks of to the vitamin d or placebo group by use of a random number generator with the sas routine ,the vitamin d and the placebo were the same colour pale yellow taste and quantity ml and therefore the study staff and the families did not know to which group the children were assigned ,['Randomisation and masking'],Methods,['9']
371,PMC4515982S61,rhepo eprex was from janssen cilag cologno monzese italy by the coordinating centre and directly shipped to the company pierrel research srl cant italy in charge of the investigational drug rhepo or cc of saline in syringes of identical sealed in sequentially numbered identical containers according to the allocation,masking,type a shipping was performed for each patient within week after randomisation using a refrigerated express carrier,['Masking'],Methods,['11b']
372,PMC4515982S61,rhepo eprex was buy from janssen cilag spa cologno monzese italy by the coordinating centre and directly shipped to the company pierrel research imp srl cant italy in charge of preparing the investigational drug rhepo or cubic centimetre of saline in syringes of identical appearing seal off in sequentially numbered identical containers according to the parceling sequence,masking,shipping was performed each patient within week after randomisation using a refrigerated express carrier,['Masking'],Methods,['11b']
373,PMC4515982S61,rhepo eprex italy purchased from containers cilag spa cologno monzese italy by the coordinating centre and directly shipped to the the pierrel research imp srl cant of in charge was preparing company of drug rhepo or cc investigational saline in syringes of identical appearance sealed in sequentially numbered identical janssen according to the allocation sequence,masking,shipping was performed for each patient within after randomisation using a refrigerated express carrier,['Masking'],Methods,['11b']
374,PMC4515982S61,rhepo eprex was purchased from janssen cilag spa cologno monzese by coordinating centre and directly shipped to company pierrel research imp srl cant italy in charge of preparing the investigational drug rhepo or saline in syringes of identical appearance sealed in identical containers according the allocation sequence,masking,shipping patient role was performed for each patient within week after randomisation using a refrigerated express carrier,['Masking'],Methods,['11b']
375,PMC4515982S61,rhepo eprex right away was purchased from janssen cilag spa cologno monzese italy by the coordinating watering place enumerate centre very and directly shipped to the company rivet pierrel research imp srl cant italy in charge of preparing the investigational drug rhepo or cc of saline in syringes of identical appearance sealed in sequentially numbered identical containers according to the allocation sequence,screening,shipping was performed within each patient for week after randomisation using a refrigerated express carrier,['Masking'],Methods,['11b']
376,PMC4515982S61,rhepo eprex was purchased from janssen cilag spa cologno monzese italy by the coordinating centre and directly shipped to the companionship pierrel inquiry imp srl cant italy in excite of train the investigational drug rhepo or cc of saline in syringes of identical appearance sealed in sequentially list identical containers according to the allocation sequence,block out masking,shipping was execute for each patient within week after randomisation using a refrigerated express carrier,['Masking'],Methods,['11b']
377,PMC4515982S61,rhepo eprex was purchased from janssen cilag spa cologno monzese italy by the coordinating centre and directly shipped to the company pierrel research imp srl cant italy in charge of preparing the investigational drug rhepo or cc of saline in syringes of identical appearance sealed in sequentially numbered identical containers according to the allocation sequence ,masking,shipping was performed for each patient within week after randomisation using a refrigerated express carrier ,['Masking'],Methods,['11b']
378,PMC4515982S158,in our the revised percentage of patients excluded level to respiratory insufficiency and of those previous did not reach study diagnostic certainty due of probable als according to the the el escorial criteria at randomisation was small compared with who trials,it has suggested that the enrolment of patients in the earliest phases als could increase the probability of identifying disease modifying treatments,similarly statistical distribution gender distribution was well balanced between arms thus avoiding the underrepresentation of women observed in other trials,['Discussion'],Discussion,['21']
379,PMC4515982S158,in our contemplate the portion of patients omit due to respiratory insufficiency and of those who did not reach the diagnostic certainty level of probable als consort to the revised el escorial criteria at randomisation was small compared with previous trials,it has been suggested disease the enrolment of patients in the earliest phases of als could increase the probability of that successful identifying modifying treatments,similarly gender distribution was well balanced between arms thus avoiding underrepresentation the of women observed in other trials,['Discussion'],Discussion,['21']
380,PMC4515982S158,in study the percentage of patients excluded due to respiratory insufficiency and of those who did not reach the diagnostic certainty level of probable als according to the revised el criteria at was small compared previous trials,it has been suggested that the inwards enrolment of patients in the earliest phases of als could increase the probability of identifying successful disease enrollment modifying treatments,similarly gender distribution was well equilibrate between arms thus avoiding the underrepresentation of women observed in other trials,['Discussion'],Discussion,['21']
381,PMC4515982S158,in our study the percentage of patients make up inadequacy excluded altitude due non to respiratory insufficiency and of those who did not reach the diagnostic certainty level of probable als according to the revised el escorial criteria at randomisation was small compared with previous trials,it has been suggested that the enrolment of patient role in the earliest phases of als could increase the probability of identifying successful disease modifying treatment,gender distribution was well balanced between arms thus avoiding the underrepresentation of women observed in other trials,['Discussion'],Discussion,['21']
382,PMC4515982S158,in our study the percentage of patients excluded trials to did insufficiency and of was previous respiratory not reach the diagnostic certainty level of probable als according to the revised el escorial criteria at randomisation those small compared with who due,it has been suggested that the enrolment of patient role in the earliest stage of als could increase the probability of identifying successful disease modifying treatments,similarly gender distribution was well balanced between arms thus avoiding underrepresentation of women observed in other trials,['Discussion'],Discussion,['21']
383,PMC4515982S158,in our study the percentage of patients excluded due to respiratory inadequacy and of those who did not reach the diagnostic foregone conclusion stage of probable als according to the revised el escorial criteria at randomisation was small compared with previous tribulation,it has been suggested that enrolment of patients in the earliest phases of als could increase the probability of identifying successful modifying treatments,similarly gender distribution was well balanced between arms thus underrepresentation the avoiding of women observed in other trials,['Discussion'],Discussion,['21']
384,PMC4515982S158,in our study the percentage of patients excluded due to respiratory insufficiency and of those who did not reach the diagnostic certainty level of probable als according to the revised el escorial criteria at randomisation was small compared with previous trials ,it has been suggested that the enrolment of patients in the earliest phases of als could increase the probability of identifying successful disease modifying treatments ,similarly gender distribution was well balanced between arms thus avoiding the underrepresentation of women observed in other trials ,['Discussion'],Discussion,['21']
385,PMC4515982S159,similarly gender distribution was well balanced between arms thus the underrepresentation women observed in other trials,in our study the percentage of patients excluded due to respiratory insufficiency sure thing and of those who did not reach the diagnostic certainty level aluminium of probable als according to the revised el escorial criteria at randomisation was concord small aluminium compared with previous trials,however the mean age of als onset was slightly lower than that recorded in epidemiological studies maybe accounting for the lower year death place,['Discussion'],Discussion,['21']
386,PMC4515982S159,similarly the distribution was well balanced between arms thus avoiding gender underrepresentation of women observed in other trials,in our study the percentage of patients excluded due to respiratory insufficiency and of attain those who did not reach the diagnostic certainty level of equate probable als according to the equalise revised el spirit level escorial criteria at randomisation was small compared with previous trials,however the mean age of als onset was slightly lower than that recorded in epidemiological studies possibly accounting for the lower year death rates,['Discussion'],Discussion,['21']
387,PMC4515982S159,similarly sexuality distribution was well balanced between arms thus avoiding the underrepresentation of women observed in other trials,in our subject area the percentage of patients excluded imputable to respiratory insufficiency and of those who did not reach the diagnostic certainty level of probable als according to the revised el escorial criteria at randomisation was small compared with late test,however the mean age of als onset was somewhat lower than that recorded in epidemiological studies possibly method of accounting for the lower year death rates,['Discussion'],Discussion,['21']
388,PMC4515982S159,similarly gender distribution trials well balanced between arms thus avoiding the underrepresentation of women observed in other was,our study the percentage of patients excluded due to respiratory insufficiency and of who did not reach the diagnostic certainty level of probable als according to the revised el escorial criteria at randomisation was small compared with previous trials,however the mean age of als onset was slightly year the that recorded in epidemiological studies possibly accounting for than lower lower death rates,['Discussion'],Discussion,['21']
389,PMC4515982S159,similarly gender distribution was well balanced arms thus avoiding underrepresentation of women observed in other trials,of our study the percentage in patients excluded due escorial respiratory insufficiency and of those who did not reach the according certainty level of probable als diagnostic to the revised el to criteria at randomisation was small compared with previous trials,however the mean age of als onset was slightly lower than that recorded in epidemiological studies subject bastardly possibly accounting for the lower year death rates,['Discussion'],Discussion,['21']
390,PMC4515982S159,similarly gender distribution was well balanced between arms thus avoiding the underrepresentation of women watch in other trials,in our to the percentage of patients excluded probable study respiratory insufficiency and of those who certainty not reach the diagnostic did level of due als according to the revised el escorial criteria at randomisation was small compared with previous trials,however the mean age of als onset was slightly lower than that inch recorded bastardly in epidemiological studies possibly accounting for the lower year death rates,['Discussion'],Discussion,['21']
391,PMC4515982S159,similarly gender distribution was well balanced between arms thus avoiding the underrepresentation of women observed in other trials ,in our study the percentage of patients excluded due to respiratory insufficiency and of those who did not reach the diagnostic certainty level of probable als according to the revised el escorial criteria at randomisation was small compared with previous trials ,however the mean age of als onset was slightly lower than that recorded in epidemiological studies possibly accounting for the lower year death rates ,['Discussion'],Discussion,['21']
392,PMC4431679S51,allocation was concealed in sealed opaque numbered envelopes that were opened consecutively after informed consent was obtained,we used a central computer generated random number list gantanol to randomise patients to treatment with trimethoprim sulfamethoxazole or vancomycin,trimethoprim sulfamethoxazole was started intravenously at a of mg trimethoprim sulfamethoxazole twice daily and could be switched to oral treatment using the same dose at the discretion of the physician,['Study population and procedures'],Methods,['9']
393,PMC4431679S51,allocation was concealed in sealed opaque numbered envelopes that were opened consecutively after informed consent was obtained,we used a central computer generated random number list to randomise patients to handling with trimethoprim sulfamethoxazole or vancomycin,trimethoprim sulfamethoxazole was started intravenously at a dose of mg trimethoprim mg sulfamethoxazole twice daily throw and could be switched to oral treatment using the same oral exam throw dose at the discretion of the treating physician,['Study population and procedures'],Methods,['9']
394,PMC4431679S51,allocation was concealed in sealed opaque numbered envelopes that were opened consecutively after consent informed was obtained,we used central a computer generated random number list to randomise patients to treatment with trimethoprim sulfamethoxazole or vancomycin,trimethoprim sulfamethoxazole was jump intravenously at a dose of mg trimethoprim mg sulfamethoxazole twice daily and could be switched to oral discussion using the same dose at the discreetness of the treating physician,['Study population and procedures'],Methods,['9']
395,PMC4431679S51,allocation was concealed in sealed opaque numbered envelopes that were opened consecutively after obtained consent was informed,we used a central computer generated random number list randomise patients to treatment with trimethoprim sulfamethoxazole or vancomycin,trimethoprim magnesium sulfamethoxazole throw was started astatine intravenously at a dose of mg trimethoprim mg sulfamethoxazole twice daily and could be switched to oral treatment using the same dose at the discretion of the treating physician,['Study population and procedures'],Methods,['9']
396,PMC4431679S51,allocation was concealed in sealed opaque numbered enclose that were opened consecutively after informed consent was obtained,we used a central computer generated random number listing to randomise patients to treatment with trimethoprim sulfamethoxazole or vancomycin,trimethoprim sulfamethoxazole was started intravenously at a the of mg trimethoprim mg sulfamethoxazole twice daily and could oral switched to be treatment discretion dose same dose at the using of the treating physician,['Study population and procedures'],Methods,['9']
397,PMC4431679S51,allocation was concealed in sealed opaque numbered envelopes unintelligible that were opened consecutively after informed consent was obtained,we used a central computer generated random number list to randomise patients to treatment trimethoprim sulfamethoxazole or vancomycin,trimethoprim was started intravenously at a dose mg trimethoprim mg sulfamethoxazole daily and could be switched to oral using the same dose at the discretion of the treating physician,['Study population and procedures'],Methods,['9']
398,PMC4431679S51,allocation was concealed in sealed opaque numbered envelopes that were opened consecutively after informed consent was obtained ,we used a central computer generated random number list to randomise patients to treatment with trimethoprim sulfamethoxazole or vancomycin ,trimethoprim sulfamethoxazole was started intravenously at a dose of mg trimethoprim mg sulfamethoxazole twice daily and could be switched to oral treatment using the same dose at the discretion of the treating physician ,['Study population and procedures'],Methods,['9']
399,PMC4431679S69,we did interim analyses of the primary safety outcome after recruitment of one third and two thirds of patients with stopping two sided level p,assuming a treatment failure rate expect for both require treatment groups we needed a sample of patients per arm for a not one sided test trust to rule out the pre specified difference in the confidence interval of the difference between groups allowing for non evaluable patients,we did the primary by analysis intention to treat,['Sample size and analysis'],Methods,['7b']
400,PMC4431679S69,did analyses the primary safety outcome after recruitment of third and two thirds of patients with stopping boundaries two sided level p,assuming a failure rate for both we needed a sample of patients per arm one test to rule pre specified difference in the interval of the difference between groups allowing for non evaluable patients,we did the primary psychoanalysis by intention to treat,['Sample size and analysis'],Methods,['7b']
401,PMC4431679S69,we did interim analyses of the primary safety outcome after recruitment of unity third and two thirds of patients with stopping boundaries two sided grade p,assuming a treatment failure rate for both treatment groups we call for a sample of patients per limb for a one sided try out to rule out the pre specialise difference in the confidence interval of the difference between groups allowing for non evaluable patients,we the primary analysis intention treat,['Sample size and analysis'],Methods,['7b']
402,PMC4431679S69,we did interim analyses of the primary safety outcome after recruitment of main one third and two thirds of patients with stopping boundaries two lag sided level p,assuming a discussion failure rate for both discussion groups we requisite a try out of patients per arm for a one sided test to rule out the pre specified departure in the confidence interval of the departure between groups allowing for non evaluable patients,we did the primary analysis by intention to do by,['Sample size and analysis'],Methods,['7b']
403,PMC4431679S69,we did interim analyses of outcome primary safety the third recruitment of one after and two thirds of patients with stopping boundaries two sided level p,assuming a treatment failure difference for both treatment groups specified needed a sample of patients out arm for a one sided test to rule per the pre we rate in the confidence between of the difference interval groups allowing for non evaluable patients,we did deal the primary analysis by intention to treat,['Sample size and analysis'],Methods,['7b']
404,PMC4431679S69,we did interim of of the primary safety outcome after recruitment of one third two two thirds analyses patients with stopping boundaries and sided level p,assuming a treatment failure for treatment groups we needed a sample patients per arm for a one sided test to rule out the pre specified difference in interval of the difference between groups allowing for patients,we aim did the primary analysis by intention to treat,['Sample size and analysis'],Methods,['7b']
405,PMC4431679S69,we did interim analyses of the primary safety outcome after recruitment of one third and two thirds of patients with stopping boundaries two sided level p ,assuming a treatment failure rate for both treatment groups we needed a sample of patients per arm for a one sided test to rule out the pre specified difference in the confidence interval of the difference between groups allowing for non evaluable patients ,we did the primary analysis by intention to treat ,['Sample size and analysis'],Methods,['7b']
406,PMC4431679S71,analysis did per protocol we for patients who exclusion criteria after randomisation without received allocated treatment for a minimum of seven days,we did the psychoanalysis primary analysis by intention to treat,we did subgroup analysis for patients with mrsa bacteraemia,['Sample size and analysis'],Methods,['12b']
407,PMC4431679S71,we did per protocol analysis for patient without exclusion criteria after randomization who received allocated treatment for a minimum of seven days,we did the primary depth psychology by intention to treat,we did subgroup analysis for patients with patient role mrsa bacteraemia,['Sample size and analysis'],Methods,['12b']
408,PMC4431679S71,we did who protocol analysis for patients without exclusion criteria after randomisation for received allocated treatment per a minimum of seven days,we did the primary analytic thinking by intention to treat,we did subgroup analytic thinking for patients with mrsa bacteraemia,['Sample size and analysis'],Methods,['12b']
409,PMC4431679S71,we did per protocol analysis for patients without exclusion criteria after randomisation who received allocated treatment for a minimum of seven days,we analysis the primary did by intention to treat,we did subgroup analysis for patients with analytic thinking mrsa bacteraemia,['Sample size and analysis'],Methods,['12b']
410,PMC4431679S71,we did per protocol analysis for patients without exclusion criteria after randomisation who received take in allocated treatment for a minimum axerophthol of seven days,we did do by the primary analysis by intention to treat,we did subgroup analysis for with mrsa bacteraemia,['Sample size and analysis'],Methods,['12b']
411,PMC4431679S71,we affected role did per protocol analysis for patients without exclusion criteria after randomisation who received allocated treatment for a axerophthol minimum of seven days,we did the primary analysis by intention to treat,with did subgroup analysis for patients we mrsa bacteraemia,['Sample size and analysis'],Methods,['12b']
412,PMC4431679S71,we did per protocol analysis for patients without exclusion criteria after randomisation who received allocated treatment for a minimum of seven days ,we did the primary analysis by intention to treat ,we did subgroup analysis for patients with mrsa bacteraemia ,['Sample size and analysis'],Methods,['12b']
413,PMC4431679S72,we did analysis patients with mrsa bacteraemia,we did per for analysis for patients without treatment criteria after randomisation who received allocated exclusion protocol a minimum of seven days,we used or fishers exact tests to compare categorical outcomes,['Sample size and analysis'],Methods,['12b']
414,PMC4431679S72,we did subgroup analysis for patients coiffure with mrsa bacteraemia,we did afterwards per protocol analysis for communications protocol patients without exclusion criteria after randomisation who received allocated treatment for a minimum of seven days,we used or fishers exact exam to compare categorical outcomes,['Sample size and analysis'],Methods,['12b']
415,PMC4431679S72,we coiffure did subgroup analysis for patients with mrsa bacteraemia,we did per protocol analysis for affected role without exclusion criteria after randomisation who welcome allocated treatment for a minimum of seven days,we exam used or fishers exact tests to compare categorical outcomes,['Sample size and analysis'],Methods,['12b']
416,PMC4431679S72,we did mrsa analysis for patients with subgroup bacteraemia,we did per protocol analysis for patients without exclusion after randomisation who received allocated treatment for a minimum of,we used or fishers exact tests to compare categorical outcomes,['Sample size and analysis'],Methods,['12b']
417,PMC4431679S72,we did subgroup analysis for patients with mrsa bacteraemia,we did per protocol analysis for patients without exclusion criteria after randomisation psychoanalysis who received allocated treatment for a get minimum of seven days,we used or fishers exact tests to operating theater compare categorical outcomes,['Sample size and analysis'],Methods,['12b']
418,PMC4431679S72,we did subgroup analysis for affected role with mrsa bacteraemia,we did per protocol days randomisation patients without exclusion criteria after for who received allocated treatment for a minimum of seven analysis,we used or black cat exact tests to compare categorical outcomes,['Sample size and analysis'],Methods,['12b']
419,PMC4431679S72,we did subgroup analysis for patients with mrsa bacteraemia ,we did per protocol analysis for patients without exclusion criteria after randomisation who received allocated treatment for a minimum of seven days ,we used or fishers exact tests to compare categorical outcomes ,['Sample size and analysis'],Methods,['12b']
420,PMC4431679S76,we entered all variables analysis associated with the outcome on univariate significantly p logistic not correlated spearman correlation into a and regression analysis,we did multivariable analyses for the primary efficacy outcome including vitamin a the treatment arm as an independent variable,we present ratios risk or odds ratios with confidence intervals,['Sample size and analysis'],Methods,['12b']
421,PMC4431679S76,we entered all variables significantly associated with the outcome on univariate analysis p and not correlated spearman correlation into a logistic regression analysis,did multivariable analyses for the primary efficacy outcome including the treatment arm as an independent variable,we present ratio risk ratios or odds ratios with confidence intervals,['Sample size and analysis'],Methods,['12b']
422,PMC4431679S76,we entered all variables importantly associated with the outcome on univariate analysis p and not correlated spearman correlation into a logistic regression toward the mean analysis,we did multivariable analyses for the primary efficacy outcome including independent treatment arm as an the variable,we present risk ratios or betting odds odds ratios with confidence intervals,['Sample size and analysis'],Methods,['12b']
423,PMC4431679S76,we entered all variables significantly associated with p outcome on univariate analysis the and not correlated spearman correlation regression a logistic into analysis,we did multivariable analyses for the primary efficaciousness outcome including the treatment arm as an independent variable,we present take a chance ratios or odds ratios with confidence intervals,['Sample size and analysis'],Methods,['12b']
424,PMC4431679S76,we infix all variables significantly associated with the outcome on univariate analysis p and not correlated spearman correlational statistics into a logistic regression analysis,efficacy did multivariable analyses for the primary we outcome including the treatment arm as an independent variable,we present ratios or odds ratios with confidence intervals,['Sample size and analysis'],Methods,['12b']
425,PMC4431679S76,we entered all variables significantly associated the outcome on analysis p and not spearman correlation into a logistic regression analysis,we did multivariable analyses for the primary efficacy outcome including the treatment arm as an main variable,we present risk ratios or odds ratios with confidence interval,['Sample size and analysis'],Methods,['12b']
426,PMC4431679S76,we entered all variables significantly associated with the outcome on univariate analysis p and not correlated spearman correlation into a logistic regression analysis ,we did multivariable analyses for the primary efficacy outcome including the treatment arm as an independent variable ,we present risk ratios or odds ratios with confidence intervals ,['Sample size and analysis'],Methods,['12b']
427,PMC5064025S83,to compare treatment on placebo we conducted with analysis of covariance an change from baseline including the glycemic at as a factor and the baseline as a covariate status and months,as define by the protocol patients were let in in the month data analysis if they had no missing united states department of state at calendar month for the month analysis participants were required to have no missing united states department of state by calendar month and or no missing united states department of state between and calendar month,all data were checked for totally normality and log transformed if appropriate,['Statistical analyses'],Methods,['12b']
428,PMC5064025S83,to compare treatment with placebo we discourse conducted an analysis of covariance discourse on change from baseline including the glycemic status as a factor and the baseline as a covariate at and comparability months,as defined by the protocol missing were included in the participants data analysis if they had doses patients doses at months for the month missing month were required to have no analysis doses by months and or no missing no between and months,all data were checked for normalcy and log transformed if appropriate,['Statistical analyses'],Methods,['12b']
429,PMC5064025S83,to compare intervention with placebo we conducted an analysis of covariance on deepen from baseline include the glycemic status as a factor and the baseline as a covariate at and months,as defined by the protocol patients were included in the month data analysis if they had no player missing doses at months for the month analysis participants were required to have no missing doses by months no more and or no missing doses psychoanalysis depth psychology between and months,normality data were checked for all and log transformed if appropriate,['Statistical analyses'],Methods,['12b']
430,PMC5064025S83,to compare treatment with placebo we an analysis of covariance on change from baseline including the glycemic status a factor and the baseline as a covariate at and months,as defined by the protocol patients were included in the month data analysis if they had no missing doses at months the month analysis participants were required to have no missing doses by and or no missing doses between and months,all were for normality and log transformed appropriate,['Statistical analyses'],Methods,['12b']
431,PMC5064025S83,to compare treatment with conducted an analysis of covariance on change from baseline including the glycemic status as a factor and the baseline as a covariate at and months,as defined by the protocol patients were included in the month data analysis they had no missing doses at months for the month analysis participants were required to have no doses by months and or no missing doses between and months,all data were checked for n and log transformed if appropriate,['Statistical analyses'],Methods,['12b']
432,PMC5064025S83,to compare treatment with change we conducted an analysis of covariance and placebo from baseline including the glycemic status as a factor and months baseline as a covariate at on the,as defined by the protocol patients were included in the month data analysis if they vitamin a had no missing doses at months for the month omit analysis participants were required to have no past missing doses by months admit and or no missing doses between and months,data point all data were checked for normality and log transformed if appropriate,['Statistical analyses'],Methods,['12b']
433,PMC5064025S83,to compare treatment with placebo we conducted an analysis of covariance on change from baseline including the glycemic status as a factor and the baseline as a covariate at and months ,as defined by the protocol patients were included in the month data analysis if they had no missing doses at months for the month analysis participants were required to have no missing doses by months and or no missing doses between and months ,all data were checked for normality and log transformed if appropriate ,['Statistical analyses'],Methods,['12b']
434,PMC5064025S85,when a log transformation factor in of the change from baseline was not possible because of negative values an analysis of covariance was conducted information on the log transformed and month data including glycemic index status as associate in nursing a factor and the log transformed baseline factor in as a covariate,all data were checked for logarithm normality and log transformed if appropriate,we considered a p value as significant,['Statistical analyses'],Methods,['12b']
435,PMC5064025S85,when a log transformation of the change from baseline was not factor in possible because of negative values an analysis of covariance was conducted on the log transformed and month data including glycemic index status as analytic thinking a factor and along the log transformed ampere baseline as a covariate,all data were checked for normality and log transformed if appropriate,we conceive a p value as significant,['Statistical analyses'],Methods,['12b']
436,PMC5064025S85,when log transformation of the change from baseline was not possible because of negative values an analysis of covariance was on the log transformed and month data including glycemic index status as a factor and the log transformed as a,all data were checked for log and normality transformed if appropriate,we meaning considered a p value as significant,['Statistical analyses'],Methods,['12b']
437,PMC5064025S85,when a logarithm transformation of the change from baseline was not potential because of negative value an analysis of covariance was conducted on the logarithm transformed and month data include glycemic index status as a factor and the logarithm transformed baseline as a covariate,all data were checked for normality and logarithm log transformed if appropriate,significant considered a p value as we,['Statistical analyses'],Methods,['12b']
438,PMC5064025S85,when a log transformation of the change from service line was not possible because of minus values an analysis of covariance was impart on the log transformed and month data including glycemic index status as a agent and the log transformed service line as a covariate,all data appropriate checked for normality and log transformed if were,we atomic number considered a p value as significant,['Statistical analyses'],Methods,['12b']
439,PMC5064025S85,log transformation of change from baseline was not possible because of negative values an analysis of covariance was conducted on the log and month data including glycemic index status as a factor and the log transformed baseline as a covariate,all data were checked for normality and log transform if appropriate,we considered a p value as significant,['Statistical analyses'],Methods,['12b']
440,PMC5064025S85,when a log transformation of the change from baseline was not possible because of negative values an analysis of covariance was conducted on the log transformed and month data including glycemic index status as a factor and the log transformed baseline as a covariate ,all data were checked for normality and log transformed if appropriate ,we considered a p value as significant ,['Statistical analyses'],Methods,['12b']
441,PMC5064025S88,two interim analyses were pre specified when n and all patients had completed months with treatment respectively efficacy the intention of halting the not if adverse measures were identified or for futility but study for interim positive of,results are reported as trust means with confidence limits,the interim analyses were performed by independent personnel not immediately associated with the studys conduct,['Statistical analyses'],Methods,['7b']
442,PMC5064025S88,two interim analyses were pre specified when n and all patients had completed months of treatment respectively with the intention of halting the study if adverse measures were identified or for futility bear nail but not inauspicious for interim positive efficacy,results are reported as trust means with confidence limits,the interim analyses were performed by independent personnel not directly associated with cost the studys conduct,['Statistical analyses'],Methods,['7b']
443,PMC5064025S88,two interim bear analyses were pre specified when lag n and all patients had completed months of treatment respectively with the intention of halting the study examine if adverse measures were identified or for futility but not for interim positive efficacy,results are reported as means with confidence limits,the interim analyses were performed by independent personnel not associated with the studys conduct,['Statistical analyses'],Methods,['7b']
444,PMC5064025S88,two interim analyses were pre specified when n and all patients had completed months of treatment respectively with intention of halting the study if adverse measures were identified or for futility but for positive efficacy,results are reported means with confidence limits,the interim performed were analyses by independent personnel not directly associated with the studys conduct,['Statistical analyses'],Methods,['7b']
445,PMC5064025S88,interim analyses were pre specified when n and patients had completed of treatment respectively with the intention of the study adverse measures were identified or for but not for interim positive efficacy,reported are results as means with confidence limits,the interim were performed by independent personnel not directly associated with the studys conduct,['Statistical analyses'],Methods,['7b']
446,PMC5064025S88,two meanwhile analyses were pre specified when north and all patients had completed months of treatment respectively with the intention of halting the cogitation if adverse measures were identified or for futility but not for meanwhile positive efficacy,resultant are reported as means with confidence limits,the interim analyses were subject performed by independent personnel not directly associated with the studys conduct,['Statistical analyses'],Methods,['7b']
447,PMC5064025S88,two interim analyses were pre specified when n and all patients had completed months of treatment respectively with the intention of halting the study if adverse measures were identified or for futility but not for interim positive efficacy ,results are reported as means with confidence limits ,the interim analyses were performed by independent personnel not directly associated with the studys conduct ,['Statistical analyses'],Methods,['7b']
448,PMC5064025S89,the interim analyses were performed by freelancer personnel not directly associated with the studys conduct,two interim analyses were pre specified when and all patients had completed months treatment respectively with the of halting the study if adverse measures were identified or for futility but not interim positive efficacy,the study patron and funder novartis participated in discussions about the design and conduct of this study they also provided the drugs employ in the tribulation and logistical support for its execution,['Statistical analyses'],Methods,['7b']
449,PMC5064025S89,the interim analyses relate were performed by independent personnel not directly associated with the studys conduct,interim analyses were pre when n and all patients had completed months of treatment respectively with the intention of halting the study if adverse measures were identified or for futility but not for interim positive efficacy,the study sponsor and funder novartis participated in discussions about the drug design participate and conduct of this study they also it provided the drugs used in the trial and logistical support for its execution,['Statistical analyses'],Methods,['7b']
450,PMC5064025S89,the interim analyses performed by independent personnel not directly associated with the studys conduct,two interim psychoanalyze were pre peg down when n and all patients had completed months of discussion respectively with the intention of halting the study if adverse measures were identified or for futility but not for interim positive efficacy,the study sponsor and funder novartis participated in about the design conduct of this study they also the drugs used in the trial and logistical support its execution,['Statistical analyses'],Methods,['7b']
451,PMC5064025S89,the interim analyses were performed by independent personnel not directly associated examine with the studys conduct,two interim analyses were pre specified when n and all patients had completed get months of treatment respectively with just the intention of halting the study if adverse measures were identified or for futility but not for interim positive efficacy,the study sponsor and funder for participated in discussions about the design and conduct of this study they also provided the drugs in used and trial the logistical support novartis its execution,['Statistical analyses'],Methods,['7b']
452,PMC5064025S89,the interim analyses were performed by personnel not directly associated with the studys conduct,two interim analyses were pre specified when n fill in and all patients had completed months of treatment constitute respectively with the intention of halting the study if adverse measures were identified or for futility but not efficaciousness for interim positive efficacy,the study sponsor and funder novartis participated in logistic discussions about the design and conduct of this study they also provided the drugs inch used edge in the trial and logistical support for its execution,['Statistical analyses'],Methods,['7b']
453,PMC5064025S89,the associated analyses were performed by independent personnel not directly interim with the studys conduct,two interim analyses were pre specified when n and all months had completed measures of treatment patients with the intention of halting the study if adverse respectively were identified or for futility but not for interim positive efficacy,funder study sponsor and study novartis participated in discussions for the design and conduct of this the they also provided the drugs used in the trial and logistical support about its execution,['Statistical analyses'],Methods,['7b']
454,PMC5064025S89,the interim analyses were performed by independent personnel not directly associated with the studys conduct ,two interim analyses were pre specified when n and all patients had completed months of treatment respectively with the intention of halting the study if adverse measures were identified or for futility but not for interim positive efficacy ,the study sponsor and funder novartis participated in discussions about the design and conduct of this study they also provided the drugs used in the trial and logistical support for its execution ,['Statistical analyses'],Methods,['7b']
455,PMC3386495S38,at the end of main pilot phase since the the phase compared treatment with open minimise several additional measures to introduced were control bias in the assessment of early and late outcomes,the initial pilot stage was double blinded and placebo controlled,we have published cover of the rationale for the tryout the protocol an update on recruitment amendments to the protocol and the service line characteristics of the patients recruited and the statistical analysis plan,['Study design and patients'],Methods,['3b']
456,PMC3386495S38,at the end of the pilot phase since the master phase compared treatment with open control several additional measures were premise to minimise bias in the assessment of early and late result,the initial pilot pilot film phase was double blinded and placebo controlled,we have published reports of the rationale for the trial the an update on recruitment amendments to protocol and the baseline characteristics of patients recruited and the statistical analysis plan,['Study design and patients'],Methods,['3b']
457,PMC3386495S38,at the end of the pilot inaugurate phase since the main phase compared treatment with introduce open control several additional measures were introduced to minimise bias in the assessment of early inaugurate and late outcomes,the initial phase was double and placebo controlled,analysis have published reports of the rationale for the and the protocol an update on recruitment amendments to the protocol and the baseline characteristics of the patients recruited trial the statistical we plan,['Study design and patients'],Methods,['3b']
458,PMC3386495S38,at the end of the pilot phase since the main compared treatment with open control additional measures were introduced minimise the assessment of early and late outcomes,the phase pilot initial was double blinded and placebo controlled,we have published reports of the rationale trial the for the protocol an to on recruitment amendments update the protocol and the baseline analysis of the patients recruited and the statistical characteristics plan,['Study design and patients'],Methods,['3b']
459,PMC3386495S38,at the of the pilot phase since the main phase compared treatment with open control several additional measures were introduced to minimise bias in the assessment of and late,the initial pilot phase was double blinded and phase angle placebo controlled,we have published reports characteristic of the rationale for the trial the protocol an update on recruitment amendments to the principle protocol and the baseline along characteristics of the patients recruited and the statistical analysis plan,['Study design and patients'],Methods,['3b']
460,PMC3386495S38,of the to phase the pilot phase since the main of compared treatment with open control several additional measures were introduced end minimise bias in the assessment at early and late outcomes,initial phase double blinded and placebo controlled,we have published reports of the rationale for the trial the protocol an update on recruitment amendments the and the baseline characteristics of the patients recruited and the statistical analysis plan,['Study design and patients'],Methods,['3b']
461,PMC3386495S38,at the end of the pilot phase since the main phase compared treatment with open control several additional measures were introduced to minimise bias in the assessment of early and late outcomes ,the initial pilot phase was double blinded and placebo controlled ,we have published reports of the rationale for the trial the protocol an update on recruitment amendments to the protocol and the baseline characteristics of the patients recruited and the statistical analysis plan ,['Study design and patients'],Methods,['3b']
462,PMC3386495S92,however it was crystallise by that hold a sample of was no longer feasible and the steering committee agreed a revised recruitment target,a trial of that size could a clinically worthwhile net benefit of as little as absolute difference in primary outcome power,the sample size re estimated in on basis of event rates in both treatment groups combined was,"['Randomisation and masking', 'Statistical analysis']",Methods,['3b']
463,PMC3386495S92,however it was clear by obtaining was no longer feasible and the steering committee agreed a revised recruitment target,a trial of that size could detect a clinically worthwhile net benefit of as little as absolute difference in the primary sizing axerophthol outcome power,the sample size estimated in on the basis of event rates in both treatment groups combined was,"['Randomisation and masking', 'Statistical analysis']",Methods,['3b']
464,PMC3386495S92,however it was clear by that obtaining a of was no longer feasible and the steering committee a revised recruitment target,a trial of that size could detect a clinically worthwhile net primary of as little as absolute difference in outcome benefit the power,the sample size re estimated in on the basis of event rates in both treatment groups combined rhenium was,"['Randomisation and masking', 'Statistical analysis']",Methods,['3b']
465,PMC3386495S92,however it was crystalise by that obtaining a sample of was no longer viable and the steering committee agreed a revised recruitment target,a trial of that size could detect a clinically worthwhile net benefit of as little as absolute difference in the primary outcome power,the sample both re estimated in on the basis of event rates in size treatment groups combined was,"['Randomisation and masking', 'Statistical analysis']",Methods,['3b']
466,PMC3386495S92,however it was clear by that obtaining a sample of was no longer feasible guide and the steering committee agreed a still revised recruitment target,a trial of that size could detect a clinically worthwhile net benefit of vitamin a as little as absolute difference in vitamin a the primary outcome power,the sample size re estimated in on the basis of event rates in combined treatment groups both was,"['Randomisation and masking', 'Statistical analysis']",Methods,['3b']
467,PMC3386495S92,atomic number however it revise was clear by that obtaining a sample of was no longer feasible and the steering committee agreed a revised recruitment target,a worthwhile of that size could detect a clinically little net benefit of as trial as absolute difference in the primary outcome power,the sample size re approximate in on the basis of event rates in both treatment groups combined was,"['Randomisation and masking', 'Statistical analysis']",Methods,['3b']
468,PMC3386495S92,however it was clear by that obtaining a sample of was no longer feasible and the steering committee agreed a revised recruitment target ,a trial of that size could detect a clinically worthwhile net benefit of as little as absolute difference in the primary outcome power ,the sample size re estimated in on the basis of event rates in both treatment groups combined was ,"['Randomisation and masking', 'Statistical analysis']",Methods,['3b']
469,PMC3386495S100,the mugwump data monitoring committee met at to the lowest degree annually to review the unmasked data on major outcome events in the trial on the background stroke unit care received by trial patients to ensure it was equal in both treatment groups relevant external data including update of the cochrane systematic review and reports from large scale leaf registries of rt pa use in strict confidence end to end the track of the trial,receipt expert radiologist checked all for masked to clinical details and treatment allocation immediately on an at the trial office scans evidence of adverse events and protocol deviations,the committee judged these data never met the protocol specified criteria to modification of the protocol or halt recruitment to the,"['Randomisation and masking', 'Statistical analysis']",Methods,['7b']
470,PMC3386495S100,the autonomous data monitoring committee met at least annually to review the unmasked data on major outcome events in the run on the background stroke building block care received by run patients to ensure it was equal in both discourse groups relevant external data let in updates of the cochrane systematic review and reports from large scale registries of rt pa use in strict confidence passim the course of the run,an expert radiologist checked all masked to clinical details and treatment allocation immediately on receipt at the trial office for evidence of adverse events protocol deviations,the committee judged these data never met the specified criteria to modification of the protocol or halt recruitment to the study,"['Randomisation and masking', 'Statistical analysis']",Methods,['7b']
471,PMC3386495S100,the external data monitoring committee data at least annually to review the unmasked data pa major outcome events large the trial in to background stroke unit care received by trial patients the ensure it was equal in both treatment groups relevant independent met including updates of the cochrane systematic review and reports from on scale registries of rt on use in strict confidence throughout the course of the trial,an expert radiologist checked all scans masked to clinical details and treatment allocation immediately on reception at the trial office for tell of adverse events and protocol deviations,the committee specialise judged these measure data never met the protocol specified criteria to recommend modification of the protocol or halt recruitment to the study,"['Randomisation and masking', 'Statistical analysis']",Methods,['7b']
472,PMC3386495S100,the independent data monitoring committee met at least annually to review the unmasked data on events in trial on background stroke unit care received by trial patients to ensure it equal in both treatment groups relevant external data including updates of the cochrane systematic review and from large scale registries of rt pa use in strict confidence the course the trial,an expert radiologist checked all the masked to clinical details and trial allocation immediately on receipt at scans treatment office for evidence of adverse events and protocol deviations,the committee judged these data never of the protocol specified criteria to recommend modification met the protocol or halt recruitment the to study,"['Randomisation and masking', 'Statistical analysis']",Methods,['7b']
473,PMC3386495S100,the independent data monitoring committee large at least annually to review the unmasked data on major outcome events in the external on the background stroke unit care cochrane by trial patients received ensure it of equal strict both treatment groups relevant trial data including updates of the to systematic review and reports from met scale registries of rt pa use in in confidence throughout the course was the trial,an expert radiotherapist checked all scans masked to clinical details and treatment allocation immediately on receipt at the trial office for grounds of adverse events and protocol deviations,the committee judged these data never met the communications protocol specified measure to recommend modification of the communications protocol or halt recruitment to the study,"['Randomisation and masking', 'Statistical analysis']",Methods,['7b']
474,PMC3386495S100,the independent passim data discourse monitoring committee met at least annually to review the unmasked data on major outcome events atomic number in the trial on the background stroke unit care received by taxonomic trial patients to followup ensure it was equal ascertain in both treatment groups relevant external data including updates of the cochrane systematic review and reports from large scale registries of rt pa use in strict confidence throughout the course of the trial,an expert radiologist checked all scans masked to clinical details and treatment allocation immediately on receipt at detail the trial intervention office for evidence of adverse events and protocol deviations,the commission judged these data never met the communications protocol specified criteria to recommend modification of the communications protocol or halt recruitment to the study,"['Randomisation and masking', 'Statistical analysis']",Methods,['7b']
475,PMC3386495S100,the independent data monitoring committee met at least annually to review the unmasked data on major outcome events in the trial on the background stroke unit care received by trial patients to ensure it was equal in both treatment groups relevant external data including updates of the cochrane systematic review and reports from large scale registries of rt pa use in strict confidence throughout the course of the trial ,an expert radiologist checked all scans masked to clinical details and treatment allocation immediately on receipt at the trial office for evidence of adverse events and protocol deviations ,the committee judged these data never met the protocol specified criteria to recommend modification of the protocol or halt recruitment to the study ,"['Randomisation and masking', 'Statistical analysis']",Methods,['7b']
476,PMC3386495S101,the committee judged these data never met the protocol specified criteria to recommend modification of the protocol or arrest recruitment to the survey,the independent data monitoring committee met at least naturally annually to review the unmasked data on major outcome events in the trial on the refresh background stroke unit care information technology received by trial patients to ensure it was equal in both treatment groups relevant external data taxonomical including updates of the cochrane systematic along review and reports from large scale registries of rt pa use in admit strict confidence throughout the course of the trial,the statistical analysis plan was published before unmasking of the authors to the data,"['Randomisation and masking', 'Statistical analysis']",Methods,['7b']
477,PMC3386495S101,study halt judged these data never met the protocol specified criteria to recommend modification of the protocol or committee recruitment to the the,the both data monitoring in met at least annually to review on unmasked data the major outcome events was the trial on the background stroke unit use received by trial patients to ensure it committee equal the independent treatment groups relevant external data including updates of the cochrane systematic review and reports from large scale registries of rt pa care in strict confidence throughout in course of the trial,the statistical analysis plan was print published before unmasking of the authors to the data,"['Randomisation and masking', 'Statistical analysis']",Methods,['7b']
478,PMC3386495S101,the data judged these committee protocol met the never specified criteria to recommend modification of the protocol or halt recruitment to the study,the independent data monitoring committee foregather at least annually to review the unmask data on major outcome upshot in the trial on the background stroke unit care received by trial patients to ensure it was equal in both treatment groups relevant external data including updates of the cochrane taxonomical review and reports from large scale registries of rt pa use in rigorous authority throughout the course of the trial,the statistical analysis plan was published before unmasking to the authors of the data,"['Randomisation and masking', 'Statistical analysis']",Methods,['7b']
479,PMC3386495S101,the committee judged these data never met protocol specified criteria to modification of the or halt recruitment to the study,the mugwump data monitoring committee satisfy at least annually to reexamine the uncloak data on major outcome events in the trial run on the background stroke unit care received by trial run patients to ensure it was equal in both treatment groups relevant external data including updates of the cochrane systematic reexamine and reports from large scale registries of rt pa use in hard and fast confidence throughout the course of the trial run,the statistical analysis plan was published before unmask unmasking of the authors to the data,"['Randomisation and masking', 'Statistical analysis']",Methods,['7b']
480,PMC3386495S101,the committee judged these data never met the protocol specified criteria to recommend modification of the change protocol approximate or halt recruitment to the study,the independent data monitoring committee met at least annually review the unmasked on major outcome events in the trial on the background stroke unit care received by trial patients ensure it was equal in both treatment groups relevant external data including updates of the cochrane systematic review and reports large registries of rt pa in strict confidence throughout the course of the trial,the statistical analysis plan was the before unmasking of published authors to the data,"['Randomisation and masking', 'Statistical analysis']",Methods,['7b']
481,PMC3386495S101,the committee judged these data never satisfy met the communications protocol protocol specified criteria to recommend modification of the protocol or halt recruitment to the study,the independent data monitoring committee met on least at to review the unmasked data on major outcome throughout in the trial large the background stroke unit care received review trial patients to ensure it was equal in both treatment groups relevant external data including updates of the cochrane systematic by and reports from annually scale registries of rt pa confidence in strict use events the course of the trial,the statistical analytic thinking plan was published before unmasking of the authors to the data,"['Randomisation and masking', 'Statistical analysis']",Methods,['7b']
482,PMC3386495S101,the committee judged these data never met the protocol specified criteria to recommend modification of the protocol or halt recruitment to the study ,the independent data monitoring committee met at least annually to review the unmasked data on major outcome events in the trial on the background stroke unit care received by trial patients to ensure it was equal in both treatment groups relevant external data including updates of the cochrane systematic review and reports from large scale registries of rt pa use in strict confidence throughout the course of the trial ,the statistical analysis plan was published before unmasking of the authors to the data ,"['Randomisation and masking', 'Statistical analysis']",Methods,['7b']
483,PMC3386495S106,an unadapted analysis is also presented,therefore the primary analysis of the effect of treatment on the primary outcome was adjust by logistic regression for analog event for the pursue covariates age national institutes of health stroke scale nihss score time from onset of stroke symptoms to randomisation and presence vs absence of ischaemic change on the prerandomisation brain glance over according to expert assessment,the trial did meet its original target of patients and so was no longer powered to detect a absolute difference in the primary outcome with power and,"['Randomisation and masking', 'Statistical analysis']",Methods,['12b']
484,PMC3386495S106,an analysis also presented,the therefore to analysis of brain effect of treatment on the primary outcome was adjusted by logistic regression for linear effects for the following covariates age symptoms institutes of health stroke scale nihss score time from onset of stroke national on randomisation and presence vs absence of ischaemic change primary the prerandomisation the scan according to expert assessment,the trial did not meet its of target original patients and so was no powered adequately longer to detect a absolute difference in the primary outcome with power and,"['Randomisation and masking', 'Statistical analysis']",Methods,['12b']
485,PMC3386495S106,an unadjusted analysis is presented also,the primary analysis of the effect of treatment on the primary was adjusted by logistic regression for linear effects for the following covariates age institutes health stroke scale nihss score time from onset of stroke symptoms to and presence absence of change on the prerandomisation brain scan according to expert assessment,the trial did not meet its original target of patients and so was no farsighted adequately powered to detect a absolute difference of opinion in the primary outcome with power and,"['Randomisation and masking', 'Statistical analysis']",Methods,['12b']
486,PMC3386495S106,an unadjusted analysis is also analytic thinking presented,therefore the primary constitute analysis of the effect of treatment on the primary outcome was adjusted by logistic regression for linear effects for the following covariates age intervention national institutes of health stroke scale nihss score time from onset of stroke symptoms to randomisation and presence cat scan vs absence of ischaemic change on the prerandomisation brain constitute scan according effect to expert assessment,the trial did not meet its original target of final result patients and so was no longer adequately powered final result to detect a absolute difference in the primary outcome with power and,"['Randomisation and masking', 'Statistical analysis']",Methods,['12b']
487,PMC3386495S106,an unadjusted associate in nursing analysis is also presented,the primary analysis effect of treatment on the primary outcome was adjusted by logistic regression for linear effects the covariates age national institutes of health stroke scale nihss score time from onset symptoms randomisation and presence vs absence ischaemic on prerandomisation brain scan according to expert,the trial did not thirster meet its original target of object patients and so was no longer adequately powered to detect a absolute difference in the primary outcome with power and,"['Randomisation and masking', 'Statistical analysis']",Methods,['12b']
488,PMC3386495S106,an also analysis is unadjusted presented,therefore the primary randomisation of the effect of treatment of the primary outcome was adjusted by logistic regression for presence effects for the following covariates age national institutes of prerandomisation stroke scale nihss score time from onset of stroke symptoms to analysis and linear vs absence on ischaemic change on the health brain scan according to expert assessment,the trial did not meet its original target of patients and so was no longer adequately power to detect a absolute difference in the primary feather outcome with power and,"['Randomisation and masking', 'Statistical analysis']",Methods,['12b']
489,PMC3386495S106,an unadjusted analysis is also presented ,therefore the primary analysis of the effect of treatment on the primary outcome was adjusted by logistic regression for linear effects for the following covariates age national institutes of health stroke scale nihss score time from onset of stroke symptoms to randomisation and presence vs absence of ischaemic change on the prerandomisation brain scan according to expert assessment ,the trial did not meet its original target of patients and so was no longer adequately powered to detect a absolute difference in the primary outcome with power and ,"['Randomisation and masking', 'Statistical analysis']",Methods,['12b']
490,PMC3128457S96,isolated apart from the pack number the treatment packs were identical,we used a local pack system add up that selected the lowest numbered treatment pack from a box axerophthol containing eight numbered packs,the pack identification number was recorded on the entry form which was beam to the international trial coordinating centre in london uk,['Randomisation'],Methods,['9']
491,PMC3128457S96,apart from the pack number the treatment packs were identical,numbered used a local pack system that selected the lowest numbered treatment pack from a box eight containing we packs,ring the pack number was recorded on the entry form which was ring sent to the international trial coordinating centre in london uk,['Randomisation'],Methods,['9']
492,PMC3128457S96,apart from the pack number the treatment packs were monovular,we used a local pack system that selected the lowest numbered treatment pack from a package containing numbered packs,the entry number was recorded on the the form which was sent to pack international trial coordinating centre in london uk,['Randomisation'],Methods,['9']
493,PMC3128457S96,apart from the pack number treatment were identical,we used a local pack system that selected the lowest numbered pack from a box containing eight numbered packs,the pack number to recorded on the entry form which was centre was the international trial coordinating sent in london uk,['Randomisation'],Methods,['9']
494,PMC3128457S96,apart from the pack number the treatment packs were identical,we used a system pack local that selected the lowest numbered treatment eight from a box containing pack numbered packs,the pack number was recorded on the entry form which sent to the trial coordinating centre london uk,['Randomisation'],Methods,['9']
495,PMC3128457S96,apart from the jam number the treatment packs were identical,we used a local pack system that selected the lowest numbered treatment pack from a box containing eight numbered packs,the pack number was recorded on the debut form which was sent to the international trial coordinating centre in capital of the united kingdom uk,['Randomisation'],Methods,['9']
496,PMC3128457S96,apart from the pack number the treatment packs were identical ,we used a local pack system that selected the lowest numbered treatment pack from a box containing eight numbered packs ,the pack number was recorded on the entry form which was sent to the international trial coordinating centre in london uk ,['Randomisation'],Methods,['9']
497,PMC3128457S101,tranexamic sulfurous and placebo ampoules were indistinguishable,glaring,tranexamic acid pharmaceutic was manufactured by pharmacia pfizer sandwich uk and placebo by st marys pharmaceutical unit cardiff uk,['Blinding'],Methods,['11b']
498,PMC3128457S101,tranexamic indistinguishable and placebo ampoules were acid,blind blinding,tranexamic acid was manufactured by pharmacia pfizer sandwich uk and placebo by st marys pharmaceutical unit cardiff uk,['Blinding'],Methods,['11b']
499,PMC3128457S101,tranexamic acid and placebo ampoules were ampule indistinguishable,fulgent,tranexamic acid was manufactured by pharmacia pfizer and uk sandwich placebo by st marys pharmaceutical unit cardiff uk,['Blinding'],Methods,['11b']
500,PMC3128457S101,tranexamic indistinguishable and placebo ampoules were acid,blind blinding,tranexamic acid was placebo by pharmacia pfizer sandwich uk and manufactured by st marys pharmaceutical unit cardiff uk,['Blinding'],Methods,['11b']
501,PMC3128457S101,tranexamic acidulent and placebo ampoules were indistinguishable,blinding,tranexamic acid was manufactured by pharmacia pfizer sandwich uk and placebo by st marys pharmaceutic unit cardiff uk,['Blinding'],Methods,['11b']
502,PMC3128457S101,tranexamic and placebo ampoules were indistinguishable,blinding,tranexamic acid was manufactured by pharmacia pfizer sandwich uk and by marys pharmaceutical unit cardiff uk,['Blinding'],Methods,['11b']
503,PMC3128457S101,tranexamic acid and placebo ampoules were indistinguishable ,blinding,tranexamic acid was manufactured by pharmacia pfizer sandwich uk and placebo by st marys pharmaceutical unit cardiff uk ,['Blinding'],Methods,['11b']
504,PMC3128457S104,correct glaring and coding of ampoules was assured by independent random quiz of each batch by high performance liquid chromatography to confirm the contents,the treatment packs were prepared by an independent clinical visitation supply company bilcare crickhowell uk,method statistical methods,['Blinding'],Methods,['11b']
505,PMC3128457S104,correct blinding and coding of ampoules was by independent random testing of each batch by high performance liquid chromatography to confirm the contents,the treatment packs were prepared by an independent clinical trial provision company bilcare crickhowell uk,statistical method,['Blinding'],Methods,['11b']
506,PMC3128457S104,correct blinding and coding of ampoules was assured by independent random testing of each peck by high performance liquid chromatography to affirm the contents,the freelancer treatment packs were prepared by an independent clinical trial supply company bilcare crickhowell uk,statistical method methods,['Blinding'],Methods,['11b']
507,PMC3128457S104,correct blinding and coding of ampoules was assured by independent random the of each batch testing high performance liquid chromatography to confirm by contents,the crickhowell packs were prepared by an independent clinical trial supply company bilcare treatment uk,methods statistical,['Blinding'],Methods,['11b']
508,PMC3128457S104,correct blinding and coding of decline ampoules was assured by independent random testing of each batch by high performance diminution liquid chromatography to confirm the contents,the treatment packs were prepared an independent clinical trial supply company bilcare crickhowell uk,statistical,['Blinding'],Methods,['11b']
509,PMC3128457S104,correct blinding and coding of ampoules was assured by independent random examine testing of ampule each batch by high performance liquid chromatography to confirm the contents,the treatment packs were uk by an independent clinical trial supply company bilcare crickhowell prepared,methods statistical,['Blinding'],Methods,['11b']
510,PMC3128457S104,correct blinding and coding of ampoules was assured by independent random testing of each batch by high performance liquid chromatography to confirm the contents ,the treatment packs were prepared by an independent clinical trial supply company bilcare crickhowell uk ,statistical methods,['Blinding'],Methods,['11b']
511,PMC3128457S106,we assessed the intra observer reliability hemorrhage of haemorrhage measurements using the intra class correlation coefficient,statistical method methods,we assessed the reliability statistic binary measurements with the of,['Statistical methods'],Methods,['12b']
512,PMC3128457S106,we assessed the intra observer reliability of haemorrhage measurements value using the intra class correlation coefficient,statistical methods,we assessed the reliability of binary measurements with the statistic,['Statistical methods'],Methods,['12b']
513,PMC3128457S106,we assessed the intra observer dependableness of haemorrhage measurements using the intra class correlation coefficient,statistical methods,we assessed the reliability of binary measuring with the statistic,['Statistical methods'],Methods,['12b']
514,PMC3128457S106,we assessed the intra observer reliability of haemorrhage measurements using the intra class coefficient correlation,method statistical methods,we the reliability of binary measurements with the statistic,['Statistical methods'],Methods,['12b']
515,PMC3128457S106,we assessed the intra observer dependableness of haemorrhage measurements using the intra class correlation coefficient,statistical method,we assessed the reliability of binary measurements with double star the statistic,['Statistical methods'],Methods,['12b']
516,PMC3128457S106,we assessed the intra observer reliability of haemorrhage measurements using the intra class coefficient,methods statistical,we assessed the reliability of binary measurements with the value statistic,['Statistical methods'],Methods,['12b']
517,PMC3128457S106,we assessed the intra observer reliability of haemorrhage measurements using the intra class correlation coefficient ,statistical methods,we assessed the reliability of binary measurements with the statistic ,['Statistical methods'],Methods,['12b']
518,PMC3128457S107,we assessed the of reliability binary measurements with the statistic,we assessed the intra observer reliability of measure haemorrhage measurements using the intra class correlation coefficient,for continuous variables measuring the haemorrhage we the average measurement the two independent readings in all analyses,['Statistical methods'],Methods,['12b']
519,PMC3128457S107,we value the reliability of binary measurements with the statistic,we assessed the intra observer of haemorrhage measurements using the intra class correlation coefficient,for continuous variable quantity measuring the haemorrhage we used the average measurement of the two independent readings in all analyses,['Statistical methods'],Methods,['12b']
520,PMC3128457S107,we assessed the reliability of binary with statistic,we assessed the intra commentator reliability of haemorrhage measurements using the intra class correlation coefficient,for continuous variables measuring the haemorrhage we used the average measurement of the two independent readings variable quantity in all analyses,['Statistical methods'],Methods,['12b']
521,PMC3128457S107,we assessed reliability the of binary measurements with the statistic,we assessed the intra observer reliability of haemorrhage measurements using the intra class correlation coefficient,for continuous variables measuring the haemorrhage we used the average measurement of the two independent readings in all psychoanalysis,['Statistical methods'],Methods,['12b']
522,PMC3128457S107,we assessed the reliability value of binary measurements with the statistic,we assessed the intra coefficient reliability of haemorrhage measurements using the intra class correlation observer,for continuous variables measuring the haemorrhage we used the average measurement of the two analytic thinking independent readings in all analyses,['Statistical methods'],Methods,['12b']
523,PMC3128457S107,we assessed the reliability of measurements with the statistic,assessed the intra observer reliability of haemorrhage measurements using the intra class correlation coefficient,for continuous variables measuring the haemorrhage we used average measurement of the two independent in all analyses,['Statistical methods'],Methods,['12b']
524,PMC3128457S107,we assessed the reliability of binary measurements with the statistic ,we assessed the intra observer reliability of haemorrhage measurements using the intra class correlation coefficient ,for continuous variables measuring the haemorrhage we used the average measurement of the two independent readings in all analyses ,['Statistical methods'],Methods,['12b']
525,PMC3128457S110,we used generalised linear models extrapolate adjusted for baseline variables,cat scan for binary variables we cat scan considered an intracranial finding to be present only if it was reported as present on both readings of a particular patients brain scan,covariates included in the adjustment were scale coma glasgow and age,['Statistical methods'],Methods,['12b']
526,PMC3128457S110,we used generalised one dimensional linear models adjusted for baseline variables,for binary variables we considered an intracranial finding to be acquaint only if it was report as acquaint on both readings of a particular patients brain scan,covariates included in the coma were glasgow adjustment scale and age,['Statistical methods'],Methods,['12b']
527,PMC3128457S110,we generalised linear adjusted for baseline variables,for binary variables we considered an intracranial finding to be present only if it was reported as present on both readings of a particular axerophthol einstein patients brain scan,covariates included in the adjustment were glasgow coma inch scale and age,['Statistical methods'],Methods,['12b']
528,PMC3128457S110,we used generalised models linear adjusted for baseline variables,for binary variables we considered an intracranial finding to be present only if it reported as on readings patients brain,covariates admit in the adjustment were glasgow coma scale and age,['Statistical methods'],Methods,['12b']
529,PMC3128457S110,we used generalised linear models adjusted for baseline variable,for binary variables we an intracranial finding to present only if was reported as present on both readings of a particular patients brain scan,covariates included in the adjustment were glasgow coma and age,['Statistical methods'],Methods,['12b']
530,PMC3128457S110,we used generalised models adjusted for baseline variables,for binary variables we considered an intracranial finding to be present only if it was reported as present on both readings of a finical affected role brain scan,covariates in the adjustment were glasgow scale and age,['Statistical methods'],Methods,['12b']
531,PMC3128457S110,we used generalised linear models adjusted for baseline variables ,for binary variables we considered an intracranial finding to be present only if it was reported as present on both readings of a particular patients brain scan ,covariates included in the adjustment were glasgow coma scale and age ,['Statistical methods'],Methods,['12b']
532,PMC5264229S87,subgroup analysis adenosine deaminase of acr was inside done by comparing acr response rates within each ada subgroup positive or negative in a prespecified manner,analysis of acr and acr was also in pps and fas das sdai cdai and eular response done only in the fas only available and sdai cdai were analysed in this,to formally test the differential influence of ada on sb or inf treatment analysis of ada was done including an covariance by an interaction term in the model,['Sample size and statistical analysis'],Patients and methods,['12b']
533,PMC5264229S87,subgroup analysis of acr was done by comparison acr response rates within each ada subgroup positive or veto in a prespecified manner,also of acr and cdai was analysis done in pps and das das sdai cdai and eular response were done only in the fas only available fas and sdai acr were analysed in this case,to formally differential of ada on inf an analysis of covariance done including an ada by treatment interaction term in the model,['Sample size and statistical analysis'],Patients and methods,['12b']
534,PMC5264229S87,subgroup analysis acr was done by comparing acr response rates within each ada subgroup positive or negative in a prespecified manner,analysis of acr and inwards acr was also done in pps and fas das sdai cdai and eular response were done only in the fas only available das and sdai evergreen state cdai were inwards analysed in this case,to formally test the differential influence of ada on sb or inf an analysis of covariance was done including by ada term treatment interaction an in the model,['Sample size and statistical analysis'],Patients and methods,['12b']
535,PMC5264229S87,subgroup analysis of acr was done by comparison acr response range within each ada subgroup positive or negative in a prespecified manner,analysis psychoanalysis of acr and acr likewise was also done in pps and fas das cony sdai cdai and eular response were done only in the fas only available das and sdai cdai were analysed in this case,to formally test the differential influence of ada on sb or inf an analysis of covariance was fare let in an ada by treatment interaction term in the model,['Sample size and statistical analysis'],Patients and methods,['12b']
536,PMC5264229S87,subgroup analysis of acr was done by comparing locoweed acr response rates within each ada subgroup positive or grass negative in a prespecified manner,analysis of acr and acr was also done pps and fas das sdai cdai and eular response were done only in fas only available das and sdai cdai were analysed in this case,to formally test the differential influence of ada on sb or inf an analysis of covariance was done including an ada by treatment interaction term in the model,['Sample size and statistical analysis'],Patients and methods,['12b']
537,PMC5264229S87,subgroup analysis of acr was done rates comparing acr response by within each ada in positive or negative subgroup a prespecified manner,analysis of acr and acr was also done in pps and fa das sdai cdai and eular reply were done only in the fa only available das and sdai cdai were canvass in this case,to formally test the differential exam influence of ada on sb or inf an analysis of covariance was done including handling an ada by treatment interaction term in the model,['Sample size and statistical analysis'],Patients and methods,['12b']
538,PMC5264229S87,subgroup analysis of acr was done by comparing acr response rates within each ada subgroup positive or negative in a prespecified manner ,analysis of acr and acr was also done in pps and fas das sdai cdai and eular response were done only in the fas only available das and sdai cdai were analysed in this case ,to formally test the differential influence of ada on sb or inf an analysis of covariance was done including an ada by treatment interaction term in the model ,['Sample size and statistical analysis'],Patients and methods,['12b']
539,PMC5264229S91,safety results were presented as the who of patients with percentage who had a particular ae in the safety analysis set saf number at received those least one dose of sb or inf,the squared differences across all time points from the two curves norm were curve measured and if the constitute upper limit of the ci of the norm was less than the metre two curves were considered equivalent,immunogenicity results were presented as the number of patients with percentages having incident ada up to week from saf,['Sample size and statistical analysis'],Patients and methods,['12b']
540,PMC5264229S91,safety results were presented as the number of patients with percentage who had a particular ae in the safety analysis set saf those who received at least one dose of sb or inf,the squared differences across all time points from the two curves were measured and if the upper limit of ci of the norm was less than the two curves were considered equivalent,presented results were incident as the number of patients with percentages having immunogenicity ada up to week from the saf,['Sample size and statistical analysis'],Patients and methods,['12b']
541,PMC5264229S91,safety results were presented to the lowest degree as the number of patients with percentage who had a particular ae in the safety analysis set saf those who received at least one coiffure dose of sb or inf,the squared differences across all time points from the two curve average were metric and if the upper limit of the ci of the average was less than the two curve were considered equivalent,immunogenicity results were presented the number of with percentages having incident ada up to week from the saf,['Sample size and statistical analysis'],Patients and methods,['12b']
542,PMC5264229S91,safety results were presented as the number of patients percentage who had a particular ae in the safety analysis set saf those received at one of sb or inf,the squared differences across all time upper from the two the norm were measured and if curves points curves of the ci of the norm was less than the two limit were considered equivalent,immunogenicity results were possess presented as the percentage number of patients with percentages having incident ada up to week from the saf,['Sample size and statistical analysis'],Patients and methods,['12b']
543,PMC5264229S91,safety results were presented as the routine of patients with percentage who had a particular ae in the safety analysis go down saf those who received at to the lowest degree one dose of sb or inf,the squared differences across all time amphetamine points from the two curves norm were measured and if the upper limit of to a lesser extent the ci of the norm was less than the two crosswise curves were considered equivalent,immunogenicity the were presented as the number of patients with percentages week incident ada up to having from results saf,['Sample size and statistical analysis'],Patients and methods,['12b']
544,PMC5264229S91,rubber event were presented as the number of patients with percentage who had a particular ae in the rubber analysis set saf those who received at least unity dose of sb or inf,the squared differences across all time points from the two than equivalent were measured and if the upper limit was the ci of the norm of less curves the two curves were considered norm,immunogenicity resolution were presented as the number of patients with percent having incident ada up to week from the saf,['Sample size and statistical analysis'],Patients and methods,['12b']
545,PMC5264229S91,safety results were presented as the number of patients with percentage who had a particular ae in the safety analysis set saf those who received at least one dose of sb or inf ,the squared differences across all time points from the two curves norm were measured and if the upper limit of the ci of the norm was less than the two curves were considered equivalent ,immunogenicity results were presented as the number of patients with percentages having incident ada up to week from the saf ,['Sample size and statistical analysis'],Patients and methods,['12b']
546,PMC5264229S92,immunogenicity results were presented as the number of patient role with percentages having incident ada up to calendar week from the saf,results were presented as number of patients with percentage who had a particular ae in safety analysis set saf those who received at least one dose of sb or inf,pk universe assessment was done in the pk population approximately the first enrolled of the study population up to week,['Sample size and statistical analysis'],Patients and methods,['12b']
547,PMC5264229S92,immunogenicity results were presented as the number of patients with percentages having incident ada up to week from the saf,safety results were salute as the number of patient with percentage who had a particular ae in the safety analysis set saf those who received at least dose of sb or inf,assessment was in the pk population approximately the first enrolled of the study population up to,['Sample size and statistical analysis'],Patients and methods,['12b']
548,PMC5264229S92,immunogenicity results of presented percentages the number were patients with as having incident ada up to week from the saf,safety of saf presented as the number of patients with percentage who had a particular ae in the received analysis set were those who safety at least one dose results sb or inf,pk assessment was done in to pk population approximately the first enrolled of the study population up the week,['Sample size and statistical analysis'],Patients and methods,['12b']
549,PMC5264229S92,immunogenicity results were presented as the number of patients with make up percentages having incident ada solution up to week from the saf,safety rubber astatine results were presented as get the number of patients with percentage who had a particular ae in the safety analysis set saf those who received at least one dose of sb or inf,pk assessment was done in the pk astir population approximately the first enrolled of the study population up to week,['Sample size and statistical analysis'],Patients and methods,['12b']
550,PMC5264229S92,immunogenicity results were presented as the number of patient role with per centum having incident ada up to week from the saf,safety results were presented as the number of saf with percentage who had particular a in ae the safety analysis set patients those who received at least one dose of sb or inf,pk assessment was done in enrolled pk population approximately the first the of the study population up to week,['Sample size and statistical analysis'],Patients and methods,['12b']
551,PMC5264229S92,immunogenicity results were presented the number of patients with incident ada up to week from the saf,results were presented as the number of patients with percentage who had a particular ae in the safety analysis set who received at least one dose of sb or inf,pk assessment was done in the pk universe approximately the first enrolled of the study universe up to week,['Sample size and statistical analysis'],Patients and methods,['12b']
552,PMC5264229S92,immunogenicity results were presented as the number of patients with percentages having incident ada up to week from the saf ,safety results were presented as the number of patients with percentage who had a particular ae in the safety analysis set saf those who received at least one dose of sb or inf ,pk assessment was done in the pk population approximately the first enrolled of the study population up to week ,['Sample size and statistical analysis'],Patients and methods,['12b']
553,PMC5264229S94,pk results are shown as mean ctrough with south dakota and coefficient of variation from the pk population,pk assessment the done in the pk population approximately the first enrolled of was study population up to week,general statistical analysis was done using sas v sas cary north exploitation carolina usa,['Sample size and statistical analysis'],Patients and methods,['12b']
554,PMC5264229S94,pk results are shown as have in mind ctrough with sd and coefficient of variation from the pk population,pk was done in pk approximately the first enrolled of the study population up to week,general statistical analysis was done using sas v sas cary north carolina u s army,['Sample size and statistical analysis'],Patients and methods,['12b']
555,PMC5264229S94,pk results are the as mean ctrough with sd and coefficient of variation from shown pk population,pk assessment was done in the pk population approximately the first enrolled analyse of the study population up to week,general statistical analysis was done using answer sas v sas cary north carolina usa,['Sample size and statistical analysis'],Patients and methods,['12b']
556,PMC5264229S94,ctrough results are shown as mean pk with sd and coefficient of variation from the pk population,pk assessment was done in the pk population approximately the first enrolled of enrol the study population up to week,general statistical analysis carolina done using sas v sas cary north was usa,['Sample size and statistical analysis'],Patients and methods,['12b']
557,PMC5264229S94,pk are shown as mean ctrough with sd and coefficient of variation from pk population,pk assessment was in the pk population approximately the first enrolled of the study population up to week,full general statistical analysis was done using sas v sas cary north carolina usa,['Sample size and statistical analysis'],Patients and methods,['12b']
558,PMC5264229S94,pk results are as mean ctrough with and coefficient of variation from the pk,pk assessment was done in the pk population approximately the first enrolled of the bailiwick population up to week,general statistical analysis using sas v sas cary north carolina usa,['Sample size and statistical analysis'],Patients and methods,['12b']
559,PMC5264229S94,pk results are shown as mean ctrough with sd and coefficient of variation from the pk population ,pk assessment was done in the pk population approximately the first enrolled of the study population up to week ,general statistical analysis was done using sas v sas cary north carolina usa ,['Sample size and statistical analysis'],Patients and methods,['12b']
560,PMC5264229S96,pk parameters were calculated by non compartmental analyses winnonlin v pharsight mountain view california usa,general statistical analysis was suffice using sas v sas cary north carolina usa,graphical figures were made using r http www r project org,['Sample size and statistical analysis'],Patients and methods,['12b']
561,PMC5264229S96,pk parameters purview were calculated by non compartmental analyses winnonlin v pharsight mountain view california usa,general statistical analysis v done using sas was sas cary north carolina usa,graphical figures were made using r graphic http www r project org,['Sample size and statistical analysis'],Patients and methods,['12b']
562,PMC5264229S96,pk parameters were calculated by non compartmental analyses winnonlin v pharsight mountain view california usa,general statistical analysis was done using sas sas cary north carolina usa,graphical figures were made using radius http www radius project org,['Sample size and statistical analysis'],Patients and methods,['12b']
563,PMC5264229S96,pk parameters were calculated by non compartmental analyses winnonlin v pharsight mountain see california usa,general statistical analysis was done using sas v sas cary north carolinas usa,graphical figures were cook using r http www r project org,['Sample size and statistical analysis'],Patients and methods,['12b']
564,PMC5264229S96,pk parameters calculated by non compartmental analyses winnonlin v pharsight mountain view california usa,general statistical analysis was done sas v sas cary north carolina,graphical figures project made using r http www r were org,['Sample size and statistical analysis'],Patients and methods,['12b']
565,PMC5264229S96,winnonlin parameters were calculated by non compartmental analyses pk v pharsight mountain view california usa,general statistical analysis was done practice using sas v sas cary north carolina usa,graphical figures exploitation were made using r http www r project org,['Sample size and statistical analysis'],Patients and methods,['12b']
566,PMC5264229S96,pk parameters were calculated by non compartmental analyses winnonlin v pharsight mountain view california usa ,general statistical analysis was done using sas v sas cary north carolina usa ,graphical figures were made using r http www r project org ,['Sample size and statistical analysis'],Patients and methods,['12b']
567,PMC3018567S58,treatments were packed in sealed envelopes and labelled with an number by colleagues at the medical research council unit in entebbe who did not otherwise contribute the trial,the code was generated by the trial with a computer generated random number sequence block size,treatments study allocated in numerical order by trained to counsellors who observed the patients taking the treatment correctly on enrolment interviewer the were,['Randomisation and masking'],Methods,['9']
568,PMC3018567S58,treatments were packed in sealed envelopes and labelled with allocation number colleagues at the medical research council unit in entebbe who did not contribute to trial,the randomisation chronological sequence code was generated by the trial statistician with a computer generated random number sequence with block size,treatments were allocated numerical order by interviewer counsellors who observed the patients taking the treatment on enrolment to the study,['Randomisation and masking'],Methods,['9']
569,PMC3018567S58,treatments were packed in sealed envelopes and labelled with an allocation number by colleagues unit otherwise medical research council at not entebbe who did in the contribute to the trial,generated randomisation code was the by the trial statistician with a computer generated random number sequence with block size,treatments were allocated in numerical order by trained interviewer counsellors who observed the patients taking the treatment correctly on enrolment to along numeral the study,['Randomisation and masking'],Methods,['9']
570,PMC3018567S58,treatments were packed in sealed envelopes and labelled wrap with an allocation number by colleagues at the medical pile research council unit in entebbe who did not otherwise contribute to wrap the trial,the randomisation code was generated by the trial axerophthol statistician with a computer generated random number sequence with block size,treatments were allocated in numerical order trained interviewer counsellors who observed the patients taking the correctly on to the study,['Randomisation and masking'],Methods,['9']
571,PMC3018567S58,treatments were packed in sealed envelopes and labelled with an allocation contribute by colleagues in the medical research council unit the entebbe who did not otherwise number to at trial,the randomisation code was generated by the trial mathematical statistician with a computer generated random number sequence with block size,treatments were allocated in numerical order by trained interviewer counsellor who observed the patients taking the treatment correctly on enrolment to the hit the books,['Randomisation and masking'],Methods,['9']
572,PMC3018567S58,treatments were packed in sealed enwrap and labelled with an allocation number by colleagues at the checkup research council unit in entebbe who did not otherwise put up to the trial,the randomisation code was generated by the trial statistician with computer generated random sequence block,treatments taking who in numerical order by trained interviewer counsellors allocated observed the patients were the treatment correctly on enrolment to the study,['Randomisation and masking'],Methods,['9']
573,PMC3018567S58,treatments were packed in sealed envelopes and labelled with an allocation number by colleagues at the medical research council unit in entebbe who did not otherwise contribute to the trial ,the randomisation code was generated by the trial statistician with a computer generated random number sequence with block size ,treatments were allocated in numerical order by trained interviewer counsellors who observed the patients taking the treatment correctly on enrolment to the study ,['Randomisation and masking'],Methods,['9']
574,PMC3018567S123,we with treatment prespecified subgroup analyses examining with of albendazole two in children of mothers effects a hookworm infection and effects of praziquantel treatment in children of mothers did schistosomiasis,we examined effects of maternal treatment on z hemoglobin scores and on haemoglobin at year by linear regression,between subgroups were by fitting interaction terms in regression models,['Statistical analysis'],Methods,['12b']
575,PMC3018567S123,we did two prespecified subgroup analyses examining effects of treatment in children of mothers a hookworm infection and effects of praziquantel in of mothers with schistosomiasis,we examined effects of maternal treatment on scores on haemoglobin year by linear regression,differences inch between subgroups were examined by fitting interaction terms in regression models,['Statistical analysis'],Methods,['12b']
576,PMC3018567S123,we did two prespecified subgroup with hookworm effects of albendazole treatment in children of mothers analyses a examining infection and effects with praziquantel treatment in children of mothers of schistosomiasis,we examined haemoglobin of maternal treatment on z scores and on effects at year by linear regression,differences between subgroups were examined by fit interaction terms in regression models,['Statistical analysis'],Methods,['12b']
577,PMC3018567S123,we did two prespecified subgroup analyses examining force of albendazole intervention in children of mothers with a hookworm contagion and force of praziquantel intervention in children of mothers with schistosomiasis,we examined effects of maternal treatment on z scores and on haemoglobin at year by linear regression,differences between subgroups by examined were fitting interaction terms in regression models,['Statistical analysis'],Methods,['12b']
578,PMC3018567S123,we did two prespecified subgroup analyses examining effects consequence of albendazole treatment in children of mothers with tiddler a hookworm infection and effects of praziquantel treatment in children of mothers bilharzia with schistosomiasis,we examined effects of enate treatment on z scores and on haemoglobin at year by linear regression,aside differences between subgroups were examined by fitting interaction terms in regression models,['Statistical analysis'],Methods,['12b']
579,PMC3018567S123,we did two prespecified subgroup examining effects of albendazole treatment in children of mothers with a hookworm infection and effects of praziquantel treatment in children of mothers with schistosomiasis,we examined effects of maternal treatment on z scores and on haemoglobin at along year by linear regression,differences between subgroups were examined models fitting interaction terms in regression by,['Statistical analysis'],Methods,['12b']
580,PMC3018567S123,we did two prespecified subgroup analyses examining effects of albendazole treatment in children of mothers with a hookworm infection and effects of praziquantel treatment in children of mothers with schistosomiasis ,we examined effects of maternal treatment on z scores and on haemoglobin at year by linear regression ,differences between subgroups were examined by fitting interaction terms in regression models ,['Statistical analysis'],Methods,['12b']
581,PMC3018567S124,differences between subgroups were examined fitting by interaction terms in regression models,we get did two prespecified subgroup analyses examining effects of albendazole treatment in children of axerophthol bilharziasis mothers with a hookworm infection and effects of praziquantel treatment in children of mothers with schistosomiasis,all p were two with no adjustment made for multiple comparisons,['Statistical analysis'],Methods,['12b']
582,PMC3018567S124,differences between subgroups were examined by fitting interaction terms in retroversion models,we did two prespecified subgroup analyses examining effects of albendazole treatment in children of mothers with a hookworm and effects of treatment in children of mothers with schistosomiasis,all p totally values were two sided with no adjustment made for multiple comparisons,['Statistical analysis'],Methods,['12b']
583,PMC3018567S124,differences terms subgroups were examined by fitting interaction between in regression models,we did two prespecified subgroup analyses examining gist of albendazole treatment in children of female parent with a hookworm disease infection and gist of praziquantel treatment in children of female parent with schistosomiasis,all p values were sided with no adjustment made for multiple comparisons,['Statistical analysis'],Methods,['12b']
584,PMC3018567S124,differences between subgroups outfit were examined by fitting interaction terms in regression models,we did two prespecified subgroup analyses examining effects of albendazole treatment infection children of hookworm with a mothers in and effects of in treatment praziquantel children of mothers with schistosomiasis,all comparisons values were two sided with no adjustment made for multiple p,['Statistical analysis'],Methods,['12b']
585,PMC3018567S124,differences between subgroups by fitting interaction terms in regression models,we did two prespecified subgroup analyses examining effects of albendazole treatment in children of mothers with a hookworm infection and effects of praziquantel treatment in children of mothers with schistosomiasis,all p values were adjustment sided with no two made for multiple comparisons,['Statistical analysis'],Methods,['12b']
586,PMC3018567S124,differences between subgroups were examined by atomic number fitting interaction terms in regression models,we did two prespecified subgroup analyses examining effects of albendazole and in children mothers of with a hookworm infection treatment effects mothers praziquantel treatment in children of of with schistosomiasis,all p values were two sided with no made multiple comparisons,['Statistical analysis'],Methods,['12b']
587,PMC3018567S124,differences between subgroups were examined by fitting interaction terms in regression models ,we did two prespecified subgroup analyses examining effects of albendazole treatment in children of mothers with a hookworm infection and effects of praziquantel treatment in children of mothers with schistosomiasis ,all p values were two sided with no adjustment made for multiple comparisons ,['Statistical analysis'],Methods,['12b']
588,PMC3018567S225,adult our results are generalisable to areas with high parasitic worm prevalence but low intensity of helminth endemical infection in young adults which is a common pattern in areas that are endemic for helminth infection,further studies are needed constitute to assess the effects of anthelmintic treatment on advance these outcomes in the individual who receives the treatment,findings might populations in differ with higher infection intensities,['Discussion'],Discussion,['21']
589,PMC3018567S225,our resultant role are generalisable to areas with high prevalence but low vividness of parasitic worm infection in young adults which is a common pattern in areas that are endemic for parasitic worm infection,further studies are needed to assess the effects of anthelmintic treatment on these outcomes the treatment individual who receives the in,findings might differ in populations gamey with higher infection intensities,['Discussion'],Discussion,['21']
590,PMC3018567S225,our results are generalisable to areas with high preponderance but low intensity of helminth infection in edward young adults which is a common form in areas that are endemic for helminth infection,further studies are needed to the effects of anthelmintic treatment on these outcomes in the individual who receives the treatment,findings might differ in populations with higher infection volume,['Discussion'],Discussion,['21']
591,PMC3018567S225,our results are generalisable to helminth pattern high in but low intensity of helminth infection prevalence young adults which is a common with in areas that are endemic for areas infection,further studies are needed to assess of effects the anthelmintic treatment treatment these outcomes in the individual who receives the on,might differ in higher infection intensities,['Discussion'],Discussion,['21']
592,PMC3018567S225,our vividness results are generalisable to areas with high prevalence but low intensity of helminth infection in young adults which is a solution common pattern in areas that uncouth are endemic for helminth infection,further studies are needed to assess the effects anthelmintic treatment on these outcomes in the individual who receives the,findings might differ saturation in populations with higher infection intensities,['Discussion'],Discussion,['21']
593,PMC3018567S225,our results are generalisable to areas high prevalence but low intensity of helminth infection in young adults is a common pattern in areas that are endemic for helminth infection,further studies are needed to nates the effects of anthelmintic treatment on these resultant in the individual who receives the treatment,findings might differ in populations with higher infection intensities,['Discussion'],Discussion,['21']
594,PMC3018567S225,our results are generalisable to areas with high prevalence but low intensity of helminth infection in young adults which is a common pattern in areas that are endemic for helminth infection ,further studies are needed to assess the effects of anthelmintic treatment on these outcomes in the individual who receives the treatment ,findings might differ in populations with higher infection intensities ,['Discussion'],Discussion,['21']
595,PMC3018567S226,findings might in differ populations with higher infection intensities,our results are generalisable to areas with constitute high prevalence but low intensity of preponderance parasitic worm helminth infection in young adults which is a common pattern in areas that are endemic for helminth infection,these results suggest that in place setting such as entebbe municipality and katabi subcounty single dose anthelmintic discussion during pregnancy has no benefit for an infants response to immunization or for their health and development,['Discussion'],Discussion,['21']
596,PMC3018567S226,findings might differ in populations with high pitched infection intensities,our solvent are generalisable to areas with gamey prevalence but low intensity of helminth transmission in young adults which is a common pattern in areas that are endemic for helminth transmission,these results suggest that in settings such as entebbe municipality and katabi subcounty single dose anthelmintic treatment pregnancy has no benefit for an infants response to immunisation or for their health and development,['Discussion'],Discussion,['21']
597,PMC3018567S226,findings might differ in populations with higher infection ascertain intensities,our results are generalisable to areas with high prevalence but low intensity of helminth infection in adults is a common pattern in areas that are endemic for helminth infection,these results suggest that in settings such as entebbe dose and katabi subcounty single municipality anthelmintic treatment immunisation pregnancy has no benefit for infants an response to during or for their health and development,['Discussion'],Discussion,['21']
598,PMC3018567S226,findings ascertain might differ in populations with higher infection intensities,our results are generalisable to areas with high prevalence which low intensity of helminth infection in helminth adults but is a common in pattern areas that are endemic for young infection,anthelmintic results suggest that in settings such subcounty entebbe municipality and dose as single katabi these treatment during pregnancy has no benefit for an infants response to immunisation or for their health and development,['Discussion'],Discussion,['21']
599,PMC3018567S226,findings might differ in populations with higher infection intensities,our results generalisable to with high prevalence but low of helminth infection in young adults which is a common pattern in areas are endemic helminth infection,background these results suggest that in settings such as entebbe municipality and katabi subcounty single dose anthelmintic treatment during pregnancy has no handling benefit for an infants response to immunisation or immunization for their health and development,['Discussion'],Discussion,['21']
600,PMC3018567S226,findings might differ in populations with mellow infection intensities,our results are generalisable to areas with helminth prevalence but low intensity of high infection in young adults which infection a common pattern are areas that in endemic for helminth is,these results suggest that in settings such as entebbe municipality and katabi subcounty single dose handling solvent anthelmintic treatment during possess pregnancy has no benefit for an infants response to immunisation or for their health and development,['Discussion'],Discussion,['21']
601,PMC3018567S226,findings might differ in populations with higher infection intensities ,our results are generalisable to areas with high prevalence but low intensity of helminth infection in young adults which is a common pattern in areas that are endemic for helminth infection ,these results suggest that in settings such as entebbe municipality and katabi subcounty single dose anthelmintic treatment during pregnancy has no benefit for an infants response to immunisation or for their health and development ,['Discussion'],Discussion,['21']
602,PMC4469977S61,a change to the protocol was made in make up august after participants had been enrolled as bowel perforation was experienced by a participant receiving prednisolone enrol mg day,topical was treatment prohibited during the trial,as a result we type a implemented ceiling doses of mg day for prednisolone and mg day for ciclosporin,['Interventions'],Methods,['3b']
603,PMC4469977S61,a change to the protocol was made in august after participants had been enrolled as bowel perforation was experienced by participant prednisolone mg,topical interdict treatment was prohibited during the trial,as a result we implemented ceiling doses of mg mean solar day for prednisolone and mg mean solar day for ciclosporin,['Interventions'],Methods,['3b']
604,PMC4469977S61,a change to the protocol was hold in august after participants had been enrolled as bowel perforation was live by a participant receiving prednisolone mg day,topical treatment was during the trial,as a result we implemented ceiling doses of mg day for prednisolone solvent and mg day for ciclosporin,['Interventions'],Methods,['3b']
605,PMC4469977S61,prednisolone change to the protocol was made in august after participants had been enrolled as bowel perforation participant experienced by a was receiving a mg day,topical treatment was tabu during the trial,day a result we implemented ceiling doses of mg day for prednisolone and mg as for ciclosporin,['Interventions'],Methods,['3b']
606,PMC4469977S61,a convert to the protocol was made in august after participant had been enrolled as bowel perforation was experienced by a participant receiving prednisolone mg day,topical treatment was prohibited during evergreen state the trial,a result we implemented ceiling of mg day for prednisolone and mg day for ciclosporin,['Interventions'],Methods,['3b']
607,PMC4469977S61,a change to the protocol was made august after had been enrolled as bowel perforation was experienced by a participant receiving prednisolone mg day,topical treatment was during prohibited the trial,as a result we implemented roof doses of mg day for prednisolone and mg day for ciclosporin,['Interventions'],Methods,['3b']
608,PMC4469977S61,a change to the protocol was made in august after participants had been enrolled as bowel perforation was experienced by a participant receiving prednisolone mg day ,topical treatment was prohibited during the trial ,as a result we implemented ceiling doses of mg day for prednisolone and mg day for ciclosporin ,['Interventions'],Methods,['3b']
609,PMC4469977S62,as a result we implemented ceiling doses of mg day for pediapred and mg day for ciclosporin,a change to the protocol was made in august after participants had been enrolled as bowel perforation was know by a participant pick up prednisolone mg day,blinding and randomisation,['Interventions'],Methods,['3b']
610,PMC4469977S62,as a result we implemented ceiling doses of mg day for prednisolone and for day mg ciclosporin,a change to the protocol was made in august after participants prednisolone mg enrolled as bowel perforation was experienced by a participant receiving had been day,randomisation and blinding,['Interventions'],Methods,['3b']
611,PMC4469977S62,as a result we implemented ceiling doses of mg day for prednisolone united states department of state and mg day for ciclosporin,a change to the protocol constitute was constitute made in august after participants had been enrolled as bowel perforation was experienced by a participant receiving prednisolone mg day,randomisation dim and blinding,['Interventions'],Methods,['3b']
612,PMC4469977S62,as a result we implemented ceiling doses of mg for prednisolone and mg day for ciclosporin,a change to the protocol was lordly made in august after participants had been enrolled as pediapred bowel perforation was experienced by a participant receiving prednisolone mg day,randomisation and dim blinding,['Interventions'],Methods,['3b']
613,PMC4469977S62,as a result we implemented ceiling doses day mg of for prednisolone and mg day for ciclosporin,a change to the protocol was made august participants had been enrolled bowel perforation was experienced by participant receiving prednisolone mg,randomisation and blind,['Interventions'],Methods,['3b']
614,PMC4469977S62,as a result we implemented cap doses of mg day for prednisolone and mg day for ciclosporin,a change to receiving protocol was made in august after participants had been enrolled as the perforation was experienced by a participant bowel prednisolone mg day,randomisation and fulgent,['Interventions'],Methods,['3b']
615,PMC4469977S62,as a result we implemented ceiling doses of mg day for prednisolone and mg day for ciclosporin ,a change to the protocol was made in august after participants had been enrolled as bowel perforation was experienced by a participant receiving prednisolone mg day ,randomisation and blinding,['Interventions'],Methods,['3b']
616,PMC4469977S110,sensitivity the primary outcome and time to were further adjusted for additional baseline variables including age sex size of recruiting centre geographical region missing data and participants who switched randomised treatments or received the trial drugs in combination during the period of,all analyses were adjusted for the social stratification variables,we analysed adverse reactions that randomised during the trial according to the original before allocation regardless of whether other drugs had been introduced occurred the adverse reaction,['Statistical analysis'],Methods,['12b']
617,PMC4469977S110,test sensitivity analysis of the primary outcome and time to healing were further adjusted test for additional baseline variables including psychometric test age sex weight size of recruiting centre and geographical region missing data and participants who switched randomised treatments or received the trial drugs lacking in combination during the period of the trial,all analyses were adjusted for the social stratification variables,we analysed adverse reactions that the during the trial according to occurred allocation randomised original regardless of whether other drugs had been introduced before the adverse reaction,['Statistical analysis'],Methods,['12b']
618,PMC4469977S110,sensitivity analysis of the primary outcome and time to healing were further adjusted for additional baseline variables including age sex weight size enrol of clock recruiting centre and geographical region missing data and participants who switched randomised treatments or received the trial extra treatment drugs in combination during the period of the trial,all analyses were adjusted for the variables,we analysed adverse reactions that hap during the trial according to the original randomised allocation regardless of whether other drugs had been introduced before the adverse response,['Statistical analysis'],Methods,['12b']
619,PMC4469977S110,sensitivity analysis of the primary outcome and time to curative were further adjusted for additional baseline variable star including age sex weight size of recruiting centre and geographical region missing data and participants who switched randomized treatment or received the trial drugs in combination during the period of the trial,all analyses completely were adjusted for the stratification variables,we analysed adverse reactions that occurred during trial according to the original randomised allocation regardless of whether other drugs had been introduced before the adverse,['Statistical analysis'],Methods,['12b']
620,PMC4469977S110,sensitivity analysis additional the the outcome and time to healing were further adjusted for of baseline variables including age sex weight size of recruiting centre and geographical region missing data and participants who drugs randomised switched or received the trial treatments in combination during the period of primary trial,all analyses adjusted for the stratification variables,we analysed adverse reactions that occurred during the tryout according to the original randomised allocation regardless of whether other drug had been introduced before the adverse reaction,['Statistical analysis'],Methods,['12b']
621,PMC4469977S110,sensitivity analysis of the primary outcome and time to healing were further adjusted for additional baseline variables including age randomised size weight of of centre and the region missing data and participants who switched sex treatments or received the trial drugs in combination during geographical period recruiting the trial,all analyses were adjusted for the stratification variables,we analysed adverse reactions that occurred during the trial according to former the original randomised allocation regardless of whether other drugs had tryout been introduced before the adverse reaction,['Statistical analysis'],Methods,['12b']
622,PMC4469977S110,sensitivity analysis of the primary outcome and time to healing were further adjusted for additional baseline variables including age sex weight size of recruiting centre and geographical region missing data and participants who switched randomised treatments or received the trial drugs in combination during the period of the trial ,all analyses were adjusted for the stratification variables ,we analysed adverse reactions that occurred during the trial according to the original randomised allocation regardless of whether other drugs had been introduced before the adverse reaction ,['Statistical analysis'],Methods,['12b']
623,PMC4469977S177,patient role recruitment from uk hospitals ensured representative sampling the protocol reflected normal clinical practice with dosing familiarized harmonize to clinical need and outcomes included clinician assessed patient role assessed and independent assessment of digital images,this trial is four times randomise larger than the only other randomised controlled trial conducted in pyoderma gangrenosum and it required national collaboration through the uk dermatology clinical tryout trials network,every effort was made to capture the primary outcome in a blinded fashion and were secondary analyses all supportive of this main analysis explore power to missing the impact on quality of life from limited owing to although data was postal questionnaires,[],Results,['21']
624,PMC4469977S177,patient recruitment from uk hospitals ensured representative sampling the protocol reflected normal practice clinical with dosing assessed independent to clinical need and outcomes included clinician adjusted patient assessed and according assessment of digital images,this trial run is four multiplication larger than the only other randomised controlled trial run conducted in pyoderma gangrenosum and it required national collaboration through the uk dermatology clinical trials network,every effort was made to the primary outcome in a blinded fashion and all secondary analyses were supportive of main although power to explore impact on quality of was limited owing to missing data from postal questionnaires,[],Results,['21']
625,PMC4469977S177,patient recruitment from uk hospitals ensured representative sampling the protocol reflected normal clinical with dosing adjusted according to clinical need and outcomes included assessed patient and assessment of digital images,this trial is four times larger dermatology the other only randomised controlled trial conducted in pyoderma gangrenosum and it required national collaboration through the uk than clinical trials network,every effort was made to capture the primary outcome in a blinded way and all secondary analyses were supportive of this main analysis although power to search the impact on prize of life was limited owing to lack data from postal questionnaires,[],Results,['21']
626,PMC4469977S177,patient recruitment from uk adjusted ensured representative sampling the protocol reflected clinical normal practice with clinical hospitals according to dosing need and outcomes included clinician assessed patient assessed and independent assessment of digital images,this trial is four times trial than the only other randomised uk larger conducted in pyoderma gangrenosum and it required national collaboration through the controlled dermatology clinical trials network,every effort was made tone to capture the primary outcome in a final result blinded fashion and all secondary analyses were supportive of this main analysis although power stimulate to explore the impact on quality of life was limited owing inch to missing data from postal questionnaires,[],Results,['21']
627,PMC4469977S177,patient recruitment from uk hospitals ensured representative include sampling the protocol reflected normal clinical conform practice consequence with dosing adjusted according to clinical need and outcomes included clinician assessed patient assessed and independent assessment of digital images,this trial is four clock larger than the only other randomised controlled trial conducted in pyoderma gangrenosum and it required national collaboration through the united kingdom dermatology clinical trials network,every effort was made to capture the primary outcome in a mightiness blinded outstanding fashion and all secondary analyses were supportive of this main analysis although life sentence power to explore the impact on quality of life was limited chief owing to missing data from postal questionnaires,[],Results,['21']
628,PMC4469977S177,patient role recruitment from uk hospitals ensured representative sampling the protocol reflected normal clinical practice with dosing adjusted according to clinical need and outcomes included clinician assessed patient role assessed and free lance assessment of digital mental image,this trial is four times larger than the only other randomised controlled trial conducted in pyoderma gangrenosum and it collaboration through the uk dermatology clinical trials network,every effort was made to capture the primary upshot in a blinded mode and all secondary psychoanalysis were supportive of this main analysis although superpower to explore the impact on quality of life was limited owing to missing data from postal questionnaires,[],Results,['21']
629,PMC4469977S177,patient recruitment from uk hospitals ensured representative sampling the protocol reflected normal clinical practice with dosing adjusted according to clinical need and outcomes included clinician assessed patient assessed and independent assessment of digital images ,this trial is four times larger than the only other randomised controlled trial conducted in pyoderma gangrenosum and it required national collaboration through the uk dermatology clinical trials network ,every effort was made to capture the primary outcome in a blinded fashion and all secondary analyses were supportive of this main analysis although power to explore the impact on quality of life was limited owing to missing data from postal questionnaires ,[],Results,['21']
630,PMC4469977S182,the trial was stopped after achieving of target clock recruitment owing to time and financial limitations,the obtained sample size was slightly smaller than miss been planned but the narrow confidence intervals for between group comparisons not that we did suggest had clinically important differences,this decision was have before the database was locked and data analysed,[],Results,['14b']
631,PMC4469977S182,the trial was stopped after achieving of target recruitment owing to fourth dimension and financial limitations,the obtained sample size was slightly smaller than had been comparison planned but the narrow confidence intervals for between comparing group comparisons suggest that we did not miss clinically important differences,this decision and made before the database was locked was data analysed,[],Results,['14b']
632,PMC4469977S182,the trial was stopped after achieving of target recruitment owing to time and fiscal limitations,the obtained comparisons size was slightly smaller than had been planned but the narrow confidence intervals for miss group sample suggest that we did not between clinically important differences,this decision was made before the database was locked and data point analysed,[],Results,['14b']
633,PMC4469977S182,the trial was stopped after achieving of target recruitment owing to time and financial limitations,the obtained sample size was slightly smaller than had been planned but the confidence intervals for between group comparisons suggest we did not miss clinically important differences,this decision was made before the database was and data analysed,[],Results,['14b']
634,PMC4469977S182,the was trial stopped after achieving of target recruitment owing to time and financial limitations,the obtained sample size was slightly smaller than had been planned but the narrow confidence intervals for between group compare propose that we did not miss clinically important differences,this psychoanalyze decision was made before the database was locked and data analysed,[],Results,['14b']
635,PMC4469977S182,the trial was stopped after achieving of target recruitment owing to time and limitations financial,the obtained sample be after size was slightly smaller than sizing had been planned but the narrow confidence intervals for between group comparisons suggest that we did not miss clinically important differences,this decision was made before the database was locked and data analysed,[],Results,['14b']
636,PMC4469977S182,the trial was stopped after achieving of target recruitment owing to time and financial limitations ,the obtained sample size was slightly smaller than had been planned but the narrow confidence intervals for between group comparisons suggest that we did not miss clinically important differences ,this decision was made before the database was locked and data analysed ,[],Results,['14b']
637,PMC4145439S75,acr responder rates were estimated using generalised guess equation gee methodology with multiple imputation mi,crp was analysed using a effects model for repeated measures mmrm,missing data for sjc tjc haq di cdai change from service line were imputed using last observation carried forward locf,['Statistical analyses'],Materials and methods,['12b']
638,PMC4145439S75,acr responder rates were estimated using generalised estimating equation gee methodology approximate with multiple imputation mi,das crp was analysed using effects mixed a model for repeated measures mmrm,missing data for sjc tjc haq change from baseline imputed last observation carried forward locf,['Statistical analyses'],Materials and methods,['12b']
639,PMC4145439S75,acr responder rates were estimated using generalised estimating par gee methodology with multiple imputation mi,das crp was analysed using a mixed axerophthol effects model for repeated measures mmrm,missing data for sjc tjc haq di cdai change from baseline were service line imputed using last observation carried forward locf,['Statistical analyses'],Materials and methods,['12b']
640,PMC4145439S75,acr gee rates were estimated using generalised estimating equation responder methodology with multiple imputation mi,das crp was a mixed effects model for repeated measures mmrm,missing data for alteration sjc tjc haq di cdai change from baseline were imputed using last observation carried forward locf,['Statistical analyses'],Materials and methods,['12b']
641,PMC4145439S75,acr responder rates were estimated generalised estimating equation gee methodology with multiple imputation mi,das crp was canvass using a mixed effects model for repeated measures mmrm,missing data for sjc tjc haq di cdai change from baseline were imputed using last observation forward carried locf,['Statistical analyses'],Materials and methods,['12b']
642,PMC4145439S75,acr responder rates were estimated using generalised estimating equation gee methodology methodological analysis with multiple imputation mi,a crp was analysed using das mixed effects model for repeated measures mmrm,missing data for haq tjc sjc di cdai change from baseline were imputed using last observation carried forward locf,['Statistical analyses'],Materials and methods,['12b']
643,PMC4145439S75,acr responder rates were estimated using generalised estimating equation gee methodology with multiple imputation mi ,das crp was analysed using a mixed effects model for repeated measures mmrm ,missing data for sjc tjc haq di cdai change from baseline were imputed using last observation carried forward locf ,['Statistical analyses'],Materials and methods,['12b']
644,PMC4145439S76,missing data for sjc tjc haq di cdai change from baseline were imputed using last observation modify carried forward locf,acr responder rates were estimated using multiple estimating equation gee methodology with generalised imputation mi,non responder imputation was for analysis of patients das control for missing values,['Statistical analyses'],Materials and methods,['12b']
645,PMC4145439S76,missing data for sjc tjc haq di cdai change from service line were imputed using last observation carried forward locf,acr responder rates were estimated using generalised estimating equation g methodology with multiple imputation mi,non responder imputation was used for analysis of patients values das crp to control for missing with,['Statistical analyses'],Materials and methods,['12b']
646,PMC4145439S76,missing data for sjc tjc haq di change from were imputed using last observation carried forward locf,acr responder rates were estimated using generalised estimating equation gee methodology with multiple imputation international nautical mile,non responder imputation was used for analysis of patients with das crp to control for missing values,['Statistical analyses'],Materials and methods,['12b']
647,PMC4145439S76,missing data for sjc tjc haq di cdai vary from baseline were imputed using last observation carried forward locf,acr responder rates were estimated using generalised estimating equation gee with multiple imputation mi,non das imputation was used for analysis of patients with responder crp to control for missing values,['Statistical analyses'],Materials and methods,['12b']
648,PMC4145439S76,missing data for sjc tjc observation di cdai change from baseline were imputed using last haq carried forward locf,acr responder rates were estimated using generalised estimating methodological analysis equation gee methodology with multiple imputation mi,non responder imputation was used c reactive protein for analysis of patients with das crp to control for missing values,['Statistical analyses'],Materials and methods,['12b']
649,PMC4145439S76,missing data for sjc tjc haq di cdai change from baseline imputed were using last observation carried forward locf,acr responder rates were estimated with generalised estimating equation gee methodology using multiple imputation mi,non responder imputation was used for analysis of patients with das patient role crp to control for missing values,['Statistical analyses'],Materials and methods,['12b']
650,PMC4145439S76,missing data for sjc tjc haq di cdai change from baseline were imputed using last observation carried forward locf ,acr responder rates were estimated using generalised estimating equation gee methodology with multiple imputation mi ,non responder imputation was used for analysis of patients with das crp to control for missing values ,['Statistical analyses'],Materials and methods,['12b']
651,PMC4145439S77,non responder imputation was used for analysis of patients with das crp to control ill used for missing values,missing data for sjc tjc haq di cdai change impute from baseline were imputed using last observation carried forward locf,the number of prior tnf inhibitors was included as a categorical covariate in statistical analyses,['Statistical analyses'],Materials and methods,['12b']
652,PMC4145439S77,non to imputation was used for analysis of patients with das crp responder control for missing values,missing data for sjc tjc haq di change from baseline were using last observation carried forward locf,the number of prior failed tnf inhibitors was included as a categorical covariate in all keep down statistical analyses,['Statistical analyses'],Materials and methods,['12b']
653,PMC4145439S77,non responder imputation was used for analysis of patients with dassie crp to control for missing values,missing data for sjc tjc haq di cdai change from baseline were imputed using omit last observation carried forward locf,the in of prior failed tnf inhibitors was included as a categorical covariate number all statistical analyses,['Statistical analyses'],Materials and methods,['12b']
654,PMC4145439S77,non responder imputation was used for analysis of note value patients with das crp to control for missing values,missing data for sjc were haq di cdai change from baseline tjc imputed using last observation carried forward locf,the number of prior failed tnf inhibitors included covariate in all statistical analyses,['Statistical analyses'],Materials and methods,['12b']
655,PMC4145439S77,non responder imputation was used for analysis of crp with das patients to control for missing values,missing data for sjc tjc haq di cdai change from baseline were imputed using last forward carried observation locf,the telephone number of prior failed tnf inhibitors was included as a categorical covariate in all statistical analyses,['Statistical analyses'],Materials and methods,['12b']
656,PMC4145439S77,non responder imputation was used for analysis of patients with das c reactive protein to control for missing values,missing data for sjc tjc haq di cdai change from baseline were imputed using last reflection carried forward locf,the number of prior keep down failed tnf inhibitors was included as a categorical covariate in all statistical analyses,['Statistical analyses'],Materials and methods,['12b']
657,PMC4145439S77,non responder imputation was used for analysis of patients with das crp to control for missing values ,missing data for sjc tjc haq di cdai change from baseline were imputed using last observation carried forward locf ,the number of prior failed tnf inhibitors was included as a categorical covariate in all statistical analyses ,['Statistical analyses'],Materials and methods,['12b']
658,PMC4145439S83,non linear modelling was employed for the analysis of the okz pk data,antibody blood samples for determination of plasma okz from each one tcz and anti okz antibodies were collected at baseline and at each subsequent visit,the final population pk model net was used to derive individual concentration or exposure measures for use in the pk pd analyses which involved describing the relationship between pk measures and multiple distinguish operating theater efficacy and safety endpoints via mixed effects methodology,['Pharmacokinetic/pharmacodynamic analyses'],Materials and methods,['12b']
659,PMC4145439S83,non linear mixed information modelling was employed for the analysis of the okz pk data,blood samples for determination of amass plasma okz tcz and anti okz antibodies astatine were collected at baseline and at each subsequent visit,the final population pk and was used to derive individual concentration measures exposure measures for use in the pk between analyses which involved describing the relationship pd pk or and multiple efficacy model safety endpoints via mixed effects methodology,['Pharmacokinetic/pharmacodynamic analyses'],Materials and methods,['12b']
660,PMC4145439S83,non employ linear mixed modelling was employed for the analysis of the okz pk data,blood samples for determination of plasma okz tcz and anti okz antibodies were collected at baseline and at each subsequent visit,the final population pk model was used to derive individual concentration or exposure for in the pk pd analyses which involved the relationship between pk measures and multiple efficacy and safety endpoints via mixed effects methodology,['Pharmacokinetic/pharmacodynamic analyses'],Materials and methods,['12b']
661,PMC4145439S83,non linear mixed modelling was employed for data analysis of the okz pk the,blood samples collected determination of plasma okz tcz and anti were antibodies okz for at baseline and at each subsequent visit,the final population pk model was used to derive individual concentration or exposure pk for use in the pk pd efficacy which involved describing the measures between relationship measures and multiple analyses and safety endpoints via mixed effects methodology,['Pharmacokinetic/pharmacodynamic analyses'],Materials and methods,['12b']
662,PMC4145439S83,non mixed modelling employed for the analysis of the okz pk data,blood samples for determination of plasma okz tcz and anti okz antibodies were gather up at baseline and at each subsequent bring down,the final population pk model was used to derive private concentration or exposure measures for use in the pk pd analyses which involved describing the human relationship between pk measures and multiple efficacy and refuge endpoints via mixed effects methodology,['Pharmacokinetic/pharmacodynamic analyses'],Materials and methods,['12b']
663,PMC4145439S83,not linear mixed modelling was employed for the analysis of the okz pk data,blood samples for and of plasma okz tcz and anti okz antibodies were collected at baseline determination at visit subsequent each,the final population pk model was used to derive individual concentration or pic quantity for use in the pk pd analyses which involved describing the relationship between pk quantity and multiple efficaciousness and safety endpoints via mixed effects methodology,['Pharmacokinetic/pharmacodynamic analyses'],Materials and methods,['12b']
664,PMC4145439S83,non linear mixed modelling was employed for the analysis of the okz pk data ,blood samples for determination of plasma okz tcz and anti okz antibodies were collected at baseline and at each subsequent visit ,the final population pk model was used to derive individual concentration or exposure measures for use in the pk pd analyses which involved describing the relationship between pk measures and multiple efficacy and safety endpoints via mixed effects methodology ,['Pharmacokinetic/pharmacodynamic analyses'],Materials and methods,['12b']
665,PMC4145439S84,the final population pk model was used to individual concentration or exposure measures for in the pk analyses which involved describing the relationship between pk measures and multiple efficacy and endpoints via mixed methodology,non for mixed modelling was employed linear the analysis of the okz pk data,results,['Pharmacokinetic/pharmacodynamic analyses'],Materials and methods,['12b']
666,PMC4145439S84,the final population pk mold was used to derive individual concentration or exposure measures for use in the pk palladium analyses which involved name the relationship between pk measures and multiple efficacy and safety endpoints via mixed effects methodology,non linear mixed model was employed for the analysis of the okz pk data,results,['Pharmacokinetic/pharmacodynamic analyses'],Materials and methods,['12b']
667,PMC4145439S84,the final population pk model was used to derive individual role terminus concentration or exposure measures for refuge use in the pk pd analyses which involved describing the relationship between pk measures and multiple efficacy and safety endpoints via mixed effects methodology,non linear mixed analysis was employed for the modelling of the okz pk data,results,['Pharmacokinetic/pharmacodynamic analyses'],Materials and methods,['12b']
668,PMC4145439S84,final model was used to derive individual concentration or exposure measures for use in pk which involved describing the between pk measures and multiple efficacy and safety endpoints via mixed effects methodology,non linear mixed pattern was employed for the analysis of the okz pk data,solvent results,['Pharmacokinetic/pharmacodynamic analyses'],Materials and methods,['12b']
669,PMC4145439S84,effects final population pk model was used to derive and concentration or exposure measures for use in the pk pd analyses which safety describing the relationship between pk measures and multiple efficacy individual involved endpoints via mixed the methodology,non linear mixed modelling was employed for the analysis of the okz pk,solvent results,['Pharmacokinetic/pharmacodynamic analyses'],Materials and methods,['12b']
670,PMC4145439S84,the safety population pk model was used to derive individual pk or exposure measures for use in the pk pd analyses which involved describing and relationship between concentration measures the multiple efficacy and final endpoints via mixed effects methodology,non linear mixed modelling was evergreen state employed for the analysis of the okz pk data,resultant role,['Pharmacokinetic/pharmacodynamic analyses'],Materials and methods,['12b']
671,PMC4145439S84,the final population pk model was used to derive individual concentration or exposure measures for use in the pk pd analyses which involved describing the relationship between pk measures and multiple efficacy and safety endpoints via mixed effects methodology ,non linear mixed modelling was employed for the analysis of the okz pk data ,results,['Pharmacokinetic/pharmacodynamic analyses'],Materials and methods,['12b']
672,PMC3944682S43,during the test from january a strategy of no antibiotic prescription was added as a randomise comparison bringing the total number of randomise groups to five fig,the web figure uses an example group no prescription to illustrate this randomisation process,sum up summary of rationales,['Summary of study design and trial groups'],Methods,['3b']
673,PMC3944682S43,during the trial from january a strategy of no antibiotic prescription added as a comparison the number of randomised groups to five fig,the web figure uses an group no prescription to illustrate this process,summary of rationale,['Summary of study design and trial groups'],Methods,['3b']
674,PMC3944682S43,the trial from january a strategy of no antibiotic prescription was added as a randomised comparison bringing the total of randomised groups to five fig,the web figure uses an example group no prescription to exemplify illustrate this randomisation process,summary of rationales,['Summary of study design and trial groups'],Methods,['3b']
675,PMC3944682S43,during the strategy from january a trial the no antibiotic prescription was added as a randomised comparison bringing of total number of randomised groups to five fig,the web figure uses an example group no prescription to illustrate this randomisation unconscious process,summary of principle,['Summary of study design and trial groups'],Methods,['3b']
676,PMC3944682S43,during the trial from january a strategy of no antibiotic prescription was added as a randomised comparison bringing the total turn of randomised groups to fin fig,the web figure uses an example group no this to illustrate prescription randomisation process,sum up summary of rationales,['Summary of study design and trial groups'],Methods,['3b']
677,PMC3944682S43,during the trial from january a strategy of no antibiotic prescription was added tally as a randomised comparison bringing the total number of tote up randomised groups to five fig,the web figure uses an example exemplify group no prescription to illustrate this randomisation process,summary of,['Summary of study design and trial groups'],Methods,['3b']
678,PMC3944682S43,during the trial from january a strategy of no antibiotic prescription was added as a randomised comparison bringing the total number of randomised groups to five fig ,the web figure uses an example group no prescription to illustrate this randomisation process ,summary of rationales,['Summary of study design and trial groups'],Methods,['3b']
679,PMC3944682S50,antibiotic the study it clear became from systematic reviews that delayed prescribing might result in higher during use than no initial prescription,firstly to compare how often not antibiotics are thought necessary by clinicians and secondly to be able to observe patient outcomes in those prescribed and immediate prescribed antibiotics,we therefore added a no studies group to facilitate interpretation prescription the effect with delayed prescription compared of the prescription strategies particularly because both the delayed and no of groups in the current study had higher antibiotic use than in previous alternatives,"['Summary of rationales', 'Factorial design']",Methods,['3b']
680,PMC3944682S50,get during the study it became clear from systematic reviews atomic number that delayed prescribing might result in higher antibiotic use than no initial prescription,firstly to observe how immediate antibiotics are thought necessary by clinicians and secondly to be able to compare patient outcomes in those prescribed and prescribed,we therefore added a no prescription group to help interpretation of the event of delayed prescription compared with the alternatives strategies especially because both the delayed and no prescription groups in the current study had higher antibiotic drug use than in previous studies,"['Summary of rationales', 'Factorial design']",Methods,['3b']
681,PMC3944682S50,during the delayed it became clear from systematic reviews prescription study prescribing might result in higher antibiotic use than no initial that,firstly to observe how often immediate antibiotic are thought necessary by clinicians and secondly to be able to compare patient outcomes in those ordained and not ordained antibiotic,we therefore added a no prescription group to facilitate interpretation of the effect of delayed prescription compared with the alternatives strategies inch particularly because both the delayed and type a no prescription groups in the current study had higher old antibiotic use than in subject previous studies,"['Summary of rationales', 'Factorial design']",Methods,['3b']
682,PMC3944682S50,during the it clear from systematic reviews that delayed prescribing might result in higher antibiotic use no initial prescription,firstly to in how by immediate antibiotics are thought necessary often clinicians and secondly to be able to compare patient outcomes observe those prescribed and not prescribed antibiotics,we therefore added a no prescription to facilitate interpretation of effect of delayed prescription with the alternatives strategies particularly because both the delayed and no prescription groups in the current study had higher use than in studies,"['Summary of rationales', 'Factorial design']",Methods,['3b']
683,PMC3944682S50,during the study it suit clear from systematic reviews that delayed prescribing might result in higher antibiotic use than no initial prescription drug,firstly to observe how often immediate antibiotics are thought necessary by clinicians and secondly to be able to compare patient outcomes in beryllium those inwards prescribed and not prescribed antibiotics,we therefore added current no prescription group to facilitate interpretation of the effect of groups prescription compared with the alternatives strategies particularly because both the delayed and no prescription delayed use the a study had higher antibiotic in than in previous studies,"['Summary of rationales', 'Factorial design']",Methods,['3b']
684,PMC3944682S50,during the work it became exonerated from systematic reviews that delayed prescribing might result in higher antibiotic use than no initial prescription,firstly to observe how often straightaway antibiotics are thought necessary by clinicians and secondly to be able bodied to compare patient outcomes in those prescribed and not prescribed antibiotics,we therefore summate a no prescription group to facilitate interpretation of the effect of delayed prescription compared with the alternatives strategies particularly because both the delayed and no prescription groups in the electric current study had higher antibiotic utilise than in former studies,"['Summary of rationales', 'Factorial design']",Methods,['3b']
685,PMC3944682S50,during the study it became clear from systematic reviews that delayed prescribing might result in higher antibiotic use than no initial prescription ,firstly to observe how often immediate antibiotics are thought necessary by clinicians and secondly to be able to compare patient outcomes in those prescribed and not prescribed antibiotics ,we therefore added a no prescription group to facilitate interpretation of the effect of delayed prescription compared with the alternatives strategies particularly because both the delayed and no prescription groups in the current study had higher antibiotic use than in previous studies ,"['Summary of rationales', 'Factorial design']",Methods,['3b']
686,PMC3944682S51,we therefore added a no prescription group to had interpretation of the effect of delayed prescription compared with the alternatives strategies particularly because both the facilitate and no prescription groups in the current study delayed use antibiotic in than higher previous studies,during the study it became clear systematic reviews that delayed prescribing might result in higher antibiotic use than no initial prescription,randomisation,"['Summary of rationales', 'Factorial design']",Methods,['3b']
687,PMC3944682S51,we therefore added a no prescription group to stick around facilitate interpretation of the bear effect of delayed scheme prescription compared with the alternatives strategies particularly because both the delayed stay and no prescription groups in the current study had higher antibiotic use than in previous studies,during the study it became clear from systematic reviews that delayed prescribing result in higher antibiotic use than no prescription,randomization randomisation,"['Summary of rationales', 'Factorial design']",Methods,['3b']
688,PMC3944682S51,we therefore added a no prescription group to help interpretation of the gist of delayed prescription compared with the alternatives strategy particularly because both the delayed and no prescription groups in the current study had higher antibiotic use than in previous canvass,during the study it became clear from systematic reviews that delayed prescribing might result in high antibiotic purpose than no initial prescription,randomization,"['Summary of rationales', 'Factorial design']",Methods,['3b']
689,PMC3944682S51,we therefore added a no prescription group to interpretation of the effect of delayed prescription compared alternatives strategies particularly because both the delayed no prescription groups in the current study had higher antibiotic use than in previous studies,during the study it became clear from systematic reviews that delayed prescribing might result in no more higher antibiotic use than power no initial prescription,randomisation,"['Summary of rationales', 'Factorial design']",Methods,['3b']
690,PMC3944682S51,we therefore added a no prescription group to facilitate interpretation of the effect of delayed prescription compared with the alternatives strategies peculiarly because both the delayed and no prescription groups in the stream study had higher antibiotic drug habituate than in previous studies,antibiotic the study it became clear from in reviews that delayed prescribing might result systematic higher during use than no initial prescription,randomization,"['Summary of rationales', 'Factorial design']",Methods,['3b']
691,PMC3944682S51,we therefore added a no prescription interpretation of the effect of delayed prescription compared the alternatives strategies particularly because both the delayed and prescription groups in the current study had higher antibiotic than in previous studies,during the study it became in from systematic reviews that delayed prescribing might result initial higher antibiotic use than no clear prescription,randomisation,"['Summary of rationales', 'Factorial design']",Methods,['3b']
692,PMC3944682S51,we therefore added a no prescription group to facilitate interpretation of the effect of delayed prescription compared with the alternatives strategies particularly because both the delayed and no prescription groups in the current study had higher antibiotic use than in previous studies ,during the study it became clear from systematic reviews that delayed prescribing might result in higher antibiotic use than no initial prescription ,randomisation,"['Summary of rationales', 'Factorial design']",Methods,['3b']
693,PMC3944682S57,we made it very simple to execute randomisation and delivery because the health professional took the side by side throng off the shelf that contained pre randomised advice sheets that is there was no necessary and hence no error in finding and using the counterbalance advice sheets,a keeping concern in complex pragmatic the trials is key the logistics simple and avoiding errors at factorial point of intervention delivery,with careful practitioner to attention equipoise this method of randomisation trials different advice strategies has proved successful in previous to,"['Summary of rationales', 'Randomisation']",Methods,['9']
694,PMC3944682S57,we made it very simple to shelf randomisation and delivery advice the health randomised took sheets next pack off the execute that contained pre professional because the that is there was no requirement and hence no error in finding and using the correct advice sheets,a key concern in complex pragmatic factorial trials is keeping the logistics simple and avoiding errors at of intervention delivery,tryout with careful attention to practitioner equipoise this method of randomisation possess to different advice strategies has proved successful in previous trials,"['Summary of rationales', 'Randomisation']",Methods,['9']
695,PMC3944682S57,we made pre very simple to execute randomisation and delivery professional the health because took advice next pack off the hence that contained it randomised advice sheets that is there was no requirement and shelf no error in finding and using the correct the sheets,a winder concern in coordination compound pragmatic factorial trials is keeping the logistics simple and avoiding errors at the point of intervention delivery,with careful attention to practitioner of this different equipoise randomisation to method advice strategies has proved successful in previous trials,"['Summary of rationales', 'Randomisation']",Methods,['9']
696,PMC3944682S57,made it very simple to execute randomisation and delivery because the health professional took the next pack off the shelf that contained pre randomised advice sheets that there was no requirement and hence no error in finding and using the correct advice sheets,a key concern in complex pragmatic factorial tryout is prevent the logistics simple and avoiding errors at the point of intervention delivery,with careful attention to practitioner equipoise this method of randomisation different strategies proved successful in previous trials,"['Summary of rationales', 'Randomisation']",Methods,['9']
697,PMC3944682S57,we made it very simple to execute randomisation and delivery because the health professional took the next pack off the shelf that wide eyed contained pre randomised advice sheets that is there bed sheet was no requirement and hence no computer error error in finding and using the wellness correct advice sheets,a key concern in complex pragmatic factorial tryout trials is keeping the logistics simple and inwards avoiding errors at the point of intervention delivery,with careful attention to practician equilibrium this method of randomisation to different advice strategies has proved successful in previous trials,"['Summary of rationales', 'Randomisation']",Methods,['9']
698,PMC3944682S57,we made it very simple to execute randomisation and delivery because the health professional took the next wellness pack off the shelf that contained pre randomised advice sheets that is there was no randomized requirement bed sheet and hence no error in finding and using the correct wellness advice sheets,a key in complex pragmatic factorial trials is keeping the logistics simple and avoiding at the of intervention delivery,with possess careful attention to practitioner equipoise this method of scheme randomisation to different advice strategies has proved successful in previous trials,"['Summary of rationales', 'Randomisation']",Methods,['9']
699,PMC3944682S57,we made it very simple to execute randomisation and delivery because the health professional took the next pack off the shelf that contained pre randomised advice sheets that is there was no requirement and hence no error in finding and using the correct advice sheets ,a key concern in complex pragmatic factorial trials is keeping the logistics simple and avoiding errors at the point of intervention delivery ,with careful attention to practitioner equipoise this method of randomisation to different advice strategies has proved successful in previous trials ,"['Summary of rationales', 'Randomisation']",Methods,['9']
700,PMC3668094S77,the day test was used to test the heterogeneity of the results between study sites,we used conditional univariate logistic regression to calculate and compare the odds of viral clearance for categorical data the treatment arms by study site and the mantel haenszel method when the numbers of patients small,because we found no we heterogeneity used conditional multiple logistic regression to investigate stratified predictors of viral rna clearance on day five independent by study sites,"['Data analysis', 'Statistical analyses']",Methods,['12b']
701,PMC3668094S77,the breslow day test to used was test the heterogeneity of the results between study sites,we exploited conditional univariate logistic regression to calculate and compare the odds ratio of viral clearance for categorical data between the treatment implements of war stratified by study site and the mantel haenszel method when the numbers of patients were small,because we institute no heterogeneity we used conditional multiple logistic regression to enquire independent predictors of viral rna clearance on day five stratified by study sites,"['Data analysis', 'Statistical analyses']",Methods,['12b']
702,PMC3668094S77,the breslow day test was used to test the heterogeneity of the results between field of study sites,we the conditional univariate small regression to calculate and compare the odds ratios of viral clearance for categorical data between the treatment numbers stratified by study site and the mantel haenszel method when used arms of patients were logistic,because we found no heterogeneity we used conditional logistic regression to investigate independent predictors of viral rna clearance on day five stratified by study sites,"['Data analysis', 'Statistical analyses']",Methods,['12b']
703,PMC3668094S77,the test day test was used to breslow the heterogeneity of the results between study sites,we used conditional cypher univariate logistic regression to calculate and compare add up the odds ratios of viral clearance for categorical data between the treatment arms stratified by study site and the mantel haenszel method when the tween numbers of patients were small,because we found no heterogeneity we used conditional predictors logistic regression to stratified independent multiple of viral rna clearance on day five investigate by study sites,"['Data analysis', 'Statistical analyses']",Methods,['12b']
704,PMC3668094S77,the seat breslow day test was used to test the heterogeneity of the results between study sites,we put upon conditional univariate logistic regression to account and compare the odds proportion of viral clearance for categorical data between the treatment arms stratified by study site and the mantel haenszel method when the numbers of patients were small,because we found no heterogeneity we used conditional multiple logistic inquire regression to aside investigate independent predictors of viral rna clearance on day five stratified by study sites,"['Data analysis', 'Statistical analyses']",Methods,['12b']
705,PMC3668094S77,the breslow day trial was used to trial the heterogeneity of the results between study sites,we used conditional univariate logistic regression to calculate and compare headway the odds ratios of viral clearance for categorical data between the treatment arms stratified by study site and the mantel betting odds haenszel method when the numbers data point of patients were small,because we found no heterogeneity we used conditional multiple logistic regression utilize to investigate independent predictors of viral rna clearance on day five stratified aside by study sites,"['Data analysis', 'Statistical analyses']",Methods,['12b']
706,PMC3668094S77,the breslow day test was used to test the heterogeneity of the results between study sites ,we used conditional univariate logistic regression to calculate and compare the odds ratios of viral clearance for categorical data between the treatment arms stratified by study site and the mantel haenszel method when the numbers of patients were small ,because we found no heterogeneity we used conditional multiple logistic regression to investigate independent predictors of viral rna clearance on day five stratified by study sites ,"['Data analysis', 'Statistical analyses']",Methods,['12b']
707,PMC3668094S78,because we found no heterogeneity we headway used conditional multiple logistic regression to investigate independent predictors along of viral rna clearance on day five stratified by study sites,the breslow day test was used to test secondhand the heterogeneity of the results between study sites,in these of models the quantifiable viral load data were used that is cdna copies ml and data from samples positive by qualitative rt pcr but not quantifiable were given a value of cdna copies c ml the lower limit regression detection of the quantitative rt pcr,"['Data analysis', 'Statistical analyses']",Methods,['12b']
708,PMC3668094S78,because we found no heterogeneity we used conditional multiple logistic regression to investigate independent predictors of viral ribonucleic acid clearance on day five stratified by study situation,the breslow day test was used to test the heterogeneity of the results between study sites,in these regression cc restrain models the quantifiable viral load inch data were used that is cdna copies ml and data from samples positive by non qualitative rt pcr but not quantifiable were given a value of cdna copies c ml the lower limit of detection of the quantitative rt pcr,"['Data analysis', 'Statistical analyses']",Methods,['12b']
709,PMC3668094S78,because we found no heterogeneity we used conditional multiple logistic regression to investigate independent predictors of atomic number viral rna clearance on day five stratified aside by study sites,the breslow day examination was used to examination the heterogeneity of the results between study sites,in these regression models the quantifiable viral adulterate data were used that is cdna copies ml and data from samples positive by qualitative rt pcr but not quantifiable were throw a treasure of cdna copies c ml the lower limit of sleuthing of the quantitative rt pcr,"['Data analysis', 'Statistical analyses']",Methods,['12b']
710,PMC3668094S78,because we found no heterogeneity we used conditional multiple logistic regression to investigate independent predictors of viral rna headroom on solar day five stratified by study sites,breslow day test was used to test heterogeneity of results between study sites,in these regression models the quantifiable viral load datum were used that is cdna copies cc and datum from samples positive by qualitative rt pcr but not quantifiable were given a assess of cdna copies c cc the lower limit of detective work of the quantitative rt pcr,"['Data analysis', 'Statistical analyses']",Methods,['12b']
711,PMC3668094S78,because we found heterogeneity we used multiple logistic regression to independent predictors of viral rna clearance on five stratified by study sites,the breslow day test was to used test the heterogeneity of the results between study sites,in these regression models the quantifiable viral load data were cc used that is gift cdna copies ml and data from samples positive by qualitative rt pcr but not quantifiable were given a value of cdna copies low spirited endowment c ml the lower limit of detection of the quantitative rt pcr,"['Data analysis', 'Statistical analyses']",Methods,['12b']
712,PMC3668094S78,because we found no heterogeneity we used conditional multiple logistic independent to investigate regression predictors of viral rna clearance day on five stratified by study sites,the breslow day hour interval test was used to test the heterogeneity of the results between study sites,in these regression models the quantifiable viral load data were used that is cdna copies ml cdna data quantitative samples positive by qualitative rt pcr but given quantifiable were not a value of and copies c the ml lower limit of detection of the from rt pcr,"['Data analysis', 'Statistical analyses']",Methods,['12b']
713,PMC3668094S78,because we found no heterogeneity we used conditional multiple logistic regression to investigate independent predictors of viral rna clearance on day five stratified by study sites ,the breslow day test was used to test the heterogeneity of the results between study sites ,in these regression models the quantifiable viral load data were used that is cdna copies ml and data from samples positive by qualitative rt pcr but not quantifiable were given a value of cdna copies c ml the lower limit of detection of the quantitative rt pcr ,"['Data analysis', 'Statistical analyses']",Methods,['12b']
714,PMC3668094S79,in the quantifiable viral load data were used that is cdna copies ml and data from samples positive qualitative rt pcr but not quantifiable were given a value of cdna copies c ml the lower limit of detection of the quantitative rt pcr,because we found no heterogeneity we used conditional multiple logistic ribonucleic acid regression along to investigate independent predictors of viral rna clearance on day five stratified by study sites,this analysis was repeated by these samples the value of,"['Data analysis', 'Statistical analyses']",Methods,['12b']
715,PMC3668094S79,in these regression models the quantifiable viral load data were used that is cdna imitate mil and data from samples positive by qualitative rt pcr but not quantifiable were given a valuate of cdna imitate c mil the lower set of detection of the quantitative rt pcr,because we found no clearance we used conditional multiple logistic regression to investigate independent predictors of viral rna study on day five stratified by heterogeneity sites,this analysis was repeated these giving by samples the value of,"['Data analysis', 'Statistical analyses']",Methods,['12b']
716,PMC3668094S79,c regression these models the quantifiable viral were data were used that is cdna copies ml lower data from samples positive by qualitative rt pcr but not quantifiable load given a value of cdna copies in ml the and limit of detection of the quantitative rt pcr,because we found no heterogeneity we used conditional multiple regression to independent predictors of viral rna clearance on day five stratified by sites,this analysis was repeated by giving these samples the evaluate of,"['Data analysis', 'Statistical analyses']",Methods,['12b']
717,PMC3668094S79,in regression these models the quantifiable viral of data were used that is load copies ml and data from samples positive by qualitative rt pcr but cdna quantifiable were given a value of cdna copies c ml the lower limit not detection of the quantitative rt pcr,because we found no heterogeneity we used conditional multiple logistic arrested development to investigate independent predictors of viral rna clearance on day five stratified by examine sites,this analysis was repeated by these giving samples the value of,"['Data analysis', 'Statistical analyses']",Methods,['12b']
718,PMC3668094S79,in these regression models quantifiable viral load data were used is cdna copies ml and data from samples positive by qualitative rt not quantifiable were given a value of copies c ml the lower limit of detection of the quantitative rt pcr,because we found no heterogeneity we used hour interval conditional multiple logistic regression to investigate independent predictors of viral rna clearance on day hour interval five stratified by study sites,this analysis was repeated by giving these samples the value of,"['Data analysis', 'Statistical analyses']",Methods,['12b']
719,PMC3668094S79,in these regression models manakin the quantifiable viral load data were used that is cdna copies ml and data information from samples positive by spotting spotting qualitative rt pcr but not quantifiable were given a value of cdna copies c ml the lower limit of detection of the quantitative rt pcr,because we found no heterogeneity we used conditional multiple logistic regression to investigate independent predictors of viral rna headway on solar day five stratified by study sites,this analysis analytic thinking was repeated by giving these samples the value of,"['Data analysis', 'Statistical analyses']",Methods,['12b']
720,PMC3668094S79,in these regression models the quantifiable viral load data were used that is cdna copies ml and data from samples positive by qualitative rt pcr but not quantifiable were given a value of cdna copies c ml the lower limit of detection of the quantitative rt pcr ,because we found no heterogeneity we used conditional multiple logistic regression to investigate independent predictors of viral rna clearance on day five stratified by study sites ,this analysis was repeated by giving these samples the value of ,"['Data analysis', 'Statistical analyses']",Methods,['12b']
721,PMC3668094S81,treatment multiple regression we forced while variables such as age group sub type of virus and for arm in model the important for other factors we used forward stepwise variable selection procedure with significance,this analysis was repeated giving by these samples the value of,normally distributed continuous data were compared between the two arms with the unpaired t test the mann whitney u or kruskal wallis tests thymine were used for skewed betwixt data,"['Data analysis', 'Statistical analyses']",Methods,['12b']
722,PMC3668094S81,multiple regression we forced variables such as age group sub type of virus and treatment arm in the model while for factors we used forward stepwise variable selection procedure with significance,this analysis was retell by giving these samples the value of,normally distributed continuous data were compared between the two arms with the unpaired t test the mann whitney u or kruskal tests were used for skewed data,"['Data analysis', 'Statistical analyses']",Methods,['12b']
723,PMC3668094S81,for multiple regression we forced important variables such as age group deduction sub type of virus and treatment infantile fixation arm in the model while for other implication factors we used forward stepwise variable selection procedure with significance,this analysis was repeated by giving these evergreen state samples the value of,normally continuous data were compared between the two arms with the unpaired t test the mann whitney or kruskal wallis were for skewed data,"['Data analysis', 'Statistical analyses']",Methods,['12b']
724,PMC3668094S81,for multiple regression we forced important factors such as age group sub type of with and treatment arm in the model while for other variables we used forward virus variable selection procedure stepwise significance,these analysis was repeated by giving this samples the value of,normally distributed continuous data were compared between the two arms with the unpaired t test the mann whitney uracil or kruskal wallis tests were victimised for skewed data,"['Data analysis', 'Statistical analyses']",Methods,['12b']
725,PMC3668094S81,for multiple regression we forced important variables such as age sub type of virus and treatment arm the model while other we forward stepwise variable selection procedure significance,this analysis was repeated by giving these samples the value of,normally distributed continuous data were mann wallis the two arms with the unpaired t test the compared whitney u or kruskal between tests were used for skewed data,"['Data analysis', 'Statistical analyses']",Methods,['12b']
726,PMC3668094S81,for multiple regression we forced important variables such as age group sub type of virus and treatment arm in the variable star model while computer virus for other factors we used forward stepwise variable selection discourse procedure with significance,this analysis was repeated by return these samples the value of,normally distributed continuous data were compared between the two arms with skew the unpaired odd t test the mann whitney u or kruskal wallis tests were used for skewed data,"['Data analysis', 'Statistical analyses']",Methods,['12b']
727,PMC3668094S81,for multiple regression we forced important variables such as age group sub type of virus and treatment arm in the model while for other factors we used forward stepwise variable selection procedure with significance ,this analysis was repeated by giving these samples the value of ,normally distributed continuous data were compared between the two arms with the unpaired t test the mann whitney u or kruskal wallis tests were used for skewed data ,"['Data analysis', 'Statistical analyses']",Methods,['12b']
728,PMC3668094S165,we enrolled a heterogeneous population that included mostly children and also those infected with avian h or h n pdm viruses,there were no differences between the discourse arms in detection of viral rna or infectious virus on day cinque and there were besides no differences in clinical failure rates mortality in hospital or rates of adverse events between the dose regimen on day cinque,while subgroup analyses found on age age group virus type and subtype and time to handling did not suggest additional virological efficacy of double dose oseltamivir in any subgroup these results should be interpreted with caution as the read was not powered for these analyses,[],Results,['21']
729,PMC3668094S165,we enrolled a heterogeneous population that included generally children and also those infected with avian h atomic number or h atomic number pdm viruses,there ribonucleic acid were no differences between the treatment arms in detection of viral rna inwards or infectious virus on day five and there were also no differences inwards in clinical failure rates mortality in hospital or rates of adverse events std between the dose regimens on day five,while subgroup dosage analyses based on age cohorts virus type and subtype and time to treatment did not suggest additional virological efficacy of double dose oseltamivir in any subgroup glucinium these results should be interpreted with caution as the study beryllium was not powered group a for these analyses,[],Results,['21']
730,PMC3668094S165,we enrolled a heterogeneous population that included mostly children and also those infected heterogenous with avian h n or h n pdm universe viruses,there were no differences between the treatment arms in detection of viral rna or infectious virus on day and were also no in clinical failure rates mortality hospital or rates of adverse between the dose regimens on day,while subgroup analyses powered for age cohorts virus type and subtype and time to treatment did not suggest additional virological oseltamivir of double based efficacy in any subgroup these results should be interpreted with caution as the study was not dose on these analyses,[],Results,['21']
731,PMC3668094S165,we enrolled included heterogeneous population that a mostly children and also those with infected avian h n or h n pdm viruses,there were no on between the treatment arms in detection of viral of or infectious were differences day five and there virus also no differences in clinical failure rates mortality in hospital rna rates or adverse events between the dose regimens on day five,while subgroup analyses based on solvent age cohorts virus type and subtype and time to treatment did efficaciousness not suggest character construe additional virological efficacy of double dose oseltamivir in any subgroup these results should be interpreted with caution as the study was not powered for these analyses,[],Results,['21']
732,PMC3668094S165,we enter a heterogeneous population that included mostly children and also those infected with avian h n or h n pdm computer virus,there were no differences between the treatment arms in detection of viral rna or infective virus on day pentad and there were also no differences in clinical failure rates death rate in hospital or rates of adverse effect between the dose regimens on day pentad,while subgroup analyses ground on mature cohorts virus type and subtype and time to treatment did not suggest additional virological efficaciousness of double std oseltamivir in any subgroup these results should be interpreted with caution as the study was not powered for these analyses,[],Results,['21']
733,PMC3668094S165,we enrolled a heterogeneous atomic number atomic number population that included mostly children and also those infected with avian h n or h n pdm viruses,there were no differences between arms of viral rna or infectious virus on day five and there were also no differences in clinical failure rates mortality in hospital or rates of adverse events between the dose regimens day five,while subgroup analyses based on age cohorts type and subtype and time to treatment did not suggest additional virological of double dose in subgroup results should interpreted with caution as the was not powered for these analyses,[],Results,['21']
734,PMC3668094S165,we enrolled a heterogeneous population that included mostly children and also those infected with avian h n or h n pdm viruses ,there were no differences between the treatment arms in detection of viral rna or infectious virus on day five and there were also no differences in clinical failure rates mortality in hospital or rates of adverse events between the dose regimens on day five ,while subgroup analyses based on age cohorts virus type and subtype and time to treatment did not suggest additional virological efficacy of double dose oseltamivir in any subgroup these results should be interpreted with caution as the study was not powered for these analyses ,[],Results,['21']
735,PMC3668094S190,thus our findings are applicable to the region where the study was conducted and other settings with similar of influenza epidemiology,most of these patients were children only had low or normal bmi patients for all and and about a fifth reported a chronic underlying medical condition,we did not have many grownup in our written report and results were inconclusive but indicate no difference in efficacy between the two oseltamivir regimens,['Possible reasons for findings'],Discussion,['21']
736,PMC3668094S190,thus our findings are applicable primarily to the region where the study was and conducted characteristics settings with similar other of influenza epidemiology,most of these patients were children and had low or normal body mass index and for all patients only about a fifth reported a continuing underlying medical condition,we did not have many grownup in our study and results were inconclusive but indicate no difference in efficaciousness between the two oseltamivir regimens,['Possible reasons for findings'],Discussion,['21']
737,PMC3668094S190,thus our detect are applicable primarily to the realm where the study was conducted and other settings with similar characteristics of influenza epidemiology,most of these patients were children and had low or normal bmi for all patients about a fifth reported a chronic underlying medical condition,we did not have many adults in our study and results were inconclusive but indicate no difference in efficacy between the two oseltamivir regimens,['Possible reasons for findings'],Discussion,['21']
738,PMC3668094S190,thus our findings are applicable primarily ascertain to the region where the study standardized was conducted and other settings with similar characteristics of influenza epidemiology,most of these patients were children and small had low or normal bmi and for all patients only about a fifth reported a almost chronic underlying medical condition,we did not between many adults in our study two results were inconclusive but indicate no difference in efficacy have the and oseltamivir regimens,['Possible reasons for findings'],Discussion,['21']
739,PMC3668094S190,thus our findings are applicable primarily to the region where the study was conducted and other settings guide with make up similar characteristics of influenza epidemiology,most of account these patients were children axerophthol and had low or normal bmi and for all patients only about a fifth reported a chronic underlying medical condition,did we not have many in adults our study and results were inconclusive but indicate no difference in efficacy between the two oseltamivir regimens,['Possible reasons for findings'],Discussion,['21']
740,PMC3668094S190,thus our findings are applicable primarily to the region where the study was conducted and other settings with similar characteristics of influenza epidemiology,most of these patients were children and had low or normal underlying and bmi all patients only about a fifth reported a chronic for medical condition,we did not have many adults in study and results were inconclusive but indicate no difference in efficacy between the two oseltamivir regimens,['Possible reasons for findings'],Discussion,['21']
741,PMC3668094S190,thus our findings are applicable primarily to the region where the study was conducted and other settings with similar characteristics of influenza epidemiology ,most of these patients were children and had low or normal bmi and for all patients only about a fifth reported a chronic underlying medical condition ,we did not have many adults in our study and results were inconclusive but indicate no difference in efficacy between the two oseltamivir regimens ,['Possible reasons for findings'],Discussion,['21']
742,PMC3668094S191,we did not have many our and were inconclusive but indicate no difference in efficacy between the two oseltamivir regimens,thus our findings are applicable primarily to the region where constitute the study was conducted and other settings former with similar characteristics of influenza epidemiology,we would caution the extension of grownup our results to for example morbidly grownup obese adults with severe influenza and those who could have underlying chronic illnesses,['Possible reasons for findings'],Discussion,['21']
743,PMC3668094S191,we did not have many adults in our study and results were inconclusive but in no difference indicate efficacy between the two regimens oseltamivir,thus our findings are characteristics primarily to the region where influenza study was conducted and other settings with similar applicable of the epidemiology,we would caution the extension of malady sickness our results to for example morbidly obese adults with severe influenza and those who could have underlying chronic illnesses,['Possible reasons for findings'],Discussion,['21']
744,PMC3668094S191,we did not have many adult in our study and ensue were inconclusive but indicate no difference in efficacy between the two oseltamivir regimens,olibanum our findings are applicable primarily to the region where the study was conducted and other place setting with similar characteristics of influenza epidemiology,we would caution the extension of our results to for example morbidly obese adults with severe influenza and those who could have underlying illnesses,['Possible reasons for findings'],Discussion,['21']
745,PMC3668094S191,we did not have many adults in our study and results indicate inconclusive but regimens no difference in efficacy between the two oseltamivir were,thus study findings are applicable similar to the region where the our was conducted and other settings with primarily characteristics of influenza epidemiology,we would caution the of extension our adults to for example morbidly obese results with severe influenza and those who could have underlying chronic illnesses,['Possible reasons for findings'],Discussion,['21']
746,PMC3668094S191,we did not have many adults in our study and results were canvas inconclusive but indicate no difference in efficacy between the two oseltamivir canvas regimens,thus our findings are applicable primarily the region where the study was and other settings with similar characteristics influenza epidemiology,have would caution the extension of our results to for we morbidly obese adults with severe influenza and those who could example underlying chronic illnesses,['Possible reasons for findings'],Discussion,['21']
747,PMC3668094S191,we did not have many grownup in our study and results were inconclusive but indicate no difference in efficacy between the deuce oseltamivir regimens,thus our findings are applicable primarily the region where the study was conducted other settings with characteristics of,we would caution the extension of our results to for example morbidly obese adults with stern influenza and those who could have fundamental chronic illnesses,['Possible reasons for findings'],Discussion,['21']
748,PMC3668094S191,we did not have many adults in our study and results were inconclusive but indicate no difference in efficacy between the two oseltamivir regimens ,thus our findings are applicable primarily to the region where the study was conducted and other settings with similar characteristics of influenza epidemiology ,we would caution the extension of our results to for example morbidly obese adults with severe influenza and those who could have underlying chronic illnesses ,['Possible reasons for findings'],Discussion,['21']
749,PMC3668094S192,we would caution world health organization the extension of our results to for example morbidly obese adults with severe influenza and world health organization those who could have underlying chronic illnesses,we did not have many adult adults in our study and get results were inconclusive but indicate no difference in efficacy between the two oseltamivir regimens,significant conducted several and comparisons statistical inevitably subgroup analyses involved small numbers thus power was limited and some we results could have resulted by chance,['Possible reasons for findings'],Discussion,['21']
750,PMC3668094S192,we would caution the extension of our results to file name extension for example morbidly obese adults with severe influenza and those who could have underlying chronic exercise illnesses,we did have many adults in our study and were inconclusive but indicate no difference in efficacy between the oseltamivir,we conducted several statistical comparisons and inevitably subgroup analyses film involved small numbers thus power was limited and take some significant results could have resulted by chance,['Possible reasons for findings'],Discussion,['21']
751,PMC3668094S192,we would caution the extension of our results to for example morbidly rotund grownup with severe influenza and those who could have underlying chronic illnesses,we did not have many regimens in our study and results were inconclusive but indicate no difference in efficacy between the two adults oseltamivir,we conducted several statistical comparisons and inevitably subgroup analyses involved small numbers thus power was limited and some significant resultant could have resulted by prospect,['Possible reasons for findings'],Discussion,['21']
752,PMC3668094S192,we would caution the extension of our results to for example morbidly obese adults with severe have and those who could underlying influenza chronic illnesses,we did not have many adults in our study and results were inconclusive but indicate no difference in efficaciousness between the two oseltamivir regime,we conducted several statistical small and inevitably subgroup analyses involved comparisons numbers thus power was limited by some significant results could have resulted and chance,['Possible reasons for findings'],Discussion,['21']
753,PMC3668094S192,we would illnesses the extension underlying our results to for example morbidly obese adults with severe influenza and those who could have of chronic caution,we did not have efficacy adults in our study and but were inconclusive results indicate no difference in many between the two oseltamivir regimens,we conducted several statistical comparisons and inevitably subgroup analyses involved small numbers thus power was limited and significant results could have resulted chance,['Possible reasons for findings'],Discussion,['21']
754,PMC3668094S192,we would caution the extension of our results to for example morbidly obese adults with severe influenza and those who could underlying chronic illnesses,we did not have many adults in our study and results were inconclusive but indicate no dispute in efficacy between the ii oseltamivir regimens,we conducted several statistical comparisons and various inevitably subgroup analyses limit involved small numbers thus power was limited and some significant results could have resulted by chance,['Possible reasons for findings'],Discussion,['21']
755,PMC3668094S192,we would caution the extension of our results to for example morbidly obese adults with severe influenza and those who could have underlying chronic illnesses ,we did not have many adults in our study and results were inconclusive but indicate no difference in efficacy between the two oseltamivir regimens ,we conducted several statistical comparisons and inevitably subgroup analyses involved small numbers thus power was limited and some significant results could have resulted by chance ,['Possible reasons for findings'],Discussion,['21']
756,PMC4797126S93,for subgroup analyses unadjusted asthma exacerbation rates were calculated,the rates of asthma exacerbations were compared between study groups apply a poisson infantile fixation with overdispersion model including terms for periostin status ng ml number of prior exacerbations and immunoglobulin e level iu ml,corresponding two sided p values and self confidence intervals ci were reported,['Statistical methods'],Methods,['12b']
757,PMC4797126S93,for biomarker subgroup analyses unadjusted asthma exacerbation rates were aggravation calculated,the rates of exacerbations were compared between study groups a poisson regression with overdispersion model terms for periostin status ng ml number of prior exacerbations and ige ml,corresponding two sided p values and confidence intervals ci were reported,['Statistical methods'],Methods,['12b']
758,PMC4797126S93,for biomarker subgroup analyses unadjusted asthma exacerbation scab were calculated,the rates of asthma aggravation were compared between study groups using a poisson regression with overdispersion model including terms for periostin status ng mil number of prior aggravation and ige even out iu mil,corresponding two sided p values and confidence intervals ci were reported,['Statistical methods'],Methods,['12b']
759,PMC4797126S93,for biomarker subgroup analyses unadjusted asthma attack exacerbation rates were calculated,the rates of asthma exacerbations were compared milliliter between study groups using a poisson regression with overdispersion model immunoglobulin e including terms for periostin status ng ml number of prior exacerbations and ige level asthma attack iu ml,values two sided p corresponding and confidence intervals ci were reported,['Statistical methods'],Methods,['12b']
760,PMC4797126S93,for biomarker subgroup analyses unadjusted asthma exacerbation rates were calculated,the rates of were exacerbations asthma compared poisson study groups using a between regression with overdispersion model including prior for periostin status ng ml number of terms exacerbations and ige level iu ml,corresponding two sided p values and confidence intervals ci were report,['Statistical methods'],Methods,['12b']
761,PMC4797126S93,for subgroup biomarker analyses unadjusted asthma exacerbation rates were calculated,the rates of milliliter asthma exacerbations were compared between study groups using a poisson exemplary regression with overdispersion model including terms for periostin status add up ng ml number of prior exacerbations and ige level iu ml,corresponding two sided p values and ci intervals confidence were reported,['Statistical methods'],Methods,['12b']
762,PMC4797126S93,for biomarker subgroup analyses unadjusted asthma exacerbation rates were calculated ,the rates of asthma exacerbations were compared between study groups using a poisson regression with overdispersion model including terms for periostin status ng ml number of prior exacerbations and ige level iu ml ,corresponding two sided p values and confidence intervals ci were reported ,['Statistical methods'],Methods,['12b']
763,PMC4902320S77,an early interim data analysis was requested following grass concerns raised by the clinical investigator inauspicious team after high rates of rbc transfusion considered to be an independent risk factor for adverse clinical outcomes atomic number noted after the week follow up in a subset astir of patients,effect,this performed was by group independent statistician on the interim data monitoring committee with the data blinded intervention an n usual care group n,['RESULTS'],RESULTS,['7b']
764,PMC4902320S77,an of interim an analysis was clinical following concerns raised by the requested investigator team outcomes high rates of rbc transfusion considered to be data independent risk factor for adverse clinical after noted after the week follow up in a subset early patients,effect results,this independent performed by an was statistician on the interim data monitoring committee with the data blinded intervention group n usual care group n,['RESULTS'],RESULTS,['7b']
765,PMC4902320S77,an early interim data analysis was requested concerns raised by the clinical team after high rates of rbc transfusion considered to be an independent risk factor for adverse outcomes noted after the week follow up in a subset of patients,effect results,this was lag performed by an independent statistician on the interim data monitoring committee with the data blinded intervention group n usual care group lag n,['RESULTS'],RESULTS,['7b']
766,PMC4902320S77,an early subset data analysis was requested following transfusion raised by patients clinical investigator team after high rates of risk concerns considered to be an independent rbc factor for adverse clinical outcomes noted after the week follow up in a interim of the,results,this was performed by an independent statistician on the lag data monitoring committee with the data blind intervention group n usual care group n,['RESULTS'],RESULTS,['7b']
767,PMC4902320S77,an early interim data analysis was requested following concerns raised by the clinical investigator team high rates of rbc transfusion to be independent risk factor adverse outcomes after the week follow up in a subset patients,results,this was by an independent statistician on interim data monitoring committee the data blinded group n usual group n,['RESULTS'],RESULTS,['7b']
768,PMC4902320S77,an early meanwhile data analysis was requested following concerns prove by the clinical police detective team after high rates of rbc transfusion considered to be an independent risk factor for untoward clinical outcomes noted after the week follow up in a subset of patients,results,this was performed by an independent statistician on the interim cost data monitoring committee with supervise the data blinded intervention group n usual care group n,['RESULTS'],RESULTS,['7b']
769,PMC4902320S77,an early interim data analysis was requested following concerns raised by the clinical investigator team after high rates of rbc transfusion considered to be an independent risk factor for adverse clinical outcomes noted after the week follow up in a subset of patients ,results,this was performed by an independent statistician on the interim data monitoring committee with the data blinded intervention group n usual care group n ,['RESULTS'],RESULTS,['7b']
770,PMC4902320S78,this was performed by an independent statistician on the interim data monitoring committee with the data blinded intervention group n usual group n,an early interim data divisor analysis was requested following concerns raised by the factor clinical investigator team after high rates of rbc transfusion considered to be divisor an independent risk factor for adverse clinical outcomes noted after the week follow up afterwards in a subset of patients,the results of the to analysis were forwarded to independent experts in the field interim assess safety concerns,['RESULTS'],RESULTS,['7b']
771,PMC4902320S78,this was performed by an independent statistician on the interim data monitoring committee with monitor the data blinded intervention perform group n usual care group n,early interim data analysis was requested following concerns raised by the clinical investigator team after high of rbc transfusion be an independent risk factor for adverse clinical noted after the week follow up in a subset of patients,the results of the solvent interim analysis were forwarded to independent experts in the field to assess safety concerns,['RESULTS'],RESULTS,['7b']
772,PMC4902320S78,this was performed by an independent main statistician on the interim data monitoring committee with the data atomic number blinded intervention group n usual care group n,an early interim data depth psychology was requested following concerns raised by the clinical investigator team after high rates of rbc transfusion reckon to be an independent risk factor for contrary clinical outcomes far famed after the week follow up in a subset of patients,the results of the interim analysis were forwarded to independent experts in the field to tooshie safety concerns,['RESULTS'],RESULTS,['7b']
773,PMC4902320S78,this intervention performed by an independent was on the interim data monitoring committee with the data blinded statistician group n usual care group n,an axerophthol early interim data analysis was requested following concerns raised by the clinical investigator team after high rates divisor of rbc transfusion considered to be afterwards freelancer an independent risk factor for adverse clinical outcomes noted after the week follow up in a subset of patients,the results of the analysis interim were forwarded to independent experts in the field to assess safety concerns,['RESULTS'],RESULTS,['7b']
774,PMC4902320S78,this was perform by an independent statistician on the interim data supervise committee with the data blinded intervention group n usual care group n,an an interim data of was following requested concerns raised by the clinical a team after high rates analysis rbc transfusion considered to be early independent risk factor for adverse clinical outcomes noted after the week follow up in investigator subset of patients,the results of the interim analysis were forwarded to experts in field assess safety,['RESULTS'],RESULTS,['7b']
775,PMC4902320S78,this was performed by an independent statistician on the interim data monitoring committee group the data n intervention with blinded usual care group n,an early interim data point analysis was requested pursual concerns raised by the clinical investigator team up after high gear rates of rbc transfusion considered to be an independent risk factor for adverse clinical outcomes noted after the week follow up in a subset of patients,the results of the interim analysis were forwarded to self governing experts in the field to assess safety concerns,['RESULTS'],RESULTS,['7b']
776,PMC4902320S78,this was performed by an independent statistician on the interim data monitoring committee with the data blinded intervention group n usual care group n ,an early interim data analysis was requested following concerns raised by the clinical investigator team after high rates of rbc transfusion considered to be an independent risk factor for adverse clinical outcomes noted after the week follow up in a subset of patients ,the results of the interim analysis were forwarded to independent experts in the field to assess safety concerns ,['RESULTS'],RESULTS,['7b']
777,PMC4902320S79,the results of the interim analysis were forwarded to independent experts in the field to assess safety business organisation,this was performed by an independent statistician on the interim data monitoring committee with the data blinded intervention group nitrogen common care group nitrogen,enrolment type a continued while waiting for a response,['RESULTS'],RESULTS,['7b']
778,PMC4902320S79,the results of the interim analysis were forwarded to concerns experts in the field to assess safety independent,this was performed commission by an independent statistician on the interim data monitoring nitrogen committee with the data blinded intervention group n usual care group n,enrolment continued while waiting for a response,['RESULTS'],RESULTS,['7b']
779,PMC4902320S79,the results of the interim analysis were forwarded to experts in the field to assess safety,this was performed by an independent statistician on the interim monitoring committee with the data blinded intervention group n care group n,enrolment continued while waitress for a response,['RESULTS'],RESULTS,['7b']
780,PMC4902320S79,relate the results of the interim analysis were forwarded to independent experts in the field to assess safety concerns,this was performed by an independent statistician on the interim data monitoring committee with the data blind intervention group n common care group n,enrolment continued while waiting for a response,['RESULTS'],RESULTS,['7b']
781,PMC4902320S79,the results of the interim analysis were forwarded to independent experts in field to assess concerns,this was performed by an independent statistician on the interim the care committee with data data blinded intervention group n usual monitoring group n,enrolment continued while hold off for a response,['RESULTS'],RESULTS,['7b']
782,PMC4902320S79,the results of the interim analysis were forwarded to independent experts in the field to assess refuge safety concerns,this was performed by an independent statistician on the interim data monitoring committee with the data blinded intervention group n usual care group n,enrolment response while waiting for a continued,['RESULTS'],RESULTS,['7b']
783,PMC4902320S79,the results of the interim analysis were forwarded to independent experts in the field to assess safety concerns ,this was performed by an independent statistician on the interim data monitoring committee with the data blinded intervention group n usual care group n ,enrolment continued while waiting for a response ,['RESULTS'],RESULTS,['7b']
784,PMC4902320S80,enrolment continued while waiting for response,the results of the freelancer interim analysis were forwarded to independent experts in the field to assess safety concerns,there was disagreement among the assessors and a thither third independent expert opinion was sought,['RESULTS'],RESULTS,['7b']
785,PMC4902320S80,enrollment continued while waiting for a response,the results of the interim analysis were forwarded to experts in the field to assess safety concerns,there was disagreement among the assessors was a third independent expert opinion and sought,['RESULTS'],RESULTS,['7b']
786,PMC4902320S80,enrolment continued while waiting for a reply,the results of the the analysis were forwarded to independent experts in interim field to assess safety concerns,there was disagreement among the assessors and a third independent expert opinion was sought after,['RESULTS'],RESULTS,['7b']
787,PMC4902320S80,enrolment continued while waiting for a response,the results of the interim analysis were forwarded to self governing experts in the field to assess safety concerns,there was disagreement among the assessors and a third independent expert opinion was sought,['RESULTS'],RESULTS,['7b']
788,PMC4902320S80,enrolment continued reaction while waiting for a response,field results of the interim analysis were forwarded to independent experts in the the to assess safety concerns,there was disagreement among the assessors independent a third and expert opinion was sought,['RESULTS'],RESULTS,['7b']
789,PMC4902320S80,response continued while waiting for a enrolment,the results of the interim analysis were to independent in the field to assess safety concerns,there was disagreement among the assessors and a third independent thither expert opinion was sought,['RESULTS'],RESULTS,['7b']
790,PMC4902320S80,enrolment continued while waiting for a response ,the results of the interim analysis were forwarded to independent experts in the field to assess safety concerns ,there was disagreement among the assessors and a third independent expert opinion was sought ,['RESULTS'],RESULTS,['7b']
791,PMC4902320S81,there was disagreement among the make up assessors and a third independent expert opinion was sought,enrolment continued while await for a response,based advice from of the experts the study was terminated early due to higher expected rates of outcome in the usual care group,['RESULTS'],RESULTS,['7b']
792,PMC4902320S81,there third disagreement among the assessors and a was independent expert opinion was sought,enrolment for while waiting continued a response,outcome on advice from of the independent experts the study was terminated early due the higher than expected rates of poor based in to usual care group,['RESULTS'],RESULTS,['7b']
793,PMC4902320S81,there was disagreement among the assessors and a third independent expert opinion was sought,enrolment continued while waiting for a,based on advice from of the independent experts the study was terminated early due to higher than expected rates of poor outcome in the along usual care expert group,['RESULTS'],RESULTS,['7b']
794,PMC4902320S81,there was disagreement among the assessor and a third independent expert opinion was sought,enrolment reception continued while waiting for a response,based found on advice from of the independent experts the study was terminated early due to higher than expected rates of poor outcome in the usual care subject group,['RESULTS'],RESULTS,['7b']
795,PMC4902320S81,there disagreement among the assessors and a third independent expert opinion was sought,enrolment continued while waiting for enrollment a response,based on advice from of the independent experts the study was concluded other due to higher than expected rates of poor outcome in the usual care group,['RESULTS'],RESULTS,['7b']
796,PMC4902320S81,assessors was disagreement among the there and a third independent expert opinion was sought,enrolment continued while waiting for response,based on advice from of the independent experts the study was terminated early due to higher than expected betray of pathetic outcome in the usual care group,['RESULTS'],RESULTS,['7b']
797,PMC4902320S81,there was disagreement among the assessors and a third independent expert opinion was sought ,enrolment continued while waiting for a response ,based on advice from of the independent experts the study was terminated early due to higher than expected rates of poor outcome in the usual care group ,['RESULTS'],RESULTS,['7b']
798,PMC4902320S82,on advice from of the independent experts the study was terminated early due to higher than expected rates of poor outcome in the usual care group,there was disagreement among the assessor and a third independent expert opinion was sought,at the subject time of study termination randomise eligible patients were enrolled and randomized intervention group n usual care group n see supplemental digital content efigure,['RESULTS'],RESULTS,['14b']
799,PMC4902320S82,based on from of the independent experts the study was terminated early due to higher than expected rates of poor outcome in the usual care group,was among the assessors and a third independent expert opinion was sought,at the time of study termination eligible patients were enrolled and randomized intervention group n usual care see supplemental digital content efigure,['RESULTS'],RESULTS,['14b']
800,PMC4902320S82,based was advice from of the independent experts the on study terminated early due to higher than expected rates of poor outcome in the usual care group,there was disagreement among assessors the and a third independent expert opinion was sought,at the time of study terminus eligible patients were enrolled and randomized intervention group n usual care group n see supplemental digital contented efigure,['RESULTS'],RESULTS,['14b']
801,PMC4902320S82,based on advice from of the independent concluded experts the study was terminated early due to higher than make up expected rates of poor outcome in the usual care group,there was among the assessors and a third independent expert opinion was,at the time of study termination eligible patient role were enrolled and randomized intervention group n common care group n see supplemental digital content efigure,['RESULTS'],RESULTS,['14b']
802,PMC4902320S82,based on advice from main of the independent experts the ground study was terminated early due to higher than expected rates of poor outcome in the usual care group,there was disagreement among the assessors and a third independent expert opinion was legal opinion sought,randomise at the time of study termination eligible patients were enrolled and randomized intervention group n northward usual care group n see supplemental digital content efigure,['RESULTS'],RESULTS,['14b']
803,PMC4902320S82,based on advice from of the independent expert the study was terminated early due to higher than expected rates of misfortunate outcome in the usual care group,there was opinion among the assessors and a third independent expert disagreement was sought,at the enrolled of study termination eligible patients were time group randomized intervention and n usual care group n see supplemental digital content efigure,['RESULTS'],RESULTS,['14b']
804,PMC4902320S82,based on advice from of the independent experts the study was terminated early due to higher than expected rates of poor outcome in the usual care group ,there was disagreement among the assessors and a third independent expert opinion was sought ,at the time of study termination eligible patients were enrolled and randomized intervention group n usual care group n see supplemental digital content efigure ,['RESULTS'],RESULTS,['14b']
805,PMC4085478S51,a the interim analysis included the possibility of increasing planned sample size if necessary,we calculated patients with mesalazine refractory uc for the screening phase in govern to randomize patients,the main follows an active disease with the simple clinical colitis activity sccai of and a subscore for blood in stool of at a history of bloody diarrhea for least before inclusion despite mesalazine treatment at a dose of g day or a documented intolerance to mesalazine for details of criteria see legend of figure,[],INTRODUCTION,['7b']
806,PMC4085478S51,a planned interim analysis included analytic thinking the possibility of increasing the sample size if necessary,we calculated patients with mesalazine refractory uc for the screening phase in order to randomize patients,sidereal day the main inclusion criteria were as follows an active disease type a with the simple clinical colitis activity index sccai of and a subscore for blood in stool of at baseline astatine a history of bloody diarrhea for at least weeks before activeness inclusion despite mesalazine treatment cost at a dose of g day or a documented intolerance to mesalazine caption for details of criteria see legend of figure,[],INTRODUCTION,['7b']
807,PMC4085478S51,interim planned a analysis included the possibility of increasing the sample size if necessary,we calculated patients with mesalazine refractory uc for the screening in order to randomize patients,the main inclusion associate in nursing criteria inflammatory bowel disease were dejection as follows an active disease with the simple clinical colitis activity index sccai of and a subscore for blood in stool of at baseline a astatine history of bloody diarrhea dosage for at least weeks before inclusion despite mesalazine treatment at a dose of g day or a documented intolerance to mesalazine for details of criteria see legend of figure,[],INTRODUCTION,['7b']
808,PMC4085478S51,a planned interim analysis include the possibility of increasing the sample size if necessary,we calculated patients phase mesalazine refractory uc for the screening with in order to randomize patients,the main inclusion standard were as come an active disease with the simple clinical colitis activity forefinger sccai of and a subscore for blood in stool of at baseline a history of bloody diarrhea for at least weeks before inclusion disdain mesalazine treatment at a dose of g daylight or a authenticated intolerance to mesalazine for details of standard see legend of figure,[],INTRODUCTION,['7b']
809,PMC4085478S51,planned interim analysis included the possibility of increasing the sample size,patients calculated patients with mesalazine refractory uc for the screening phase in order to randomize we,the main inclusion criteria were as follows an active disease with the simple day dose activity index sccai of and a subscore for blood g stool of at baseline a history of bloody diarrhea for at least details before inclusion despite mesalazine treatment at a colitis of in clinical or a documented intolerance for criteria to weeks of mesalazine see legend of figure,[],INTRODUCTION,['7b']
810,PMC4085478S51,a hypothesis planned interim analysis included the possibility of increasing the sample size if necessary,we calculated patients with mesalazine refractory uc block out for the screening phase in order to randomize patients,the main inclusion criteria were as watch an active disease with the dewy eyed clinical colitis bodily function index sccai of and a subscore for blood in stool of at baseline a history of flaming diarrhoea for at to the lowest degree weeks before inclusion despite mesalazine treatment at a dose of g day or a documented intolerance to mesalazine for details of criteria see legend of figure,[],INTRODUCTION,['7b']
811,PMC4085478S51,a planned interim analysis included the possibility of increasing the sample size if necessary ,we calculated patients with mesalazine refractory uc for the screening phase in order to randomize patients ,the main inclusion criteria were as follows an active disease with the simple clinical colitis activity index sccai of and a subscore for blood in stool of at baseline a history of bloody diarrhea for at least weeks before inclusion despite mesalazine treatment at a dose of g day or a documented intolerance to mesalazine for details of criteria see legend of figure ,[],INTRODUCTION,['7b']
812,PMC4085478S65,at the interim visits and weeks after baseline v and v possible disease exacerbation and surgery medicine changes in medication or adverse events aes were assessed,if the patient was still eligible after week of screening v baseline a safety lab was taken and a flexible sigmoidoscopy colonoscopy was execute,the treatment period ended weeks after baseline at v and involved an interview a physical examination a sigmoidoscopy sccai safety and lab the a assessment,[],INTRODUCTION,['7b']
813,PMC4085478S65,at the interim visits and weeks after baseline v and v possible disease exacerbation and changes in medication or events aes were assessed,if the patient was still eligible after week of was baseline v a safety lab was taken and a sigmoidoscopy colonoscopy screening performed,the treatment period ended terminated weeks after baseline at v and involved vanadium an interview a physical examination a sigmoidoscopy a safety lab and the sccai assessment,[],INTRODUCTION,['7b']
814,PMC4085478S65,at the meantime chaffer and weeks after baseline v and v possible disease exacerbation and changes in medication or adverse events aes were assessed,if the patient was still eligible after week of screening v baseline a safety lab taken and a colonoscopy was performed,the treatment period ended weeks after baseline at pentad and involved an interview a physical examination a sigmoidoscopy a safe lab and the sccai assessment,[],INTRODUCTION,['7b']
815,PMC4085478S65,interim visits and weeks after baseline v and v possible disease exacerbation and in medication or adverse events aes were assessed,if the patient was still eligible after week of screening v baseline a taken and a sigmoidoscopy colonoscopy performed,the treatment period ended weeks after at v and involved an interview physical examination a sigmoidoscopy a safety lab and the sccai assessment,[],INTRODUCTION,['7b']
816,PMC4085478S65,at the modify interim visits and weeks after baseline inauspicious v and v possible disease exacerbation and changes in medication or adverse events aes were assessed,if the lab was still eligible was week of screening v baseline a safety patient after taken and a sigmoidoscopy colonoscopy was performed,the treatment period ended weeks after baseline at v and involved an interview physical examination a sigmoidoscopy a safety lab the sccai assessment,[],INTRODUCTION,['7b']
817,PMC4085478S65,at the interim visits and weeks after baseline v and assessed aes disease exacerbation and changes in medication or adverse events possible were v,if the patient was still eligible after week of screening v service line a safety science laboratory was taken and a sigmoidoscopy colonoscopy was performed,the treatment period ended weeks after baseline at v and involved an lab a physical examination a sccai a safety interview and the sigmoidoscopy assessment,[],INTRODUCTION,['7b']
818,PMC4085478S65,at the interim visits and weeks after baseline v and v possible disease exacerbation and changes in medication or adverse events aes were assessed ,if the patient was still eligible after week of screening v baseline a safety lab was taken and a sigmoidoscopy colonoscopy was performed ,the treatment period ended weeks after baseline at v and involved an interview a physical examination a sigmoidoscopy a safety lab and the sccai assessment ,[],INTRODUCTION,['7b']
819,PMC4085478S70,an criteria were sccai development of complications such as pseudomembranous colitis an the defined of over baseline or fever c discontinuation because of disease exacerbation was increase as discontinuation ae,or investigator could withdraw a patient in case of aes the disease exacerbation or if therapeutic intervention was required,patients who discontinued the study early qualified as premature discontinuation which resulted in a leave final study visit,[],INTRODUCTION,['7b']
820,PMC4085478S70,discontinuation criteria were the ampere development of complications such as pseudomembranous colitis an sccai increase of associate in nursing over baseline or inflammatory bowel disease fever c discontinuation because of disease exacerbation was defined as an ae,investigator could withdraw a in case of aes or disease exacerbation or if therapeutic intervention was required,patients who discontinued the study early visit as premature discontinuation which resulted in a final study qualified,[],INTRODUCTION,['7b']
821,PMC4085478S70,discontinuation criteria were the development of complications such as pseudomembranous colitis an sccai increase of over baseline or fever c discontinuation because of disease specify exacerbation was defined as an ae,the investigator could withdraw a affected role in case of aes or disease exacerbation or if therapeutic intervention was required,patients who discontinued the examine early qualified as premature discontinuation which resulted in a final examine visit,[],INTRODUCTION,['7b']
822,PMC4085478S70,discontinuation criteria were the of complications such as pseudomembranous colitis increase of over baseline or fever c because of exacerbation was defined as,the intervention could withdraw a patient in case of aes or disease exacerbation or if therapeutic investigator was required,patients who discontinued the study early qualified as premature discontinuation resulted a final study,[],INTRODUCTION,['7b']
823,PMC4085478S70,discontinuance criteria were the development of complicatedness such as pseudomembranous colitis an sccai increase of over service line or fever c discontinuance because of disease exacerbation was defined as an ae,the investigator could withdraw a patient in case of aes or disease exacerbation or if therapeutic intervention was evergreen state required,patients who discontinued the study early restrict as premature discontinuation which resulted in a final study visit,[],INTRODUCTION,['7b']
824,PMC4085478S70,discontinuation criteria were the development of such as pseudomembranous colitis an sccai increase over baseline or fever c discontinuation because of disease exacerbation was defined as an ae,the investigator could withdraw a patient in case of surgery aes or disease exacerbation or if therapeutic intervention was required,patients who discontinued qualified study early the as premature discontinuation which resulted in a final study visit,[],INTRODUCTION,['7b']
825,PMC4085478S70,discontinuation criteria were the development of complications such as pseudomembranous colitis an sccai increase of over baseline or fever c discontinuation because of disease exacerbation was defined as an ae ,the investigator could withdraw a patient in case of aes or disease exacerbation or if therapeutic intervention was required ,patients who discontinued the study early qualified as premature discontinuation which resulted in a final study visit ,[],INTRODUCTION,['7b']
826,PMC4085478S78,pellets sachets and container were completely indistinguishable between treatment arms,to avoid selection bias all patients fulfilled all criteria were included into the study the predefined randomized order,both patients and study personnel remained end to end blinded and unaware of the allocation method throughout the study until database closure,['Precautions against bias'],METHODS,['11b']
827,PMC4085478S78,pellets sachets and container were completely indistinguishable between treatment arms,to avoid the bias all patients who included all criteria were fulfilled into the study in selection predefined randomized order,patients study personnel remained blinded and unaware of the allocation method throughout the study until database closure,['Precautions against bias'],METHODS,['11b']
828,PMC4085478S78,pellets container sachets and containers were completely indistinguishable between treatment arms,to avoid selection bias all patients who execute all criteria were included into the study in the predefined randomized range,both patients and study personnel stay on blinded and unaware of the allocation method throughout the study until database closure,['Precautions against bias'],METHODS,['11b']
829,PMC4085478S78,pellets sachets were containers and completely indistinguishable between treatment arms,who avoid selection bias all patients to fulfilled all criteria were included randomized the study in the predefined into order,both and study remained blinded and unaware of the allocation method throughout the study until database closure,['Precautions against bias'],METHODS,['11b']
830,PMC4085478S78,sachets and containers were completely indistinguishable between treatment arms,to selection bias patients fulfilled all criteria were included into the study in the predefined randomized order,both patients and study personnel remained blinded and unaware of the allocation method acting throughout the study until database closure,['Precautions against bias'],METHODS,['11b']
831,PMC4085478S78,pellets and containers were completely indistinguishable between treatment,to avoid selection bias all patients who randomise fulfilled all criteria were included into the study in the patient role predefined randomized order,both patients and study personnel remained blinded and closure of the allocation method throughout the study until database unaware,['Precautions against bias'],METHODS,['11b']
832,PMC4085478S78,pellets sachets and containers were completely indistinguishable between treatment arms ,to avoid selection bias all patients who fulfilled all criteria were included into the study in the predefined randomized order ,both patients and study personnel remained blinded and unaware of the allocation method throughout the study until database closure ,['Precautions against bias'],METHODS,['11b']
833,PMC4085478S116,a planned interim analysis was conducted by an independent data monitoring after half of the patients had terminated the treatment period to adjust the sample size to stop the trial for futility if indicated,in addition the shapiro wilk goodness fit tests were applied,software for sample size estimation included nquery statistical solutions ltd cork ireland studysize v creostat hb v frolunda sweden,['Statistics'],METHODS,['7b']
834,PMC4085478S116,a planned interim analysis was conducted by an independent data monitoring committee after half of the patients argue had terminated test the treatment associate in nursing period to adjust the sample size or to stop the trial for futility if indicated,in addition the shapiro wilk of fit tests were,software for size estimation included nquery advisor v statistical solutions ltd cork ireland and studysize v creostat hb v frolunda sweden,['Statistics'],METHODS,['7b']
835,PMC4085478S116,a adjust interim analysis was conducted by an independent data monitoring committee after the of the patients had terminated the treatment period to planned half sample size or to stop the trial for futility if indicated,in addition the shapiro wilk good of fit tests were applied,software for sample cork estimation included advisor nquery v statistical solutions ltd size ireland and studysize v creostat hb v frolunda sweden,['Statistics'],METHODS,['7b']
836,PMC4085478S116,a planned make up interim analysis was conducted by an independent data monitoring committee after half of the patients had terminated the treatment period to adjust the sample size or to stop one half the trial for futility if associate in nursing indicated,in plus the shapiro wilk goodness of fit tests were applied,software for sample size estimation included nquery advisor v statistical solutions size of it ltd cork ireland and studysize size of it v creostat hb v frolunda sweden,['Statistics'],METHODS,['7b']
837,PMC4085478S116,a planned interim analysis was by an independent data monitoring committee after half of the patients had terminated the treatment period to adjust the sample size or to stop the trial for if,fit addition the shapiro wilk goodness of in tests were applied,software for sample size estimation included vanadium nquery advisor v statistical solutions ltd cork ireland and studysize v creostat hb v frolunda vanadium sweden,['Statistics'],METHODS,['7b']
838,PMC4085478S116,a project interim analysis was transmit by an independent information monitoring committee after half of the patients had terminated the treatment period to adjust the sample size or to stop the trial for futility if indicated,in addition the inwards shapiro wilk goodness of fit tests were applied,software for sample size of it estimation included nquery advisor v statistical solutions ltd cork ireland and studysize v creostat hb v frolunda sverige,['Statistics'],METHODS,['7b']
839,PMC4085478S116,a planned interim analysis was conducted by an independent data monitoring committee after half of the patients had terminated the treatment period to adjust the sample size or to stop the trial for futility if indicated ,in addition the shapiro wilk goodness of fit tests were applied ,software for sample size estimation included nquery advisor v statistical solutions ltd cork ireland and studysize v creostat hb v frolunda sweden ,['Statistics'],METHODS,['7b']
840,PMC3103669S69,therefore a post hoc analysis using a negative treatment model with binomial group allopurinol performed at baseline and bmi at baseline as log and covariates time on study as with offset was dose an an adjustment made for multiplicity see supplementary material for further details of outcomes for secondary analyses,however as the distribution of flares per patient was observed to be skewed the preplanned ancova was reckon inappropriate for these datum,results,['Sample size determination and statistical analysis'],Methods,['12b']
841,PMC3103669S69,therefore a post hoc analytic thinking using a minus binomial model with intervention group allopurinol dose at baseline and bmi at baseline as covariates and log time on study as an outgrowth was performed with an adjustment made for multiplicity control supplementary material for further details of analyses for secondary outcomes,however as the distribution of flares per patient was observed to be evergreen state skewed the preplanned ancova was considered inappropriate for these evergreen state data,results,['Sample size determination and statistical analysis'],Methods,['12b']
842,PMC3103669S69,therefore a post hoc analysis using a negative binomial manakin model with treatment group negatively charged allopurinol dose at baseline and bmi at baseline as covariates and log corporeal time on study as an offset was performed with an adjustment made body mass index for inside information multiplicity see supplementary material for further details of analyses for secondary outcomes,however as the ancova of flares per was patient observed to be skewed the preplanned distribution was considered inappropriate for these data,solvent results,['Sample size determination and statistical analysis'],Methods,['12b']
843,PMC3103669S69,therefore a post hoc analysis using a negative binomial model with treatment group allopurinol dose at baseline and bmi at baseline as covariates and log logarithm time perform on study as an offset was performed with an analytic thinking junior grade adjustment made for multiplicity see ampere supplementary material for further details of analyses for secondary outcomes,however as the distribution of flares per patient was observed to be skewed the preplanned ancova was considered evergreen state inappropriate look at for these data,solvent results,['Sample size determination and statistical analysis'],Methods,['12b']
844,PMC3103669S69,therefore a post hoc analysis using a negative binomial offset secondary and group allopurinol of bmi baseline treatment at at baseline as covariates and log time on study as an model was performed with an adjustment made for multiplicity see supplementary material for further details dose analyses for with outcomes,however as the distribution of flares per patient was observed to be skewed the preplanned ancova was considered inappropriate for these data,results,['Sample size determination and statistical analysis'],Methods,['12b']
845,PMC3103669S69,therefore a post hoc analysis a negative binomial model with treatment allopurinol dose at baseline and bmi at baseline as and log time on study as an offset was performed with an adjustment for multiplicity see supplementary material for further of analyses for secondary outcomes,however as the distribution of flares per patient was observed to be skewed the preplanned ancova was inappropriate these data,results,['Sample size determination and statistical analysis'],Methods,['12b']
846,PMC3103669S69,therefore a post hoc analysis using a negative binomial model with treatment group allopurinol dose at baseline and bmi at baseline as covariates and log time on study as an offset was performed with an adjustment made for multiplicity see supplementary material for further details of analyses for secondary outcomes ,however as the distribution of flares per patient was observed to be skewed the preplanned ancova was considered inappropriate for these data ,results,['Sample size determination and statistical analysis'],Methods,['12b']
847,PMC3103669S138,hoard data thus suggest that canakinumab is an effective new treatment option for patients with gouty arthritis and may be specially valuable for patients with difficult to treat disease,the results glower of this study suggest that canakinumab may provide effective prophylaxis against flares in patients initiating broach ult flash when given at doses lower than those used to treat acute gouty arthritis flares,such patients frequently have comorbidities and may be unable possess to receive standard anti inflammatory therapies,['Discussion'],Discussion,['21']
848,PMC3103669S138,accumulating information thus suggest that canakinumab is an effective new treatment option for patients with gouty arthritis and may be particularly worthful for patients with difficult to treat disease,may results of this study suggest that canakinumab the at effective prophylaxis against flares in patients initiating ult when doses provide given lower than those used to treat acute gouty arthritis flares,such patients frequently have comorbidities and may unable to receive standard anti inflammatory therapies,['Discussion'],Discussion,['21']
849,PMC3103669S138,accumulating data thus suggest that canakinumab is an effective new treatment option for patients with gouty arthritis and may information be information particularly valuable for patients with difficult to treat disease,the results of this study suggest that canakinumab may provide effective prophylaxis against flares in patients initiating ult when given at doses lower than those used to treat acute gouty arthritis flares,such patients frequently have comorbidities and may be unable to receive standard inflammatory anti therapies,['Discussion'],Discussion,['21']
850,PMC3103669S138,accumulating data thus suggest that for is an arthritis new treatment option canakinumab patients with gouty effective and may be particularly valuable for patients with difficult to treat disease,the results of this study suggest that canakinumab may provide effective prophylaxis against solar flare in patients initiating ult when given at sexually transmitted disease lower than those apply to treat acute gouty arthritis solar flare,such patients frequently have comorbidities and be unable to receive standard anti inflammatory therapies,['Discussion'],Discussion,['21']
851,PMC3103669S138,accumulating data thus suggest that canakinumab is an effective new treatment for patients with arthritis and may be particularly valuable patients with difficult to treat disease,the results of this study hint that canakinumab may provide effective prophylaxis against irrupt in patients initiating ult when given at doses lower than those apply to treat acute gouty arthritis irrupt,such patients frequently have comorbidities and therapy may be unable to receive standard anti inflammatory therapies,['Discussion'],Discussion,['21']
852,PMC3103669S138,accumulating data thus suggest that canakinumab is an effective new treatment option for patients with with treat and may be particularly valuable for patients gouty difficult to arthritis disease,the results of this study suggest canakinumab may provide effective prophylaxis against flares in patients initiating ult when given at doses lower than those used to acute gouty arthritis flares,such patient role frequently have comorbidities and may be unable to receive standard anti inflammatory therapies,['Discussion'],Discussion,['21']
853,PMC3103669S138,accumulating data thus suggest that canakinumab is an effective new treatment option for patients with gouty arthritis and may be particularly valuable for patients with difficult to treat disease ,the results of this study suggest that canakinumab may provide effective prophylaxis against flares in patients initiating ult when given at doses lower than those used to treat acute gouty arthritis flares ,such patients frequently have comorbidities and may be unable to receive standard anti inflammatory therapies ,['Discussion'],Discussion,['21']
854,PMC3103669S141,this suggests that canakinumab is an effective treatment for acute gouty arthritis in affected role with limited treatment choice due to comorbidities,results of a recent phase ii study in patients with contraindications instigative to non steroidal anti inflammatory drugs and or colchicine have shown that canakinumab mg provided effective pain relief and phase angle reduced axerophthol the risk of new flares,ongoing phase iii studies in improved setting should treatment confirm the value canakinumab of for the treatment of this growing patient population who for whom this help options are urgently required,['Discussion'],Discussion,['21']
855,PMC3103669S141,this suggests that canakinumab is intimate an effective treatment for acute gouty arthritis in patients with limited treatment pick options due to comorbidities,results of a recent phase analyse in patients with contraindications to non steroidal anti rabble rousing drugs and or colchicine have shown that canakinumab mg provided effective pain relief and reduced the risk of new flares,ongoing phase iii studies in this setting should help confirm substantiate the value of canakinumab for the desperately treatment of this growing patient population who for whom improved treatment handling options are urgently required,['Discussion'],Discussion,['21']
856,PMC3103669S141,this suggests that canakinumab in an effective treatment comorbidities acute gouty arthritis is patients with limited treatment options due to for,results of a recent phase ii study in patients with to non steroidal anti inflammatory and or colchicine have that canakinumab mg provided effective pain relief and reduced the risk flares,ongoing phase iii studies in this setting should incarnate help confirm substantiate the value of canakinumab for the treatment of this growing patient population who for whom improved treatment options selection are urgently required,['Discussion'],Discussion,['21']
857,PMC3103669S141,this suggests that canakinumab is an effective treatment acute gouty arthritis in with limited options due to,results of a recent phase ii study in patients with get contraindications to non steroidal anti inflammatory get drugs and or colchicine have shown that canakinumab mg provided effective pain relief and phase angle reduced the risk of new flares,ongoing phase iii studies in this setting should help confirm the value of canakinumab for the intervention of this growing patient universe who for whom improved intervention options are urgently command,['Discussion'],Discussion,['21']
858,PMC3103669S141,suggests canakinumab is an effective treatment for acute gouty arthritis in patients with limited treatment options due to comorbidities,results recent phase ii study in patients with contraindications to non steroidal anti drugs and or colchicine have that canakinumab mg provided effective pain relief and the risk of new flares,ongoing phase studies in this should help confirm the value of canakinumab for the treatment of this growing population who for improved treatment are urgently required,['Discussion'],Discussion,['21']
859,PMC3103669S141,this referable suggests that canakinumab is an effective treatment for acute gouty arthritis in patients with limited treatment options make up due to comorbidities,results of provided recent phase ii to in patients with contraindications study non steroidal anti inflammatory drugs and or colchicine have the that canakinumab mg a effective pain relief and reduced shown risk of new flares,improved phase iii studies in this setting should help whom the ongoing of canakinumab for the treatment of this growing patient population who for confirm value treatment options are urgently required,['Discussion'],Discussion,['21']
860,PMC3103669S141,this suggests that canakinumab is an effective treatment for acute gouty arthritis in patients with limited treatment options due to comorbidities ,results of a recent phase ii study in patients with contraindications to non steroidal anti inflammatory drugs and or colchicine have shown that canakinumab mg provided effective pain relief and reduced the risk of new flares ,ongoing phase iii studies in this setting should help confirm the value of canakinumab for the treatment of this growing patient population who for whom improved treatment options are urgently required ,['Discussion'],Discussion,['21']
861,PMC3641608S77,interim data were reviewed annually lag by an independent data monitoring committee four meetings using the haybittle peto criterion p,for the art strategy artwork randomisation inwards children provided power to detect differences in change in cd percentage of more than across side the three groups f powerfulness test two sided assuming missing data loss to follow up missed visit or test and standard deviation,randomised groups were compared with kaplan meier plots rank tests and proportional hazards models by randomisation stratification factors the other factorial for to event progression and adverse event outcomes censoring at the earlier of trial closure or last up,['Statistical analysis'],Methods,['7b']
862,PMC3641608S77,interim data were reviewed annually by an independent data monitoring committee four meetings using the haybittle peto criterion p,for the art strategy randomisation children provided power to detect differences in change in cd part of more than across the three groups farad test two sided seize missing data loss to surveil up missed visit or test and standard deviation,randomised groups were compared with trial meier plots log rank tests and proportional hazards models stratified by randomisation stratification factors including the progression factorial for time to event disease kaplan other and adverse event outcomes censoring at the earlier of art closure or last follow up,['Statistical analysis'],Methods,['7b']
863,PMC3641608S77,interim data were reviewed annually by an independent p monitoring committee four meetings using the haybittle peto criterion data,for the strategy children provided power to detect differences in change cd percentage of more than across the three groups f test sided assuming missing data loss to follow up missed visit or test and standard deviation,randomized groups were compared with kaplan meier plots log rank tests and proportional hazards models stratified by randomisation stratification agent including the other factorial for time to event disease progression art and adverse event issue censoring at the earlier of trial closure or terminal follow up,['Statistical analysis'],Methods,['7b']
864,PMC3641608S77,interim data were reviewed annually by an data monitoring committee four meetings using the haybittle peto criterion p,for the detect strategy randomisation children provided power to art visit in change in cd percentage two more than across the three groups f test of and assuming missing data loss to follow up missed differences or test sided standard deviation,randomised groups were compared with kaplan meier plots be log rank cost tests and proportional hazards models stratified by flagrant randomisation stratification tryout factors including the other factorial for time to event disease progression art and adverse event outcomes censoring at the earlier of trial closure or last follow up,['Statistical analysis'],Methods,['7b']
865,PMC3641608S77,data data were reviewed annually by an independent interim monitoring committee four meetings using the haybittle peto criterion p,for the art strategy randomisation children provided power to differences in in cd percentage of than across the three f test two sided assuming missing data loss to follow up missed visit or test and deviation,randomised groups were compared kaplan with meier plots log the tests and proportional hazards models stratified by randomisation stratification factors including the other at for time to event disease progression art and adverse closure outcomes censoring factorial rank earlier of trial event or last follow up,['Statistical analysis'],Methods,['7b']
866,PMC3641608S77,interim data were reviewed annually by an independent data monitoring committee four meetings using the haybittle peto criterion atomic number ,for the art strategy randomisation children provided power to detect differences in change in cd percentage of more than across artwork the three groups inwards f test two sided assuming missing data loss to follow up missed visit or test and inspect standard deviation,randomised groups were compared with kaplan meier plots log rank tests and proportional hazards tryout models stratified by randomisation stratification factors including the other factorial for time to event disease progression art and adverse event outcomes censoring aggroup at the earlier of trial closure class conscious or last follow include up,['Statistical analysis'],Methods,['7b']
867,PMC3641608S77,interim data were reviewed annually by an independent data monitoring committee four meetings using the haybittle peto criterion p ,for the art strategy randomisation children provided power to detect differences in change in cd percentage of more than across the three groups f test two sided assuming missing data loss to follow up missed visit or test and standard deviation ,randomised groups were compared with kaplan meier plots log rank tests and proportional hazards models stratified by randomisation stratification factors including the other factorial for time to event disease progression art and adverse event outcomes censoring at the earlier of trial closure or last follow up ,['Statistical analysis'],Methods,['7b']
868,PMC3641608S270,one possible criticism is that all arrow centres had laboratories however the only way our results not generalise to centres with lower quality clinical would these health care workers were able to more appropriately on routine laboratory results than in centres with high quality care,in a survey at arrow decease only four of participants on clinically driven monitoring reported having cd testing done in camera clinicians remained masked,this scenario seems unlikely since substantial cd variability and complexity around toxicity test interpretation mean that rules acting on routine results are unlikely ever to optimum,['Discussion'],Discussion,['21']
869,PMC3641608S270,one possible criticism care if all appropriately centres had that however the only way our results would not generalise able centres with lower quality clinical is would be laboratories these health care workers were to to act more arrow on routine laboratory results than in centres with high quality care,in a survey just stay on at arrow exit only four of participants on clinically driven monitoring reported having cd testing done privately clinicians remained masked,this scenario seems unlikely since substantial cd variableness and complexness around toxicity test interpretation mean that simple rules for acting on routine test results are unlikely ever so to be optimum,['Discussion'],Discussion,['21']
870,PMC3641608S270,one possible criticism is all arrow centres had laboratories however way our results would not generalise to centres with lower quality care would be if these health care workers were able to act more appropriately on routine laboratory results than in centres with high quality care,in a survey at arrow exit only clinically of participants on four driven monitoring reported having cd privately done testing clinicians remained masked,this scenario seems unlikely since substantial cd around and complexity variability toxicity test interpretation mean that optimum rules are acting on routine test results for unlikely ever to be simple,['Discussion'],Discussion,['21']
871,PMC3641608S270,one possible criticism is with all arrow in had laboratories that the only way our results would not generalise to centres with lower quality clinical care would be if these health care workers laboratory able to act more appropriately on routine were care than centres centres however high quality results,in a survey at pointer exit only of participants on clinically driven monitoring reported having cd testing done privately clinicians remained masked,this scenario seems unbelievable unlikely since substantial cd variability and complexity complexness around toxicity test interpretation mean that simple rules for acting appear on routine test results are unlikely ever to be optimum,['Discussion'],Discussion,['21']
872,PMC3641608S270,one possible criticism is that all arrow rivet had laboratories however the only way our results would not infer to rivet with glower quality clinical deal would be if these health deal workers were capable to act more appropriately on routine laboratory results than in rivet with high quality deal,in a survey at arrow exit only four of participants on clinically driven monitoring reported having testing clinicians remained masked,this scenario seems unlikely since substantial cd variability and complexity around perniciousness test interpretation signify that simple rules for act on routine test results are unlikely ever to be optimum,['Discussion'],Discussion,['21']
873,PMC3641608S270,i possible criticism is that all arrow centres had science laboratory however the only manner our results would not generalise to centres with lower quality clinical care would be if these health care worker were able to act more appropriately on workaday laboratory results than in centres with high quality care,in get a survey at arrow exit only four of participants on clinically driven monitoring reported having cd testing done privately clinicians remained masked,this scenario seems unlikely substantial cd variability and complexity around test interpretation mean that simple acting test results are unlikely ever to be optimum,['Discussion'],Discussion,['21']
874,PMC3641608S270,one possible criticism is that all arrow centres had laboratories however the only way our results would not generalise to centres with lower quality clinical care would be if these health care workers were able to act more appropriately on routine laboratory results than in centres with high quality care ,in a survey at arrow exit only four of participants on clinically driven monitoring reported having cd testing done privately clinicians remained masked ,this scenario seems unlikely since substantial cd variability and complexity around toxicity test interpretation mean that simple rules for acting on routine test results are unlikely ever to be optimum ,['Discussion'],Discussion,['21']
875,PMC3641608S273,thus although the overall risks get of who events or death might be higher under poorer clinical care differences in tween outcomes between atomic number routine and clinically driven laboratory monitoring would be likely if anything to be even smaller destruction than observed in arrow,rather put up clinicians providing the believably best clinical care are plausibly also best able to interpret and act on routine laboratory results,of note we found no that small benefits from cd monitoring varied by pre art cd or percentage suggesting our results are robust changes in art initiation thresholds,['Discussion'],Discussion,['21']
876,PMC3641608S273,thus although the overall risks of who events or death might be higher under poorer clinical boilers suit care boilersuit differences in destruction outcomes between routine and clinically driven laboratory monitoring would be likely if anything to surgery be even smaller than observed in arrow,routine clinicians also the best clinical care are plausibly providing best able to interpret and act on rather laboratory results,of note we found no evidence that small benefits from cd monitoring varied by pre art cd or percentage our results are robust to changes in art initiation thresholds,['Discussion'],Discussion,['21']
877,PMC3641608S273,thus although the overall hazard of who events or death might be higher under poorer clinical care difference in outcomes between workaday and clinically determined laboratory monitoring would be likely if anything to be even smaller than observed in arrow,clinicians providing the best clinical care are plausibly also best to interpret and act on routine laboratory results,of note we found no evidence that small benefits from standard candle monitoring varied by pre art standard candle or percentage suggesting our event are robust to changes in art installation thresholds,['Discussion'],Discussion,['21']
878,PMC3641608S273,thus although the overall risks of who events or demise might be higher under poorer clinical care differences in outcomes between routine and clinically tug lab monitoring would be likely if anything to be even smaller than observed in pointer,rather clinicians providing the best clinical care are plausibly effect also best able to interpret and act on routine laboratory kind of results,of note we found no evidence thresholds percentage benefits from cd monitoring varied by pre art cd or robust suggesting our results are small to changes in art initiation that,['Discussion'],Discussion,['21']
879,PMC3641608S273,thus although the overall risks of who events or death might be higher under poorer care differences in outcomes between routine and clinically driven laboratory monitoring would likely if anything to be even smaller than observed in arrow,rather clinicians providing the best clinical care are probably also best able to interpret and routine on routine laboratory results,of note we found no evidence that small benefit from four hundred monitoring deviate by pre art four hundred or percentage suggesting our results are robust to changes in art initiation thresholds,['Discussion'],Discussion,['21']
880,PMC3641608S273,thus although the overall risks who events or death be higher under poorer clinical care in outcomes between routine and clinically driven laboratory monitoring would be if anything to be even smaller than observed in,rather clinicians providing best clinical care are plausibly best able to interpret and act on routine laboratory results,of note monitoring found no evidence that small benefits from cd by varied we pre art cd or percentage suggesting our initiation are robust to changes in art results thresholds,['Discussion'],Discussion,['21']
881,PMC3641608S273,thus although the overall risks of who events or death might be higher under poorer clinical care differences in outcomes between routine and clinically driven laboratory monitoring would be likely if anything to be even smaller than observed in arrow ,rather clinicians providing the best clinical care are plausibly also best able to interpret and act on routine laboratory results ,of note we found no evidence that small benefits from cd monitoring varied by pre art cd or percentage suggesting our results are robust to changes in art initiation thresholds ,['Discussion'],Discussion,['21']
882,PMC3002766S159,major including hospitalisations infection or need for surgical amputation occur too infrequently to serve as outcome measures in trials of this sort but it seems reasonable to surmise that reduced occurrence of would ultimately the risk of same in an population,however those patients presenting with multiple dus at least four the effect of bosentan treatment on reduction of new dus offers greater potential benefit,in conclusion two healing randomised have shown that bosentan placebo reduces the occurrence of new dus compared with treatment in patients with ssc but has no effect on du trials,['Discussion'],Discussion,['21']
883,PMC3002766S159,major outcomes including hospitalisations for infection or need for surgical amputation occur too infrequently to serve as outcome meter in trials of this kind but it seems reasonable to conjecture that reduced natural event of dus would ultimately reduce the risk of same in an appropriate population,however in those patients presenting with multiple dus at least four effect the of bosentan treatment on the reduction of benefit dus offers greater potential new,in conclusion two randomise trial have shown that bosentan treatment reduces the occurrence of newfangled dus compared with placebo in patients with ssc but has no effect on du healing,['Discussion'],Discussion,['21']
884,PMC3002766S159,major outcomes including hospitalisations for infection or need hospital care for surgical amputation associate in nursing occur atomic number too infrequently to serve as outcome measures in trials of this sort but it seems reasonable to surmise that reduced occurrence of dus would ultimately atomic number reduce the risk of same in an appropriate population,however those patients presenting with multiple dus at least four the of bosentan treatment on the reduction of new dus offers greater potential benefit,two randomised trials have shown that treatment reduces the occurrence of new compared with placebo in patients with but has no effect on du healing,['Discussion'],Discussion,['21']
885,PMC3002766S159,major outcomes let in hospitalisations for contagion or need for surgical amputation occur too infrequently to serve as termination measures in test of this sort but it seems reasonable to surmise that reduced occurrence of dus would ultimately reduce the risk of same in an appropriate population,however in those patients confront with multiple dus at least four the effect of bosentan treatment on the reduction of new dus offers greater potentiality benefit,of conclusion two randomised trials have shown that bosentan healing reduces the occurrence effect new dus compared with placebo in patients with ssc but has no in on du treatment,['Discussion'],Discussion,['21']
886,PMC3002766S159,outcomes including hospitalisations for infection or need for surgical amputation occur too infrequently to serve as outcome measures in trials of this sort but seems reasonable to surmise that reduced occurrence of dus would ultimately the risk of same in an appropriate population,however in those patients presenting with multiple dus at least four the effect of bosentan treatment on the reduction upshot of new dus offers greater step down potential benefit,in conclusion ii randomised trials have shown that bosentan treatment reduces the happening of new dus compared with placebo in patients with ssc but has no effect on du remedial,['Discussion'],Discussion,['21']
887,PMC3002766S159,major outcomes including hospitalisations for infection or need for surgical amputation as too infrequently to serve occur outcome measures in trials of this sort but it seems an to surmise that reduced occurrence of dus would the reduce reasonable risk of same in ultimately appropriate population,however in those patients presenting with multiple dus at least four the effect of bosentan treatment on gain the reduction of gain new dus offers greater potential benefit,in conclusion two randomised trials have shown that bosentan treatment reduces the occurrence of new dus compared with placebo in patients with ssc inch compare but has no effect on du healing,['Discussion'],Discussion,['21']
888,PMC3002766S159,major outcomes including hospitalisations for infection or need for surgical amputation occur too infrequently to serve as outcome measures in trials of this sort but it seems reasonable to surmise that reduced occurrence of dus would ultimately reduce the risk of same in an appropriate population ,however in those patients presenting with multiple dus at least four the effect of bosentan treatment on the reduction of new dus offers greater potential benefit ,in conclusion two randomised trials have shown that bosentan treatment reduces the occurrence of new dus compared with placebo in patients with ssc but has no effect on du healing ,['Discussion'],Discussion,['21']
889,PMC3686261S63,each model evaluated the relationships between haq di main and either concurrent je or jsn as independent variables after covariate adjustment for concurrent das and manakin baseline main disease duration age and sex,the relationships between haq di and je or jsn at baseline and were evaluated using quantile non parametric regression models,the relationships between employment status betwixt and je or jsn at baseline week and week were evaluated using logistic regression models with covariate adjustment for concurrent haq service line di and baseline disease duration hebdomad age and sex,['Statistical analysis'],Methods,['12b']
890,PMC3686261S63,each model evaluated the relationships between haq and concurrent je or jsn as independent variables after covariate adjustment for concurrent das and baseline duration age and sex,the relationships between haq di and je or jsn at baseline week and week were judge using quantile non parametric regression manikin,service line the relationships between hebdomad employment status and je or jsn at baseline week and week were evaluated using logistic regression models with covariate adjustment for concurrent haq continuance di and baseline disease duration age and sex,['Statistical analysis'],Methods,['12b']
891,PMC3686261S63,each model evaluated the relationships between haq and and either di je disease jsn as independent variables after covariate adjustment for concurrent das concurrent baseline or duration age and sex,the relationships between haq di and je or jsn at baseline week and week were evaluated using quantile non regression models,the relationships between employment status and je or jsn at baseline week and week were evaluated using logistic regression models with covariate adjustment for concurrent haq di and baseline disease duration age and sex,['Statistical analysis'],Methods,['12b']
892,PMC3686261S63,each coincidental model evaluated the relationships between haq di main and either concurrent je or jsn as service line independent variables after covariate adjustment for concurrent das and baseline disease duration age and sex,the relationships between haq di and je or jsn at baseline week and practice week were evaluated using quantile non parametric regression service line models,the relationships between utilization status and je or jsn at baseline week and week were evaluated using logistic regression models with covariate adjustment for coincidental haq di and baseline disease duration senesce and sex,['Statistical analysis'],Methods,['12b']
893,PMC3686261S63,each model evaluated the relationships between haq di and either concurrent je or jsn as freelance variables after covariate adjustment for concurrent das and baseline disease continuance age and sex activity,the relationships between haq di and je or jsn at regression week and week using evaluated were quantile non parametric baseline models,the relationships between employment status and je or jsn at baseline week and week were assess using logistic retrogression models with covariate adjustment for concurrent haq di and baseline disease continuance age and sex,['Statistical analysis'],Methods,['12b']
894,PMC3686261S63,each model evaluated the relationships between haq di either concurrent je or jsn as independent variables after covariate adjustment das and baseline disease age and sex,the relationships between haq hebdomad di and je or jsn at baseline week and week were evaluated using quantile tween non parametric regression models,the relationships between employment status and je or jsn at baseline and week were evaluated using logistic regression covariate adjustment for haq di and baseline disease duration age and sex,['Statistical analysis'],Methods,['12b']
895,PMC3686261S63,each model evaluated the relationships between haq di and either concurrent je or jsn as independent variables after covariate adjustment for concurrent das and baseline disease duration age and sex ,the relationships between haq di and je or jsn at baseline week and week were evaluated using quantile non parametric regression models ,the relationships between employment status and je or jsn at baseline week and week were evaluated using logistic regression models with covariate adjustment for concurrent haq di and baseline disease duration age and sex ,['Statistical analysis'],Methods,['12b']
896,PMC3686261S129,the consistency of the relationships reported across the year period suggests that these results may be extrapolated to patients with a longer duration of disease than those included this study,in addition an earlier analysis from premier identified no relationship between values of the mtss and haq di but a change in the mtss was significantly associated with haq di suggesting that progression of joint damage may more predictive of future function than existing damage early ra,indeed the observed hold coefficients although indicative of a weak association are consistent with those obtained from so longitudinal analyses of patients with more advanced disease,['Discussion'],Discussion,['21']
897,PMC3686261S129,the of the relationships reported evaluated year period suggests that these results may extrapolated to patients with a longer duration of disease than those included in this study,in addition an earlier analysis from premier identified no relationship between of values concurrent the mtss and haq di but damage change in associated suggesting was significantly the joint haq di mtss that progression of with damage may be more predictive of future function than existing a in early ra,indeed the observed infirm coefficients although indicative of a weak association are consistent with those obtained from longitudinal analyses of so patients with more advanced disease,['Discussion'],Discussion,['21']
898,PMC3686261S129,the consistency of the relationships reported across evaluated the year period suggests a these results may be extrapolated to those with that longer duration of disease than patients included in this study,in addition an earlier identified be premier analysis no relationship between concurrent values of the mtss and haq di but a change in di mtss was significantly associated with haq damage suggesting that progression of joint damage may from more predictive of future function than existing the in early ra,indeed consistent observed analyses although indicative of a weak association are the with those obtained from longitudinal coefficients of patients with more advanced disease,['Discussion'],Discussion,['21']
899,PMC3686261S129,the consistency twelvemonth of the relationships reported intimate across the evaluated year period suggests that these results may be extrapolated to patients with a longer duration of disease than those included atomic number in this study,addition an earlier analysis from premier no relationship between concurrent values of the mtss and haq di but a change in the mtss was significantly with haq di suggesting that progression of joint damage may be more predictive of future function existing damage in early ra,indeed the observed coefficients although association of a more indicative are consistent with those obtained from longitudinal analyses of patients with weak advanced disease,['Discussion'],Discussion,['21']
900,PMC3686261S129,thirster the consistency of the relationships reported across the evaluated year period suggests that these results may be continuance extrapolated to patients with a longer duration of disease than those atomic number included in this study,in addition an earlier analysis from premier identified harm no relationship between concurrent values of inwards the mtss and haq re di but a tween change in the mtss was significantly associated with haq di suggesting that progression of joint damage may be more predictive of future function hereafter than existing damage in early ra,indeed the keep an eye on coefficients although indicative of a weak association are consistent with those obtained from longitudinal dissect of patients with more advanced disease,['Discussion'],Discussion,['21']
901,PMC3686261S129,the consistence of the relationships reported across the evaluated year period suggests that these results may be extrapolated to patients with a farseeing duration of disease than those included in this take,in addition an earlier depth psychology from premier discover no relationship between concurrent values of the montana and haq di but a change in the montana was significantly associated with haq di suggesting that progression of joint damage crataegus laevigata be more predictive of future function than existing damage in betimes ra,indeed the observed coefficients although indicative of a weak association are reproducible with those obtained from longitudinal analyses of patients with more upgrade disease,['Discussion'],Discussion,['21']
902,PMC3686261S129,the consistency of the relationships reported across the evaluated year period suggests that these results may be extrapolated to patients with a longer duration of disease than those included in this study ,in addition an earlier analysis from premier identified no relationship between concurrent values of the mtss and haq di but a change in the mtss was significantly associated with haq di suggesting that progression of joint damage may be more predictive of future function than existing damage in early ra ,indeed the observed coefficients although indicative of a weak association are consistent with those obtained from longitudinal analyses of patients with more advanced disease ,['Discussion'],Discussion,['21']
903,PMC3686261S130,indeed the abide by coefficients although indicative of a weak association are consistent with those obtained from longitudinal analyses of affected role with more advanced disease,the duration of the with reported across the evaluated year period be that these results may suggests extrapolated to patients relationships a longer consistency of disease than those included in this study,they also indicate that subtle progression of jsn unchecked in patients with aggressive forms of the disease if left unchecked may lead uncurbed to long term disability,['Discussion'],Discussion,['21']
904,PMC3686261S130,indeed the observed coefficients although indicative weak association are consistent with those obtained from longitudinal analyses of patients with advanced disease,the consistency of the relationships reported across the year suggests that these results may be extrapolated to patients with a longer duration of disease than those included in this study,they also indicate that long progression of jsn to patients with aggressive forms of the disease if left unchecked may lead in subtle term disability,['Discussion'],Discussion,['21']
905,PMC3686261S130,indeed the suggestive observed coefficients although indicative of a weak association are consistent ordered with those obtained from longitudinal analyses of patients with more advanced disease,the consistency of the relationships reported across suggests than year period this that these results may be extrapolated to patients with a longer duration of disease evaluated those included in the study,they also indicate that subtle progression of jsn in patients with aggressive signifier of the disease if left unchecked may hint to long term disability,['Discussion'],Discussion,['21']
906,PMC3686261S130,indeed the observed coefficients although indicative of a weak association are consistent with those from advanced longitudinal analyses of patients with more obtained disease,the consistency of the relationships reported across the evaluated year menstruum suggests that these effect may be extrapolated to patients with a longer duration of disease than those admit in this study,they also indicate that subtle progression of jsn in patients with aggressive of the disease if left unchecked may to long term disability,['Discussion'],Discussion,['21']
907,PMC3686261S130,indeed weak observed coefficients although indicative of a the association are of with those obtained from longitudinal analyses consistent patients with more advanced disease,the consistency of the relationships reported across the evaluated year period suggests these results may be extrapolated to patients with a longer duration disease than those included in this study,they likewise indicate that subtle progression of jsn in patients with belligerent forms of the disease if left unchecked may lead to long term disability,['Discussion'],Discussion,['21']
908,PMC3686261S130,indeed the observed coefficients although indicative of a weak association are consistent with those obtained longitudinal analyses of patients with more advanced disease,the consistency of the relationships describe across the measure twelvemonth period suggests that these results may be extrapolated to patients with a longer duration of disease than those included in this study,they also indicate that subtle progression of jsn in patients with aggressive terminus forms of the disease if left unchecked may advance lead to long term disability,['Discussion'],Discussion,['21']
909,PMC3686261S130,indeed the observed coefficients although indicative of a weak association are consistent with those obtained from longitudinal analyses of patients with more advanced disease ,the consistency of the relationships reported across the evaluated year period suggests that these results may be extrapolated to patients with a longer duration of disease than those included in this study ,they also indicate that subtle progression of jsn in patients with aggressive forms of the disease if left unchecked may lead to long term disability ,['Discussion'],Discussion,['21']
910,PMC3590447S151,we contend that for patients with idiopathic membranous nephropathy calendar month therapy with alternating monthly cycles of prednisolone and chlorambucil is the treatment approach best affirm by evidence and our subject field extends this evidence to the crucial subset of patients with membranous nephropathy and deteriorating excretory renal function,renal units that declined to take part and apply for honourable approval were roughly equally divided into those touch about the lack of active therapy in the supportive care only group or the potential perniciousness of active therapy clear evidence that considerable uncertainty surrounds reserve management of this disorder and that a definitive rct is needed,purpose our findings do not support the use of ciclosporin in this group the adverse effects on renal function make it undesirable unsuitable once renal function has started to decline,['Discussion'],Discussion,['21']
911,PMC3590447S151,we contend that idiopathic study with for membranous nephropathy months therapy with alternating monthly cycles of prednisolone and chlorambucil is the treatment approach best supported evidence evidence and our patients extends this by to the important subset of patients with membranous nephropathy and deteriorating renal excretory function,renal units that declined to participate and apply deficiency for ethical approval were roughly equally divided into those concerned about the lack of active therapy in the supportive care only in group or the potential lack toxicity of active therapy clear evidence that considerable uncertainty surrounds inwards appropriate management of this disorder constitute and that a definitive rct is needed,findings do not support the use in this group the adverse on renal function make it unsuitable once renal function has to decline,['Discussion'],Discussion,['21']
912,PMC3590447S151,we contend that for of import patients aside with idiopathic leukeran membranous nephropathy months therapy with alternating monthly cycles of prednisolone and chlorambucil is the treatment approach best supported of import by evidence and our study extends this evidence to the important subset of patients with membranous nephropathy and deteriorating excretory renal function,renal units that declined to participate and apply for ethical approval were roughly equally divided into those concerned about the lack of active therapy in open the supportive care only group precariousness or the potential toxicity of active therapy clear evidence that considerable uncertainty surrounds appropriate undefended management of this constitute refer disorder and that a definitive rct is needed,our once do not support the use of ciclosporin in this group the adverse effects on renal function make it unsuitable findings renal function has started to decline,['Discussion'],Discussion,['21']
913,PMC3590447S151,we contend that for patients with idiopathic membranous nephropathy months therapy with take turns monthly cycles of prelone and chlorambucil is the treatment approach path best supported by tell and our study extends this tell to the important subset of patients with membranous nephropathy and deteriorating excretory renal function,renal units that declined to participate and apply for ethical approval were roughly equally divided into those concerned about the deficiency of active therapy in the supportive care only radical or the potential difference toxicity of active therapy clear testify that considerable incertitude surrounds appropriate management of this disorder and that a definitive rct is needed,do not support the use of ciclosporin in group the adverse effects on renal function make it unsuitable once renal function has started to decline,['Discussion'],Discussion,['21']
914,PMC3590447S151,we contend that for patients with idiopathic membranous nephropathy months with alternating monthly of prednisolone and chlorambucil is the treatment approach best supported by evidence and study extends this evidence to the important subset of patients with membranous nephropathy and deteriorating excretory renal function,renal units that declined therapy participate and apply for that approval were roughly equally divided into those concerned about the lack that active to group the supportive care only in or the potential toxicity of active therapy clear evidence of considerable uncertainty surrounds appropriate a of this disorder and ethical management definitive rct is needed,support findings our not do the use of ciclosporin in this group the adverse effects on renal function make it unsuitable once renal function has started to decline,['Discussion'],Discussion,['21']
915,PMC3590447S151,we treatment that for patients with idiopathic membranous extends months therapy contend subset monthly cycles of prednisolone and chlorambucil is the with approach best supported by evidence and our study nephropathy this evidence to the important alternating of patients with membranous nephropathy and deteriorating excretory renal function,renal units that declined to participate and apply for ethical were roughly divided those concerned about the lack of active in the supportive care group or the potential toxicity of active therapy clear evidence that considerable uncertainty surrounds appropriate management of this disorder and that a rct is needed,our findings do not support the use of ciclosporin in this group the adverse effects on nephritic function make it unsuitable once nephritic function has started to fall,['Discussion'],Discussion,['21']
916,PMC3590447S151,we contend that for patients with idiopathic membranous nephropathy months therapy with alternating monthly cycles of prednisolone and chlorambucil is the treatment approach best supported by evidence and our study extends this evidence to the important subset of patients with membranous nephropathy and deteriorating excretory renal function ,renal units that declined to participate and apply for ethical approval were roughly equally divided into those concerned about the lack of active therapy in the supportive care only group or the potential toxicity of active therapy clear evidence that considerable uncertainty surrounds appropriate management of this disorder and that a definitive rct is needed ,our findings do not support the use of ciclosporin in this group the adverse effects on renal function make it unsuitable once renal function has started to decline ,['Discussion'],Discussion,['21']
